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Candida albicans is an important cause of systemic infections in the immune 
compromised population. However, drug resistance and toxicity have put limits on 
antifungals efficacy. The C. albicans cell wall is considered a good therapeutic 
target due to its role in fungal pathogenicity. Thus, a potential method for improving 
antifungal drugs could be to enhance the detection of fungal cell wall antigens by 
host immune cells. Detection of C. albicans largely occurs through the receptor 
Dectin-1 that can recognize β [beta] (1,3)-glucan, an important component of 
fungal cell walls. However, a layer of glycosylated proteins masks the β (1,3)-
glucan, hiding it from immune detection. In order to better understand possible 
mechanisms of unmasking β (1,3)-glucan, we must develop a deeper 
comprehension of the mechanism behind unmasking. 
The phosphatidylserine (PS) synthase enzyme (Cho1) was reported to 
control β (1,3)-glucan exposure. In this dissertation, I utilized classical genetics 
and biochemical methods to identify the potential protein(s) involved in causing 
this phenotype. Several fungal cell wall associated signaling pathways are overly 
activated when CHO1 is disrupted, including GTPase Cdc42, a central regulator 
of cellular polarity and morphological development, and its regulated protein kinase 
Cek1. When Cek1 is activated independent of CHO1, it leads to β (1,3)-glucan 
exposure. To understand thoroughly how Cek1 and its associated pathway govern 
β (1,3)-glucan exposure, I further screened the upstream signaling protein(s) 
causing Cek1 over-activation. A novel signaling cascade was identified where the 
predicted GTPase activating protein (GAP) Lrg1 represses Cek1 activity by 
downregulating the GTPase Cdc42 and its downstream MAPKKK, Ste11. The 
consequences to virulence for upregulation of Cek1 are that pathogenicity is 
diminished in the mouse model of systemic infection, and this correlates with 
increased cytokine responses from macrophages. Data from RNA-sequencing 
demonstrates that a number of cell wall associated genes are significantly up-
regulated transcriptionally when Cek1 is hyper-activated, which might be 
responsible for the cell wall exposure. Thus, we propose a model that Cek1 
hyperactivation causes β (1,3)-glucan exposure by upregulating cell wall proteins 
 vi 




TABLE OF CONTENTS 
CHAPTER I: Introduction ................................................................ 1 
Construction of the bi-layered C. albicans cell wall ........................................... 2 
Immune-recognition of individual cell wall components ..................................... 9 
β (1,3)-glucan unmasking can be induced by manipulation of cell wall signaling 
pathways ......................................................................................................... 15 
Summary ......................................................................................................... 26 
Reference ........................................................................................................ 27 
CHAPTER II: Unmasking of Candida albicans β (1,3)-glucan Is 
Promoted by Activation of the Cek1 Pathway ............................. 36 
Abstract ........................................................................................................... 38 
Introduction ..................................................................................................... 39 
Methods .......................................................................................................... 42 
Results ............................................................................................................ 49 
Discussion ....................................................................................................... 63 
Conclusions ..................................................................................................... 69 
References ...................................................................................................... 70 
Appendix ......................................................................................................... 76 
CHAPTER III: Hyperactivation of Cek1 Attenuates Virulence in 
Candida albicans ........................................................................... 87 
Abstract ........................................................................................................... 89 
Introduction ..................................................................................................... 90 
Methods .......................................................................................................... 92 
Results ............................................................................................................ 98 
Discussion ..................................................................................................... 112 
 viii 
Reference ...................................................................................................... 116 
Appendix ....................................................................................................... 122 
CHAPTER IV: Genetic Analysis of Genes Expressed during β 
(1,3)-glucan Exposure Induced by Cek1 Hyperactivation ........ 131 
Abstract ......................................................................................................... 133 
Introduction ................................................................................................... 134 
Methods ........................................................................................................ 135 
Results .......................................................................................................... 138 
Discussion ..................................................................................................... 148 
Reference ...................................................................................................... 152 
Appendix ....................................................................................................... 155 
CHAPTER V: Conclusion and Future Direction ........................ 165 
Conclusion .................................................................................................... 166 
Future direction ............................................................................................. 167 
Reference ...................................................................................................... 174 
VITA .............................................................................................. 176 
 
 ix 
LIST OF TABLES 
Table S.2. 1. C. albicans strains used in this study ............................................. 76 
Table S.2. 2. Plasmids used in this study ........................................................... 77 
Table S.2. 3. Primers used in this study .............................................................. 78 
Table S.3. 1. C. albicans strains used in this study ........................................... 122 
Table S.3. 2. Plasmids used in this study ......................................................... 123 
Table S.3. 3. Primers used in this study ............................................................ 124 
Table 4. 1: Commonly regulated genes induced by STE11ΔN467–doxycycline vs. 
Wild-type± and STE11ΔN46 +doxycycline ........................................................... 147 
Table S.4. 1. C. albicans strains used in this study ........................................... 155 
Table S.4. 2. Genes that were differentially regulated in STE11ΔN467–doxycycline




LIST OF FIGURES  
Figure 1. 1. The structure of C. albicans cell wall.................................................. 4 
Figure 1. 2. A model of N- and O-glycosylation of C. albicans cell wall proteins 
biosynthsis. ........................................................................................................... 8 
Figure 1. 3. C. albicans β (1,3)-glucan is an important PAMP for detecting fungi.
 ............................................................................................................................ 12 
Figure 1. 4. The MAPKs pathways in C. albicans that are involved in cell wall 
construction. ....................................................................................................... 17 
Figure 2. 1. The Cek1 and Mkc1 MAP kinase signaling cascades in C. albicans 
are involved in cell wall biogenesis. .................................................................... 41 
Figure 2. 2. Cek1 and Mkc1 MAPKs exhibit increased activation in cho1Δ/Δ yeast 
cells compared to wild-type. ................................................................................ 51 
Figure 2. 3. Hyperactive Ste11 (STE11ΔN467) causes significant increases in β 
(1,3)-glucan exposure and TNF-α secretion. ...................................................... 54 
Figure 2. 4. Cdc42 activity is upregulated in cho1Δ/Δ compared to wild-type. .... 57 
Figure 2. 5. Cho1 is essential for GFP-Cdc42 polarization at the plasma 
membrane. .......................................................................................................... 60 
Figure 2. 6 Deletion of MKC1 in cho1Δ/Δ does not diminish β (1,3)-glucan 
exposure. ............................................................................................................ 62 
Figure 2. 7. Active GTP-Rho1 is de-localized in cho1Δ/Δ. .................................. 64 
Figure 2. 8. Hyper-activated Rho1 causes β (1,3)-glucan exposure. .................. 65 
Figure S.2. 1. STE11ΔN467 exhibited significantly increased β (1,3)-glucan exposure 
compared to wild-type cells. ................................................................................ 81 
Figure S.2. 2. Growth curves were measured to determine the growth rate of 
strains in YPD vs YPM. ....................................................................................... 82 
Figure S.2. 3. The exposed β (1,3)-glucan in STE11ΔN467 YPM cells was not 
restricted to bud scars. ........................................................................................ 83 
Figure S.2. 4. CDC42G12V increases β (1,3)-glucan exposure, but also reduces the 
viable cell population. .......................................................................................... 84 
Figure S.2. 5. MKC1 was knocked out in C. albicans via CRISPR-Cas9. ........... 85 
 xi 
Figure S.2. 6. Deleting one PKC1 allele in cho1Δ/Δ did not rescue β (1,3)-glucan 
exposure. ............................................................................................................ 86 
Figure 3. 1. Lrg1 represses β (1,3)-glucan unmasking in C. albicans. ................ 99 
Figure 3. 2 .The Cek1p MAPK is hyper-phosphorylated in lrg1Δ/Δ cells compared 
to wild-type ........................................................................................................ 101 
Figure 3. 3. Lrg1 inhibits the activity of GTPases Cdc42 and Ras1, but not Rho1.
 .......................................................................................................................... 103 
Figure 3. 4. Disruption of LRG1 causes Cek1 over-activation through Ste11 
MAPKKK ........................................................................................................... 106 
Figure 3. 5. LRG1 disruption significantly induces TNF-α secretion. ................ 109 
Figure 3. 6. Activated Cek1 leads to attenuated fungal virulence in the mouse 
model of systemic infection. .............................................................................. 110 
Figure 3. 7. Ste11 hyper-activation causes decreased kidney fungal burden in the 
mouse model of systemic infection. .................................................................. 111 
Figure 3. 8. A model shows that Lrg1 acts as a molecular switch regulating Cek1 
activity negatively via the GTPase Cdc42. ........................................................ 114 
Figure S.3. 1. Loss of Lrg1 decreases GTPase Rac1 activity. .......................... 126 
Figure S.3. 2. The hyperactive Ras1G13V does not display Cek1 phosphorylation.
 .......................................................................................................................... 127 
Figure S.3. 3. Cek1 MAPK is hyper-phosphorylated when the PtetOFF-STE11ΔN467 
construct is induced. ......................................................................................... 128 
Figure S.3. 4. An overnight culture of PtetOFF-STE11ΔN467 exhibits increased β (1,3)-
glucan exposure when induced. ....................................................................... 129 
Figure S.3. 5. The growth rate of different Candida strains was measured to 
determine if hyperactivation of Cek1 MAPK affects cellular growth. ................. 130 
Figure 4. 1. The PtetOFF -STE11ΔN467 strain exhibits β (1,3)-glucan exposure in a 
time-dependent manner in the absence of doxycycline. ................................... 140 
Figure 4. 2. PCA plot displays the clustering of samples within each group. .... 141 
Figure 4. 3. Housekeeping genes expression was similar among different Candida 
strains. .............................................................................................................. 144 
 xii 
Figure 4. 4. Differentially expressed genes in STE11ΔN467-inducing condition are 
enriched for cell wall repair genes..................................................................... 145 










CHAPTER I: Introduction 
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Candida species are the most common human fungal pathogens and are also 
ranked as the fourth-greatest cause of hospital-acquired bloodstream infections, 
with up to 40% mortality in epidemiological studies [1, 2]. Candida species colonize 
the human gastrointestinal tract and skin asymptomatically in immuno-competent 
individuals. Under certain condition, however, Candida species can cause 
mucosal and systemic infections. Risk factors include central venous catheter 
implants, major surgeries such as organ transplants, neutropenia, cancer therapy, 
and HIV infection. Current anti-fungal drugs include three major classes –azoles, 
polyenes, and echinocandins, and each of them has its specific drug target [3, 4]. 
However, drug toxicity and drug resistance have limited the efficacy of current anti-
fungal medicine. 
The majority of life-threatening fungal infections are opportunistic in nature, 
and a novel approach that may be necessary to complement current antifungals 
will be to simultaneously improve host immune efficacy. This can include cytokine 
therapy and other adjunctive therapy approaches [5]. A related strategy to improve 
adjunctive therapy will be to make the fungi more recognizable to the host immune 
effector cells. A better understanding of the interaction of Candida species with 
their cognate host receptors, particularly of how different cell wall components are 
recognized by their receptors on immune cells, will provide new insights that will 
facilitate such an approach. It will also improve our understanding of the process 
of fungal pathogenesis.  
The immune recognition of fungal pathogens is the first step in determining 
the host response to fungal infection, which also plays an important role in shaping 
fungal colonization and the subsequent induction of disease. Cell wall composition 
and architecture are critical in modulating host immune responses. This review will 
summarize various conditions leading to the modification of cell wall structure, and 
their immune-modulatory significance.  
 
Construction of the bi-layered C. albicans cell wall  
The C. albicans cell wall is a firm, but dynamic structure which is essential for 
fungal viability since it serves as a tough, but malleable barrier that sustains cell 
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shape and prevents osmotic lysis. It is also important for fungal virulence because 
it is the interface between the fungus and the host, and the architecture of its 
antigenic polysaccharides, lipids, and proteins presents virulence factors and 
dampens host responses. As a result, some cell wall impaired mutants (e.g. 
cho1Δ/Δ, sun41Δ/Δ, kre5Δ/Δ, phr1Δ/Δ) exhibit avirulence in the mouse systemic 
infection model [6-9]. When exposed to the immune system, cell wall components 
modulate host immune recognition in a variety of ways [10]. For instance, Dectin-
1, a C-type signaling lectin, located at the surface of myeloid-derivative immune 
cells, specifically recognizes the immunogenic polysaccharide β (1,3)-glucan and 
initiates pro-inflammatory antifungal responses including TNF-α secretion [11]. 
Chitin, a type of polysaccharide composed of N-acetylglucosamine subunit, is 
shown to have immune-inhibitory effects in a concentration- and size- dependent 
manner [10]. However, the cell wall is a multi-layered structure that minimizes the 
exposure of some of these components to the immune system. The C. albicans 
cell wall is composed of an outer layer of N- and O-linked glycosylated proteins 
with 80%-90% mannose content [12], as well as an inner layer of the core 
polysaccharides β (1,3)-glucan, β (1,6)-glucan and chitin. Each layer serves 
different roles in fungal physiology and virulence and have different components 




β-glucans are the main cell wall components in C. albicans and account for about 
60% by weight of the cell wall [8]. β (1,3)-glucan is present in the cell walls of 
plants, bacteria and fungi. It is a crucial cell wall structural polysaccharide residing 
in the inner layer of the cell wall and represents about 40% of cell wall weight [13]. 
This polysaccharide is synthesized by a plasma membrane-bound glucan 
synthase complex and uses UDP-glucose as a substrate to create a linear polymer 
of glucose covalently linked at 1-, 3- position through glycosidic bonds. The 
resultant β (1,3)-glucan is extruded into the periplasmic space where it is released 




Figure 1. 1. The structure of C. albicans cell wall.  
C. albicans has layered cell wall structure, where the inner layer is comprised of chitin and β-glucan, 
and the outer layer is made of glycosylated proteins. Chitin is synthesized by chitin synthases using 
substrate UDP-GlcNAc, and β (1,3)-glucan is synthesized by its synthase and substrate UDP-
Glucose. Glycosylated proteins (glyco-proteins) are modified by N- and O-mannans with 80%-90% 
mannose content  
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trans-glycosidase enzymes in the periplasmic space and/or cell wall [14] (Figure 
1.1). The C. albicans glucan synthase complex include two subunits: a catalytic 
subunit Fks1 and a regulatory subunit Rho1 [15]. Rho1 and Fks1 are essential in 
C. albicans [16], and this enzyme complex is the target of the echinocandin anti-
fungal drug class, which acts by inhibiting β (1,3)-glucan synthesis. Fks1 encodes 
a 210-kDa transmembrane protein, and is important for echinocandin resistance, 
as the mechanism involves point mutations clustered in two hotspot regions within 
this protein, encoding residues 641-649 and 1345 to 1365, respectively [4, 17]. 
The C. albicans genome harbors two other FKS homologs FKS2 and FKS3, which 
also play roles in echinocandin resistance. Cells lacking FKS2 or FKS3 contain 
increased amount of glucan and are more resistant to cell wall-damaging agents, 
suggesting that Fks1 expression is negatively regulated by the other two homologs 
[18].  
The small GTPase Rho1 was first identified as a regulatory subunit of the 
β-glucan synthase complex in S. cerevisiae [19]. In this organism, temperature-
sensitive mutants in ScRHO1 display thermolabile glucan synthase activities, 
which could be restored by adding purified wild-type ScRho1 protein along with 
GTP [19]. ScRho1 can be co-purified with the catalytic subunit Fks1, and is co-
localized to cell wall remodeling sites, i.e., to the bud tip during growth and to 
septum during cytokinesis [19]. CaRho1 was later identified to act in the same 
manner as ScRho1, being the regulatory subunit of glucan synthase [20]. This is 
also reflected in the sequence similarity between these two species, where 
CaRho1 shares 82.9% identity to ScRho1 in the amino acid level, and CaRHO1 
can rescue the glucan synthase activity in a Scrho1-deficient mutant. 
 β (1,6)-glucan is another critical cell wall component and plays an important 
role in stabilizing fungal cell wall integrity since it acts as linker for the attachment 
of chitin and mannan proteins to β (1,3)-glucan [8]. It accounts for ~20% of the cell 
wall weight in yeast form cells and increases to about 27% in hyphae; almost 
double the amount in S. cerevisiae [8]. The biosynthesis of β (1,6)-glucan is not 
fully understood at the biochemical level, while genetic work reveals that several 
genes appear to be involved in this process, including the KRE family and BIG1. 
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Kre5 and Kre9 are the well-studied members in this family, and they play roles in 
morphogenesis and fungal virulence. Unlike ScKRE5, deletion of both alleles of 
CaKRE5 does not affect viability, but the Cakre5Δ/Δ mutation does cause aberrant 
morphology including cell aggregation and enlarged vacuoles. Moreover, the 
individual null mutants of kre5Δ/Δ, kre9Δ/Δ, or big1Δ/Δ display a great reduction 
of β (1,6)-glucan, suggesting they are all required for the polymer’s biosynthesis 
[8, 21, 22]. It is also reported that the remaining β (1,6)-glucan polymer displays 
characteristic structural features when KRE5 is disrupted [8]. This suggests that 
Kre5 might play an indirect role in polysaccharide synthesis.  
 
Chitin  
Chitin is an essential polysaccharide in most fungal cell walls [23], and this polymer 
normally resides at the innermost layer, with a content of less than 10% of cell wall 
weight [23]. Chitin is a homopolymer of β (1,4)-linked N-acetylglucosamine 
(GlcNAc) [24]. A family of four chitin synthases encoded by CHS1, CHS2, CHS3 
and CHS8 are responsible for chitin biosynthesis with uridine diphosphate (UDP)-
GlcNAc as its substrate (Figure 1. 1). Chs1 is an essential chitin synthase that is 
required for septa formation, cell wall integrity and virulence [25]. Loss of CHS1 
prevents the daughter cells from separating from the parents, and therefore forms 
a chain of daughter cells with continuous constrictions but no septa [25]. Chs2 
preferentially expresses in hyphal cells, and disruption of CHS2 decreases chitin 
by about 40% in hyphal cells compared to the parental strain. The CHS2 null 
mutant is also prototrophic and does not exhibit attenuated virulence [26]. Chs3 is 
not required for growth, germ-tube formation, septation, but is essential for overall 
chitin synthesis, bud scar formation, virulence and stress responses [27-29]. Chs8 
is a non-essential chitin synthase in C. albicans, reflected by normal cell growth, 
morphologies and chitin content in the homozygous knockout mutant [30]. 
However, individual disruption of CHS2 and CHS8 increases the calcofluor white 
sensitivity and correlates with increased glucan content and decreased mannan 
content [30]. Two chitin microfibril architectures have been reported: long- and 
short- chitin fibrils, and they are primarily located at the septa and lateral cell walls, 
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respectively [31]. Each chitin synthase plays an individual role in synthesizing 
differing microfibril structures at specific locations in the cell wall [24]. Chitin can 
also be remodeled through the actions of four chitinases (Cht1-4), which cleave 
the glycosidic bonds in chitin, therefore the resultant short fibril can be better 
embedded in the cell wall. 
 
Outer layer  
The outer layer of the cell wall consists of highly glycosylated mannoproteins that 
are modified by O-linked and N-linked mannosylation and phosphomannosylation 
[23] (Figure 1. 2). The glycoproteins serve a variety of functions, including 
adhesion, morphogenesis and biofilm formation. The protein O-
mannosytransferase (Pmt) family of enzymes catalyze the first step of O-
mannosylation on secretory proteins at specific serine or threonine residues during 
transit through the endoplasmic reticulum (ER), and further mannose residues can 
be added by Mnt1/2 family proteins in the Golgi [32]. Five Pmt isoforms (Pmt1-5) 
have been identified in C. albicans, where Pmt1, Pmt2 and Pmt4 are the major 
enzymes of O-mannosyl transferase, and each of them has different expression 
profiles to counteract cell wall stress. For instance, when cells are treated with the 
N-glycosylation inhibitor tunicamycin, Pmt1 expression is de-repressed, whereas 
the other two are inhibited compared to non-stressed conditions, suggesting that 
PMT isoforms play distinct roles in Candida cells for better adaptation to cell wall 
insults [33].  
The N-glycosylation processes occur as proteins cross through the ER [34]. 
The N-mannan precursor is attached to asparagines at the sequence N-X-S/T, 
where X is any amino acid, and the sugar core is further processed in the ER by 
glycosidases, resulting in a mature yet shorter N-mannan core. As proteins pass 
through the Golgi, a single mannose is attached to the core by the α (1,6)-
mannosyl transferase Och1, and further elaborated with α (1,6)-mannose by what 
is believed to be two complexes consisting of M-Pol I (Mnn9 and Van1), and then 
M Pol II (Mnn9, Mnn10, Mnn11, Anp1, and Hoc1), respectively, to form the linear 
α (1,6)-mannan backbone [35]. The branched chains are built on this backbone  
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Figure 1. 2. A model of N- and O-glycosylation of C. albicans cell wall proteins.  
N-glycosylation initiates at the ER, where the N-mannan is attached to asparagines at the sequence N-X-S/T. When the protein passes 
through the Golgi, a single mannose is attached to the core by Och1, and further elaborated with α (1,6)-mannose by M-Pol I and then M 
Pol II complex to form the linear α (1,6)-mannan backbone. The branched chains consist of α (1,2)- residues that are added by α (1,2)-
mannosyl transferases Mnt4 and Mnt5, Mnn2 family, and Mnn5. β (1,2)-mannan and α (1,3)-mannose are found to cap the branched chain 
by Bmt family and transferase Mnn1, respectively. The Pmt family enzymes catalyze the first step of O-mannosylation at specific serine or 
threonine residues and mannose residues are further added by Mnt1/2 family proteins in the Golgi. Phosphomannan is attached to the outer 
chain via a phosphodiester bond through transferase Mnn4 and family members, and capped with β (1,2)-mannan by Bmt family.
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and consist of α (1,2)-residues that are added by α (1,2)-mannosyl transferases 
Mnt4 and Mnt5, Mnn2 family, and Mnn5. In C. albicans, β (1,2)-mannan is found 
to cap the outer chain and is added by β-mannosyl transferases (Bmt1 and Bmt3) 
and alternatively, α (1,3)-mannose is added by transferases like Mnn1 [35, 36]. 
Phosphomannan can also be attached to the outer chain via a phosphodiester 
bond through transferase Mnn4 and family members, and capped with β (1,2)-
mannan by Bmt2, Bmt3 and Bmt4 [32].  
Most of these proteins are glycosylphosphatidylinositol (GPI) anchored, and 
GPI-anchored proteins are found ubiquitously across fungi species, and their 
functions range from enzymatic to antigenic and adhesion [23]. They are linked at 
the C-terminus through a phosphodiester bond to phosphoethanolamine which is 
attached to a tri-mannosyl-glucosamine core (Man3-GlcN) that is bound to 
phosphatidylinostol (PI) in the membrane. Release of the GPI remnant is 
accomplished by hydrolysis of the mannose-GlcN bond, and this carbohydrate 
remnant is covalently linked to β (1,6)-glucan in the cell wall [23, 37-39]. 
 
Immune-recognition of individual cell wall components 
The first step in initiation of an immune response to Candida species is the 
recognition of fungal pathogens through pattern-recognition receptors (PRRs). 
This process involves the detection of conserved pathogen-associated molecular 
patterns (PAMPs) by the cognate PRRs, including C-type lectin receptors (CLRs), 
Toll-like receptors (TLR), and Galectin-3. The distinct structures of various 
polysaccharides within the Candida cell wall represent conserved PAMPs and are 
further recognized by the corresponding PRRs during the development of anti-
fungal immune responses.  
 
β (1,3)-glucan is an important PAMP for detecting fungi 
The myeloid-expressed receptor Dectin-1 plays a major role in anti-fungal innate 
immune responses [40]. It belongs to the C-type signaling lectin family, and 
specifically recognizes β (1,3)-glucan-containing particles by its single extracellular 
carbohydrate-recognition-domain (CRD). Upon recognition of β (1,3)-glucan by 
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CRD, Dectin-1 responds through its tyrosine-based activation motif in the 
cytoplasmic tail [41, 42], which in turn triggers pro-inflammatory responses 
including phagocytosis of the fungal pathogen and induces cytokine secretion for 
fungal clearance [43]. Leukocytes derived from Dectin-1-deficient mice are unable 
to recognize fungal particles unless opsonized with serum and display impaired 
immune responses toward fungal pathogens, including reduced recruitment of 
immune cells and decreased production of pro-inflammatory cytokines. The 
Dectin-1-deficient mice are therefore susceptible to fungal infection and exhibit 
significantly enhanced systemic fungal dissemination and reduced survival rates 
when infected with some strains of C. albicans [43]. Leukocytes isolated from wild-
type mice are more capable of killing Candida cells with exposed β (1,3)-glucan by 
producing increased levels of pro-inflammatory cytokines compared to that of 
Dectin-1-deficient mice [44]. In contrast, specific strains of C. albicans did not show 
differences in virulence when infecting Dectin-1-/- mice [45], and there was a 
correlation between increased chitin levels and decreased dependence on Dectin-
1. This suggests that chitin levels can influence the relationship between exposed 
β (1,3)-glucan and Dectin-1 in the immune response to C. albicans. However, even 
in strains that are more resistant to Dectin-1 in their wild-type state, if they are 
treated with caspofungin, which exposes β (1,3)-glucan and increases chitin, 
Dectin-1 is required for clearance by the drug [45]. This suggests that β (1,3)-
glucan exposure to Dectin-1 plays an important role in clearance in response to 
caspofungin.   
While Dectin-1 acts as the major receptor for β (1,3)-glucan recognition, 
several other receptors mediate host immune responses to β (1,3)-glucan-
containing particles. TLR2 receptors synergize with Dectin-1 signaling in 
responses to zymosan, a β (1,3)-glucan preparation from yeast cell wall, by 
increasing pro-inflammatory cytokines production in vitro, in spite of the fact that 
TLR2 alone does not directly recognize zymosan nor activate immune responses 
sufficiently when stimulated by zymosan [42]. In neutrophils, phagocytosis of 
zymosan-containing particles is promoted by Dectin-1 in the absence of serum, 
but in the presence of serum it is independent [46]. Complement receptor 3 (CR3) 
 11 
is also a receptor of β (1,3)-glucan on neutrophils. Neutrophils exhibit reduced 
phagocytosis of zymosan when derived from the patients deficient in CR3, and 
these patients have higher susceptibility to fungal infections [47].   
 
Fungi can mask β (1,3)-glucan from immune surveillance  
Although fungal cells can induce host inflammatory responses by way of β (1,3)-
glucan detection, it is not surprising that fungal pathogens have evolved 
mechanisms for immune avoidance by concealing β (1,3)-glucan in various ways 
[23]. In Histoplasma capsulatum, α-glucan and the glycosyl-hydrolyase Eng1 are 
important for minimizing β-glucan exposure [48]. Alpha-glucan functions by 
concealing β-glucan, while Eng1 hydrolyzes β-(1,3)-glycosyl bonds, and therefore 
removes exposed β-glucans [49]. Aspergillus fumigatus Uge3 regulates the 
biosynthesis of galactosaminogalactan, which masks hyphal β-glucan from 
immune detection [50]. In C. albicans, β (1,3)-glucan is buried underneath the outer 
layer of glycosylated proteins in a process referred to as masking [23]. During 
infection, unmasking can occur in response to the host environment (Figure 1. 3). 
Wheeler et al. described a time-course of β (1,3)-glucan exposure during 
disseminated infection of C. albicans in a mouse model [51]. The polymer is 
masked by the outer layer of glycoprotein at the beginning of infection and 
becomes exposed after several days [51]. The percentage of cells with β (1,3)-
glucan exposed increases from about 20% (early infection, 16 hours post-infection) 
to 80% (late infection, 7 days post-infection) [51]. The exact mechanism by which 
unmasking occurs is not fully understood, but it has been observed that when C. 
albicans is exposed to neutrophils in vitro, they can damage cell wall and cause β 
(1,3)-glucan unmasking. Furthermore, caspofungin pretreatment causes 
significantly higher levels of β (1,3)-glucan exposure in C. albicans during systemic 
infection compared to the non-treated fungal cells. This drug also displays a 
filament-bias for unmasking [51]. The mechanism by which filaments are more 
readily unmasked is unknown. However, Lowman et al. reported that C. albicans 
hyphal glucan exhibited a novel glucan structure, where hyphal glucan has a 




Figure 1. 3. C. albicans β (1,3)-glucan is an important PAMP for detecting fungi.  
Under certain circumstances, β (1,3)-glucan is exposed at cell surface, and this exposure can be 
detected by its cognate receptors Dectin-1 on immune cells (macrophages and neutrophils) to 
stimulate pro-inflammatory immune responses. Chitin is recognized by the Mannose Receptor and 
further initiates anti-inflammatory responses.  
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observed that hyphal glucan is more immunogenic than yeast glucan and 
stimulates higher levels of pro-inflammatory cytokine production from human 
peripheral blood mononuclear cells (PBMCs) and macrophages by a Dectin-1 
dependent mechanism [52]. This finding provides evidence that the glucan 
architecture can influence how innate immune cells discriminate between the yeast 
form and hyphal cells of C. albicans.  
 
Impacts of β (1,3)-glucan exposure on virulence  
β (1,3)-glucan is naturally present in the cell wall of bacteria, fungi and plant, 
whereas it differs in biomass, structure, solubility and branching structure 
depending on the source. This polymer can be used as a fiber supplement, 
cosmetic products or medical uses etc. [53]. A large body of work on this 
polysaccharide is driven by the immunomodulatory effect it has in animals [13, 54]. 
Particularly in the medical mycology field, the significance of understanding β (1,3)-
glucan recognition by Dectin-1 during fungal commensalism and pathogenesis has 
been appreciated in gastrointestinal (GI) tract colonization model and a systemic 
infection model [43, 54, 55]. The human GI tract contains a large variety of 
microbes and the most frequently isolated fungi are Candida species. However, 
the factors impacting fungal cells colonization in vivo have not been thoroughly 
defined yet. Sem et al. reports that the cell wall β (1,3)-glucan exposure trait, but 
not total β (1,3)-glucan level nor other cell wall component levels, critically 
determines the ability of Candida species colonizing the GI tract [55]. Several 
mutants including the chs3Δ/Δ mutant defective in chitin biosynthesis, or the 
mnt1Δ/Δmnt2Δ/Δ double mutant defective in O-mannosylation surprisingly 
colonize in mouse GI tract well, although they individually display cell wall 
dysfunction. There is no association between in vivo fitness and the ability to grow 
under a variety of stressful environments, which the microbes normally encounter 
within the host, including organic acid, ox bile, bile salt, low pH, high reactive 
oxygen species (ROS), high NO. Instead, the fungal cell wall architecture plays an 
essential role in shaping the in vivo fitness, and this trend is also seen in different 
Candida species, including C. glabrata, C. tropicalis, and C. dubliniensis. This 
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highlights the significance of the dynamics of β (1,3)-glucan structure in shaping 
Candida cells as GI commensals or pathogens. 
Altogether, considering the crucial immunobiological relevance of β (1,3)-
glucan exposure and the mechanisms used by many pathogens to mask it, a new 
strategy for drug design may be to make fungal pathogens more visible and 
susceptible to the host immune attack by exposing β (1,3)-glucan. Goals should 
be set to identify signaling pathways that cause β (1,3)-glucan unmasking as these 
may serve as targets for novel antifungal drugs to improve adjunctive therapy.   
 
Chitin modulates inflammation based on size and dosage   
Chitin plays an important role in modulating pro- and anti-inflammatory immune 
responses in a concentration- and size-dependent manner. Low concentrations 
(<10 µg/ml) induce anti-inflammatory cytokine production, including IL-10, while 
high chitin concentrations (>100 µg/ml) strongly induce TNF-α secretion via 
Dectin-1 and TLR-2 receptors [56, 57]. Large chitin particles (>70 µm) are 
immunologically-inert, whilst intermediate sized chitins (40-70 µm) induce pro-
inflammatory cytokine production at higher dosages [57]. Small chitin particles 
(<10 µm) modulate immune responses based on concentration [56, 57]. The 
majority of chitin particles derived from C. albicans are small in size (between 1-
10 µm). Fungal chitin particles in this organism are recognized via a mannose 
receptor located on the membrane of immune cells, and chitin further induces anti-
inflammatory responses via intracellular NOD2- and TLR9- signaling [56] (Figure 
1. 3). As mentioned above increased chitin levels seems to correlate with 
decreased Dectin-1 dependence for clearance in mice in C. albicans [45]. 
Conversely, however, increased chitin exposure in response to caspofungin or 
some mutations, increases Dectin-1 dependent immune responses in vitro [45, 51, 
58]. Thus, the role of chitin levels in modulating immunity seems to be context 
dependent and needs further study.     
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Glycosylated protein recognition 
Glycosylation of cell wall proteins is critical in the immune-modulation during fungal 
infection. N-glycan is found to play a dominant role in inducing epithelial immunity 
in vitro [59]. Due to the sophisticated biochemical makeup of mannan layer, several 
PRRs are involved in the immune recognition. For instance, Mannose receptor 
primarily detects N-mannan and TLR-4 targets O-mannan, while Dectin-2 and 
Galectin-3 participate in α-mannan and β-mannan recognition respectively [59, 
60]. However, immune recognition of glycosylated proteins is not relevant for this 
study, but has been extensively studied/reviewed in [34, 36, 60-62] 
 
β (1,3)-glucan unmasking can be induced by manipulation of cell 
wall signaling pathways  
The process of cell wall biogenesis and remodeling is regulated through complex 
signaling pathways including several MAP kinase (MAPK) cascades. The MAPK 
pathways are well-conserved signaling cascades in eukaryotes, which are 
essential for coping with a wide range of stimuli, including osmotic stress, oxidative 
stress, cell wall damage, and changes in glycosylation [11, 63-66]. A conserved 
module of three kinases comprises the MAPK signaling cascade: the MAP kinase 
kinase kinase (MAPKKK), the MAP kinase kinase (MAPKK) and the MAP kinase 
(MAPK). After an upstream signal phosphorylates (activates) the MAPKKK, it in 
turn phosphorylates and activates the MAPKK, followed by MAPK phosphorylation 
and activation. The activated MAPK further phosphorylates downstream 
transcription factors to initiate gene expression for better adaption to the 
environment [66]. Three major cell wall MAPK pathways have been discovered in 
fungal pathogens, and they each play specific roles in sustaining cell wall 
architecture.   
 
Central role of Cek1 activity in controlling β (1,3)-glucan masking 
Among these MAPK pathways, Ste11-Hst7-Cek1, comprising the Cek1 MAPK 
cascade, serves pivotal functions in maintaining sophisticated cell wall structure in 
equilibrium, including masking β (1,3)-glucan from immune detection, thus 
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sustaining cell wall glycostructures [33, 64, 67] (Figure 1. 4). In this pathway, 
activated Cek1 phosphorylates downstream transcription factors including Cph1 
and Ace2 to initiate compensatory transcriptional activities. The activation of Cph1 
further stimulates the upstream Cek1 pathway by a positive feedback mechanism 
that provides transcription of higher levels of the MAP kinase [68]. Cek1 can be 
degraded by the proteasome, and is found to be a short-lived protein, as revealed 
by quick degradation to 25% of the starting levels 30mins after being treated with 
the protein synthesis inhibitor nourseothricin [69]. 
Cek1 activity is regulated tightly by multiple stimuli in C. albicans. Several 
conditions induce Cek1 phosphorylation, including disruption of 
phosphatidylserine synthase Cho1 [70], growth resumption from the overnight 
culture to fresh media [69], being treated with human salivary fungicidal histatin 5 
(Hst5) protein which protects the oral cavity from oropharyngeal candidiasis [71], 
hyperactivation of upstream GTPases Cdc42 and Rho1 [70], anti-fungal drug 
caspofungin treatment [65], cleavage of the extracellular domain of signaling mucin 
Msb2 [72], and activation of filamentous growth [73]. The quorum sensing 
molecule farnesol, in contrast, is found to inhibit Cek1 phosphorylation, mediated 
by the transmembrane adaptor protein Sho1 [69]. Besides sustaining cell wall 
structure, activated Cek1 plays a broad role in establishing fungal infections. Cek1 
is involved in the yeast-to-hyphal morphogenesis, a critical step to initiate 
pathogenicity of C. albicans. Loss of CEK1 impairs morphogenesis on certain 
agar-invasive hyphal growth media, such as Lee’s medium with mannitol as a 
carbon source instead of glucose and SLAD medium (low nitrogen) [73]. Although 
10% serum, a potent inducer for morphogenesis, induces morphologically normal 
hyphae in a cek1Δ/Δ mutant, the growth rate of mycelial colonies of the mutant is 
affected [73]. Cek1 also controls the virulence in the mouse disseminated infection 
model and the mouse mastitis model [73, 74]. Furthermore, Cek1 is involved in 
switching of regular white yeast cells to the mating-competent opaque cells and 




Figure 1. 4. The MAPKs pathways in C. albicans that are involved in cell wall construction.  
The Cek1, Mkc1 and Hog1 MAPK cascades, and their upstream activating proteins are shown. 
The Cek1 pathway is activated by upstream GTPase Cdc42 and PAK kinase Cst20. The Mkc1 
pathway is stimulated by GTPase Rho1 and protein kinase C (Pkc1). Two-component phospho-
relay system Ypd1p and Ssk1 regulates the downstream Hog1 pathway activation.  
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Cek1 disruption causes exposure of cell wall components  
The cek1Δ/Δ mutant displays unmasking of β (1,3)-glucan and hyper-sensitivity to 
agents that disturb the cell wall such as Congo red, and the N-glycosylation 
inhibitor tunicamycin [75, 76]. This mutant also exposes α (1,2)- and β (1,2)-
mannosides, suggesting the glycostructure is defective in CEK1 disruption. 
Exposed β-mannan increases the binding to murine macrophages partially through 
the recognition receptor galectin-3, although this receptor itself does not account 
for the mutant’s impaired virulence in the mouse systemic infection model [67]. 
This suggests that pathogen-specific β-mannan is not immunogenic enough to 
initiate fungal killing. Transcriptome analysis reveals that in the cek1Δ/Δ mutant, 
27 genes are down-regulated, including genes encoding proteins that respond to 
drug/chemical stress and cell wall biogenesis. This confirms the significance of the 
Cek1 pathway in cell wall construction. The transcriptomic profile of the cek1Δ/Δ 
mutant treated with tunicamycin further reveals that a significant number of genes 
involved in cell wall biogenesis are differentially expressed. The cell wall genes 
that were specifically defective in this condition include CHT2, a chitinase which 
causes chitin exposure when repressed [77]; XOG1, an exo-β (1,3)-glucanase that 
participates in glucan metabolism [78]; MSB2, a cell wall damage sensor protein 
which induces β (1,3)-glucan exposure when disrupted [72]; and EFG1, the key 
transcription factor for morphogenesis. This differential expression profile might 
account for the C. albicans hypersensitivity to cell wall insults when CEK1 is 
disrupted, and also highlights the importance of Cek1 for cell wall stress adaption 
transcriptionally.  
Ace2, another transcription factor downstream of Cek1, has been shown to 
play an important role in sustaining cell wall structure in C. albicans. The ace2Δ/Δ 
mutant displays severe β (1,3)-glucan exposure, and transcripts induced by Ace2 
upregulation are thought to be responsible for β (1,3)-glucan masking induced by 
lactate treatment [67, 79, 80]. This may be related to the role Ace2 plays in 
controlling cell wall glycostructure [76]. Damage of N-glycans is sensed by cell wall 
proteins Msb2 and Sho1, and results in the activation of Cek1, which in turns 
activates cell wall repair activities mediated by Ace2 transcriptionally [76]. In 
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addition, Ace2 controls the expressions of O-glycosylation genes in an isoform-
specific manner [33]. Under unstressed condition, Ace2 represses Pmt1 
expression via transcription factor Zcf21, and de-represses it in response to 
tunicamycin [76]. It is possible that the cell wall damage induced by CEK1 deletion 
is potentially due to loss of Ace2 transcriptional activity.   
 
Cek1 activation promotes exposure of cell wall β (1,3)-glucan  
Davis et al. reported that the phosphatidylserine (PS) synthase enzyme (Cho1) 
controls cell wall β (1,3)-glucan exposure [58]. Phospholipids are crucial 
components of cellular membranes in eukaryotes, and PS is essential for C. 
albicans virulence [6]. A cho1Δ/Δ mutant exhibits greater β (1,3)-glucan exposure 
compared to wild-type [58, 81]. This exposure allows increased recognition by 
Dectin-1 and elicits a stronger pro-inflammatory response from macrophages [11, 
58, 81]. Interestingly, in the cho1Δ/Δ mutant, both the Cek1 and Mkc1 MAPKs are 
constitutively activated [70]. Li et al. reported that conditions that induce Cek1, 
such as incubation with N-acetylglucosamine (GlcNAc), cause increased β (1,3)-
glucan exposure in C. albicans [71]. However, this has the caveat that GlcNAc 
induces yeast-to-hyphal transition, and filaments have higher level of glucan 
exposure due to the intrinsic cell wall architecture differences [52]. Chen et al. 
found that hyper-activation of Cek1 via hyperactivation of the upstream Ste11 
MAPKKK causes glucan exposure in yeast-form cells in the form of punctate 
exposed glucan foci along the periphery.  This is similar to the phenotype exhibited 
by the cho1Δ/Δ mutant and may be the reason cho1Δ/Δ exhibits β (1,3)-glucan 
exposure. Unmasking from hyperactive Cek1 stimulates an immune response, as 
up-regulated TNF-α secretion is induced from murine macrophages. The 
mechanism by which Cek1 is hyperactivated in the cho1Δ/Δ mutant is not 
completely clear but appears to be acting downstream of the small GTPase Cdc42, 
which is up-regulated in cho1Δ/Δ [70]. This indicates a model where PS synthase 
normally down-regulates Cdc42. This is most likely mediated by synthesis of PS, 
which has been shown to be an activator of GTPase activating proteins (GAPs) 
that downregulated Cdc42 in S. cerevisiae, such as Rga1 and Rga2 [82]. Thus, 
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the model is that loss of PS synthesis leads to hyperactivation of Cdc42, which in 
turn activates Cek1 and causes β (1,3)-glucan exposure. However, the mechanism 
by which this occurs is not yet known. 
Caspofungin, an echinocandin antifungal, causes β (1,3)-glucan exposure 
even at sublethal concentrations [83], and this correlates with Cek1 activation [65]. 
This suggests that Cek1 activation might contribute to β (1,3)-glucan exposure, at 
least partially, after caspofungin treatment. This also indicates that improper 
activation of Cek1 seems involved in cell wall structure alteration in different 
situations. The resultant β (1,3)-glucan exposure promoted by Cek1 
hyperactivation may be induced by the downstream transcription factor Cph1, an 
important regulator for C. albicans filament development [79], and white-to-opaque 
switching [68]. Cph1 expression depends on Cek1 and further boosts Cek1 
expression in a positive-feedback loop [68]. A Cph1-overexpressing strain under 
yeast condition induces pseudo-hyphal structure, and several hyphal-specific 
genes are induced transcriptionally [84]. The overall mechanism by which these 
proteins might cause unmasking is unknown, but discovery of this could help 
explain unmasking under cell wall altering conditions.   
 
The Mkc1 pathway does not appear to cause β-glucan unmasking 
In C. albicans, the Mkc1 MAPK cascade, consisting of Bck1-Mkk2-Mkc1, is 
activated in response to exogenous cell wall stress, oxidative stimuli, antifungal 
drugs, or low-temperature shocks [85] (Figure 1. 4). Mkc1 is also important for 
fungal virulence, as loss of MKC1 reduces fungal virulence in the mouse systemic 
infection model [86]. Although Mkc1 is central for cell wall construction in C. 
albicans, this pathway does not appear to be required for β-glucan masking in C. 
albicans, as evidenced by a lack of β-glucan unmasking in mkc1Δ/Δ mutants [87]. 
In addition, while loss of PS synthase in C. albicans increases Mkc1 activity, 
disruption of this MAPK in cho1Δ/Δ does not prevent β (1,3)-glucan exposure, but 
in fact exacerbates the phenotype in the cho1Δ/Δ mkc1Δ/Δ double mutant [70]. 
This suggests that Mkc1 is activated to compensate for cell wall disfunction when 
PS synthase is deleted, perhaps in response to hyperactivation of Cek1. Finally, a 
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hyperactive GTP-bound form of Rho1 (RHO1Q67L), located upstream of Mkc1 
pathway, displays increased β (1,3)-glucan exposure compared to wild-type. 
Surprisingly it also exhibits increased phosphorylation of Cek1 along with Mkc1 
[70]. This further suggests that the increased β-glucan exposure from the 
hyperactive RHO1Q67L mutant may be caused by Cek1 upregulation, instead of 
Mkc1.   
 
Hog1 activity contributes to neutrophil-driven β (1,3)-glucan exposure  
The Hog1 pathway, comprised of Ssk2-Pbs2-Hog1, is well-known for its response 
to osmotic stress, oxidative stress and morphogenesis [66, 88, 89] (Figure 1. 4). 
This pathway is also involved in cell wall biosynthesis, as HOG1 disruption 
increases resistance to certain cell wall inhibitors such as Congo red (a dye 
interacting with the fungal cell wall), and Nikkomycin Z (an inhibitor of chitin 
biosynthesis) [89] and enhances susceptibility to cell wall digestion by β (1,3)-
glucanase [88]. Hopke et al. discovered that the C. albicans Hog1 pathway is 
necessary for hyphal cells to respond to damage from neutrophils. Hyphae 
damaged by neutrophils exhibit increased β (1,3)-glucan exposure, but unmasking 
does not occur in the hog1Δ/Δ mutant. [11]. Neutrophil-damage of hyphae results 
in remodeling during which the outer layer of glycosylated proteins is damaged 
within seconds upon neutrophils attack, followed by chitin deposition 30 mins post-
insult, and β-glucan unmasking takes place even later. HOG1 disruption greatly 
impairs the ability of fungal cells to adapt to neutrophil attack [11]. Increased chitin 
synthesis can rescue fungal cells from cell wall stress, and chitin synthase (Chs) 3 
is shown to be essential for most of the localized chitin deposition and glucan 
unmasking during cell wall remodeling triggered by neutrophils insult. Although 
Chs2 and Chs8 are also induced, they are not responsible for β-glucan exposure 
[11]. Of note, the cell wall associated Cek1- and Mkc1- pathways are not required 
for this response. This demonstrates the specificity of individual MAPK pathways 
in coping with distinct cell wall stresses.  
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Caspofungin treatment remodels cell wall architecture  
Wheeler et al. identified that sub-lethal dosages of caspofungin upset the intricate 
cell wall structure and causes β (1,3)-glucan exposure without killing the fungi, and 
this elicits more potent proinflammatory responses including TNF-α secretion from 
the macrophages through Dectin-1 [83]. A genetic network responsible for masking 
β (1,3)-glucan was identified in a screen of the S. cerevisiae non-essential gene 
deletion mutant library. Most of the genes within the network are involved in 
regulating polarized cell wall remodeling, (i.e. polarized actin). The S. cerevisiae 
genetic network for concealing β (1,3)-glucan is partially conserved in C. albicans 
[83]. For instance, CaPHR2, the sole homolog of ScGAS1, a β-glucan 
transglycosylase, plays a role for concealing glucan in both organisms. In contrast, 
ScSLT2, a homolog of CaMKC1, is required for masking in S. cerevisae, but does 
not cause β (1,3)-glucan exposure when deleted in the pathogen.  
Badrane et al. determined that sublethal concentrations of caspofungin 
treatment causes fundamental cell wall re-arrangements, but also leads to rapid 
responses at the plasma membrane in components related to the actin 
cytoskeleton [90]. This includes redistribution of both phosphatidylinositol-(4,5)-
bisphosphate (PI (4,5) P2), a signaling phospholipid, and septins, which serve as 
scaffolds for cytokinesis events [90]. PI (4,5) P2 and septins are re-localized 5 mins 
after exposure to caspofungin, which represents an early event in response to drug 
treatment, and further re-direct chitin and cell wall proteins to deposit at the site of 
co-localization [90]. This response might be important for membrane localized cell 
wall repair proteins like chitin synthases to fix the damage caused by β (1,3)-glucan 
biosynthesis inhibition. In fact, chitin production also increases in response to 
caspofungin treatment [58, 81, 90].  
 
Acidic pH induces cell wall structure remodeling   
Sherrington et al. revealed that C. albicans adaptation to an acidic pH of 2 
promotes cell wall remodeling, exposure of both chitin and β (1,3)-glucan, and 
reduced thickness of the outer mannan layer [77]. The mechanism by which β 
(1,3)-glucan exposure is induced by acidic pH remains to be fully defined. The 
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major signaling cascades such as the Mkc1 and Hog1 pathways are not involved 
in this pH driven glucan unmasking mechanism, suggesting a non-canonical cell 
wall remodeling pathway is involved. In contrast, Chitinase 2 (Cht2) regulates chitin 
exposure in a pH-dependent manner by cleaving the glyosidic bonds in the long-
chain of chitin and allowing correct incorporation of chitin short fibril into the inner 
layer for better masking. In alkaline environments, CHT2 expression is dependent 
on the transcription factors Bcr1 and Rim101, while in the acidic environment, the 
Rim101 signaling pathway is inactivated and Cht2 expression is repressed. 
Decreased Cht2 results in longer chitin fibrils and less efficient remodeling of the 
inner layer, thus enhancing exposure of chitin at the cell surface.  
 
Physiological-relevant L-lactate enhances β (1,3)-glucan masking 
Ballou et al. has reported that changes in carbon sources alters cell wall 
architecture, particularly by using physiologically-relevant levels of L-lactate as a 
carbon source that stimulates β (1,3)-glucan masking [80]. The G-protein coupled 
receptor Gpr1, the key lactate binding receptor in C. albicans, is found to sense 
environmental lactate and plays a role in lactate-driven β (1,3)-glucan masking 
[80]. While Gpr1 is the upstream regulator of cyclic adenosine monophosphate 
(cAMP) pathway responsible for morphogenesis in this organism, neither this 
pathway nor other key morphogenetic signaling modules like Efg1 or Cph1, are 
responsible for the cell wall remodeling in lactate condition [80, 91]. Instead, the 
transcription factor Crz1, which is important for cell wall integrity, antifungal 
resistance, and cation homeostasis, is found to mediate masking induced by 
lactate in a calcineurin-independent manner [80]. This is interesting since in C. 
albicans Crz1 is thought to be regulated by calcineurin when stimulated by 
exogenous Ca2+, suggesting Gpr1 is another regulator of Crz1 activation that acts 
independently of the canonical pathway [92]. A significant number of cell wall 
genes are altered transcriptionally and some of these may facilitate the glucan 
masking process [80]. Strikingly, major changes in mannan distribution or 
disruption of several cell wall crosslinking enzymes do not appear to account for 
lactate-induced β (1,3)-glucan masking. For instance, deletion of MNN22 (α(1,2)-
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mannosyltransferase) or EXG2 (exo-1,3-beta-glucosidase) does not block 
masking caused by lactate [80].  
 
Contribution of mannan layer to β (1,3)-glucan (un)cloaking 
A number of studies have been conducted to determine if structural alterations in 
the mannan layer result in β (1,3)-glucan (un)masking under various condition [77, 
80]. Thus far, no definitive conclusion has been reached. Mnn4 is the regulator of 
mannosyl-phosphorylation of N-linked mannans to cell wall proteins [32] (Figure 1. 
3). It is reasoned that disruption of MNN4 might reduce the mannan complexity 
and therefore results in a porous mannan layer, which makes the glucan layer 
more accessible to the immune detection. However, loss of MNN4 does not cause 
higher levels of β (1,3)-glucan exposure compared to the parental strain. Some 
other characteristics such as cell growth, morphogenesis, and fungal virulence are 
not affected either [61]. This suggests that loss of phosphomannan is not sufficient 
to cause glucan exposure. In contrast, the MNN2 α (1,2)-mannosyltransferase 
family, responsible for the formation of N-glycan outer chains by addition of α (1,2)-
mannose to the α (1,6)-backbone (Figure 1. 3), is required for maintaining β (1,3)-
glucan cloaking. Loss of this family results in 70% reduction in the relative 
proportion of mannan in the cell wall, which then unmasks the β (1,3)-glucan, 
despite no changes in the overall β-glucan levels [34]. Och1, an important α (1,6)-
mannosyltransferase that initiates the outer N-glycan chain branching (Figure 1. 
3), plays a role in masking the underlying β-glucan layer. Loss of OCH1 results in 
significantly increased amounts of β-glucan and reduced mannan contents, and 
also causes β-glucan architectural changes [55, 93]. This further indicates that 
glycosylation is essential for maintaining C. albicans cell wall structure and β (1,3)-
glucan masking.  
Most of the N- and O-linked glycosylation are glycosylphosphatidylinositol 
(GPI) anchored. Due to the requirement of cell wall protein modification by GPI 
remnants, it provides an important strategy to attack the fungal pathogen. A novel 
chemical compound named gepinacin is found to specifically inhibit the activity of 
a critical acyltransferase Gwt1 in yeast, which initiates inositol acylation of GPI 
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anchor biosynthesis within the ER [94]. Incubation of C. albicans wild-type cells 
with a sublethal dose of gepinacin impairs filamentation, increases β (1,3)-glucan 
exposure and strain immunogenicity which induces higher levels of TNF-α 
secretion from murine macrophages [95]. Alternatively, disruption of CaGPI7, a 
protein essential for GPI anchor biosynthesis, blocks the decoration of the second 
mannose in the glycan with phosphoethanolamine, and subsequently unmasks β 
(1,3)-glucan [44]. The gpi7 deletion mutant further promotes the inflammatory 
response through the recruitment of immune cells in a Dectin1-dependent manner 




My dissertation focuses on the identification of signaling proteins that cause cell 
wall β (1,3)-glucan exposure in the fungal pathogen C. albicans, thus enhancing 
host immune responses. We previously found disruption of the synthesis of the 
phospholipid phosphatidylserine in C. albicans (cho1Δ/Δ mutation), then cho1Δ/Δ 
exhibits significantly increased exposure of β (1,3)-glucan to immune detection 
compared to wild-type. However, the mechanisms through which CHO1 disruption 
results in β (1,3)-glucan exposure are not clear. In Chapter II, I used genetic 
approaches to evaluate the effect of cell wall associated signaling pathways on β 
(1,3)-glucan unmasking in C. albicans, and found Cek1 MAPK cascade is involved 
in the modulation of cell wall remodeling when over-activated. In Chapter III, I 
screened the upstream regulators of Cek1 and characterized the impact of Cek1 
activity on fungal virulence. In Chapter IV, I performed RNA-sequencing analysis 
to assess the whole genome transcription profile when Cek1 is hyper-activated. In 
Chapter V, I concluded the findings in this dissertation and proposed future 
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CHAPTER II: Unmasking of Candida albicans β (1,3)-
glucan Is Promoted by Activation of the Cek1 Pathway 
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Candida albicans is among the most common causes of human fungal infections 
and is an important source of mortality. C. albicans is able to diminish its detection 
by innate immune cells through masking of β (1,3)-glucan in the inner cell wall with 
an outer layer of heavily glycosylated mannoproteins (mannan). However, 
mutations or drugs that disrupt the cell wall can lead to exposure of β (1,3)-glucan 
(unmasking) and enhanced detection by innate immune cells through receptors 
like Dectin-1, the C-type signaling lectin. Previously, our lab showed that the 
pathway for synthesizing the phospholipid phosphatidylserine (PS) plays a role in 
β (1,3)-glucan masking. The homozygous PS synthase knockout mutant, cho1Δ/Δ, 
exhibits increased exposure of β (1,3)-glucan. Several Mitogen Activated Protein 
Kinase (MAPK) pathways and their upstream Rho-type small GTPases are 
important for regulating cell wall biogenesis and remodeling. In the cho1Δ/Δ 
mutant, both the Cek1 and Mkc1 MAPKs are constitutively activated, and they act 
downstream of the small GTPases Cdc42 and Rho1, respectively. In addition, 
Cdc42 activity is up-regulated in cho1Δ/Δ. Thus, it was hypothesized that activation 
of Cdc42 or Rho1 and their downstream kinases cause unmasking. Disruption of 
MKC1 does not decrease unmasking in cho1 Δ/Δ, and hyperactivation of Rho1 in 
wild-type cells increases unmasking and activation of both Cek1 and Mkc1. 
Moreover, independent hyperactivation of the MAP kinase kinase kinase Ste11 in 
wild-type cells leads to Cek1 activation and increased β (1,3)-glucan unmasking. 
Thus, upregulation of the Cek1 MAPK pathway causes unmasking, and may be 
responsible for unmasking in cho1 Δ/Δ.  
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Introduction 
Candida albicans is a human commensal that is part of the natural flora of the oral, 
genital and gastrointestinal tracts. Candida species are also the most common 
fungal pathogens of humans and cause diseases ranging from superficial 
infections of mucosal surfaces to severe systemic bloodstream infections in 
immune-compromised patients [1-4], with a mortality rate of approximately 30% 
[2]. Three major classes of antifungals are used to treat systemic infections 
including azoles, echinocandins, and polyenes [5-7]. However, drug resistance or 
toxicity has put limits on these agents.  
The C. albicans cell wall is considered a good therapeutic drug target due 
to its role in fungal pathogenicity as it presents important virulence factors, 
antigenic cell wall proteins and polysaccharides, and serves as the intermediate 
for fungal-host interactions [3, 8, 9]. One potential method for improving anti-fungal 
strategies could be to enhance the detection of fungal cell wall antigens by host 
immune cells. A major innate immune receptor for fungi like C. albicans is Dectin-
1, a C-type signaling lectin that can recognize β (1,3)-glucan, which is an important 
component of fungal cell walls [8, 10, 11]. This recognition can initiate protective 
antifungal immune responses in innate immune cells like macrophages, dendritic 
cells and neutrophils. The fungal cell wall consists of an inner layer that is enriched 
in β (1,3)-glucan and underlying chitin, and an outer layer of mannosylated proteins 
[8]. Under normal conditions, C. albicans masks β (1,3)-glucan from Dectin-1 
detection via the outer layer of mannosylated proteins [12, 13]. However, 
unmasking of β (1,3)-glucan can be induced through treatments with drugs such 
as echinocandins [12] or by certain genetic mutations that disrupt cell wall integrity 
[12-15].  
It has been previously reported that the phosphatidylserine (PS) synthase 
enzyme (Cho1) controls cell wall β (1,3)-glucan exposure [13]. Phospholipids are 
crucial components of cellular membranes in eukaryotes. Cho1 synthesizes PS 
that can act as an end product, but also can be further decarboxylated to form 
phosphatidylethanolamine (PE). PS and PE are both essential for C. albicans 
virulence [16]. We found that the homozygous CHO1 mutant, cho1Δ/Δ, exhibits 
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greater β (1,3)-glucan exposure compared to wild-type [13, 14]. This exposure 
allows increased recognition by Dectin-1 and elicits a stronger pro-inflammatory 
response [13, 14, 17]. However, the detailed mechanism by which β (1,3)-glucan 
exposure is caused by CHO1 disruption remains unknown.  
The process of cell wall biogenesis and remodeling is governed through 
complex signaling pathways, including several mitogen-activated protein kinase 
(MAPK) cascades and their upstream Rho-type GTPases (Figure 2. 1). MAPK 
pathways are conserved signaling cascades in eukaryotes that are important for 
dealing with a wide range of stimuli, including osmotic stress, oxidative stress, cell 
wall damage, and changes in glycosylation [9, 15, 17-19]. This signaling cascade 
is composed of a conserved module of three kinases: the MAP kinase kinase 
kinase (MAPKKK), the MAP kinase kinase (MAPKK) and the MAP kinase (MAPK). 
The MAPK activates downstream transcription factors and effectors to initiate gene 
expression for better adaptation to the environment [19]. Among these MAPK 
pathways, Ste11-Hst7-Cek1 composes the Cek1 MAPK cascade, and is reported 
to control β (1,3)-glucan masking in C. albicans [15, 20, 21]. CEK1 null mutants 
display unmasking of β (1,3)-glucan and hyper-sensitivity to agents that disturb the 
cell wall such as Congo red [15]. The Mkc1 MAPK route, consisting of Bck1-Mkk2-
Mkc1, is primarily involved in cell wall construction, as well as responding to 
exogenous cell wall stress, oxidative stimuli, antifungal drugs, and low-
temperature shocks [22, 23]. Yet, this pathway does not appear to be required for 
masking in C. albicans [24], although it is hypersensitive to specific cell wall insults 
such as echinocandins or calcofluor white. 
The upstream small GTPases Cdc42 and Rho1 transmit the signal toward 
Cek1- and Mkc1- associated MAPK cascades, respectively (Figure 2. 1) [18, 23]. 
They are also important in remodeling the rigid structure of the cell wall during 
vegetative growth and during pheromone-induced morphogenesis [25]. Rho1 is a 
well-known major regulator of the cell wall integrity signaling cascade through 
several downstream effectors [23, 25-30]. Rho1 is also the regulatory subunit of β 
(1,3)-glucan synthase, and therefore directly controls cell wall biosynthesis via the 




Figure 2. 1. The Cek1 and Mkc1 MAP kinase signaling cascades in C. albicans are involved 
in cell wall biogenesis.  
The Cek1 and Mkc1 MAP kinase cascades, and their respective upstream activator signaling 
proteins are shown. Rho1 activates protein kinase C (Pkc1), which activates the Mkc1 MAP kinase 
cascade. Cdc42 activates the PAK kinase Cst20 which activates the Cek1 MAP kinase cascade. 
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essential for cellular polarized growth through a variety of downstream effector 
proteins in C. albicans, including the actin cytoskeleton regulator Bni1, and kinases 
such as PAK kinase family members Cst20/Cla4 [32-37].  
Given the role of the GTPase-associated signaling pathways in cell wall 
remodeling and regulation, we studied the impact of these signaling routes in 
affecting β (1,3)-glucan masking in the C. albicans cho1Δ/Δ PS synthase mutant. 
We found that in the cho1Δ/Δ mutant there is upregulation of the activity of both 
Cek1 and Mkc1 MAPKs. Furthermore, we present data indicating that activation of 
the Cek1 pathway, in particular, is sufficient to cause β (1,3)-glucan exposure in 
the cho1 Δ/Δ mutant. 
 
Methods 
Strains and growth media 
All of the strains and plasmids used for these experiments are described in Table 
S.2. 1 and Table S.2. 2. All the primers used in this study were described in Table 
S.2. 3. The medium used to culture strains was yeast extract-peptone-dextrose 
(YEPD) medium (1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher 
Scientific) (unless otherwise stated) [38]. To express the gene from the promoter 
of the gene for ATP sulfurylase (MET3), SD minimal medium (2% dextrose, 0.67% 
Yeast nitrogen base without amino acids) with 1mM ethanolamine (to support 
cho1Δ/Δ) was used [39]. For the induction of genes under the control of the MAL2 
maltase promoter, YPM (1% yeast extract, 2% peptone, and 2% maltose (Thermo 
Fisher Scientific)) [40] was used. To induce hyphal formation, cells were sub-
cultured in Gibco RPMI 1640 medium (Thermo Fisher Scientific). 
 
Strain construction 
For the generation of strains that conditionally express green fluorescent protein 
(GFP) tagged Cdc42 under the regulation of PMET3, we used the plasmid pTC1 
composed of PMET3-yEGFP-CDC42, which was constructed as follows. yEGFP 
was amplified with primers TRO988+TRO989 with BamHI flanking at both ends, 
and CDC42 was amplified from SC5314 genomic DNA with primers 
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TRO995+TRO996 with SacI flanking both ends. Both fragments were cloned into 
pYLC314 [41] 3-end to the MET3 promoter, where yEGFP is in frame and 5-end 
to CDC42 and connected by a sequence that encodes an 8-alanine linker. 
CDC42K183-187Q was chemically synthesized by Genescript Inc. with SacI sites. It 
was used to replace wild-type CDC42 in pTC1 to create pTC14. The pYLC314 
plasmid was made by amplifying a SAT1-PMET3 fragment from pYLC229 [41] with 
primers JCO165 + JCO166 that introduced EcoRI sites and cloning it into the 
EcoRI site in pBluescript II SK+. Both pTC1 and pTC14 were linearized within 
PMET3 using AflII, and then transformed into the strains of interests by 
electroporation. The transformation methods have been previously described [42]. 
TCO1+TCO2 were used to validate if the fragment was integrated into PMET3 locus 
in the chromosome.  
To generate the strain CaTC11 that conditionally expresses STE11ΔN467 
under the regulation of MAL2 promoter, we constructed the plasmid pTC20 that 
consists of PMAL2- STE11ΔN467-TTEF3. First, pTC19 containing the PMAL2 promoter 
was generated from pYLC314 [41]. The PMET3 was removed from pYLC314 by 
restriction with PstI. The regulatable promoter PMAL2 was amplified from wild-type 
C. albicans genomic DNA using the primers TCO36+TCO37. The promoter was 
then cloned into the PstI site of the linearized pYLC314 to create pTC19.  Then, 
the hyperactive domain of STE11ΔN467 with a TEF3 terminator was amplified from 
the PTET-ON - STE11ΔN467 plasmid (generously provided by Dr. Joachim 
Morschhausser) [43] with primers TCO42+TCO43, with BamHI at both ends and it 
was cloned into pTC19. The resultant pTC20 was then linearized with XcmI and 
transformed into wild-type SC5314.  
To generate the heterozygous deletion of PKC1, ~500 bp 5- and 3- 
untranslated regions (UTRs) flanking PKC1 were amplified as KpnI-XhoI and NotI-
SacI fragments, by using the primers TCO59+TCO60 and TCO62+TCO110, 
respectively. The 5- and 3- UTR fragments were cloned into the corresponding 
sites of the SAT1 flipper in the plasmid pSFS2A [44], respectively. The resulting 
plasmid pTC041 was digested with KpnI and SacI, and the larger fragment was 
gel purified (Qiagen Inc.) and transformed into the strains of interest. The 
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nourseothricin-resistant transformants were further cultured in medium containing 
maltose as a carbon source to induce caFLP expression, which is under MAL2 
promoter regulation. The confirmation of a PKC1 allele being deleted was verified 
with TCO63+JCO95. 
To introduce the Q67L mutation into RHO1, first the RHO1 gene was PCR 
amplified with primers TCO8+TCO72 from SC5314 genomic DNA as a SacI-NotI 
fragment and cloned into vector pBT1 to generate pTC35. To generate the pBT1 
plasmid, the MET3 promoter was removed from pYLC314 by cutting with PstI. The 
ENO1 promoter was amplified with primers BTO30+BTO31 as a BamHI-NotI 
fragment and cloned into pYLC314 to generate pBT1. Then primers 
TCO74+TCO75 were used to create pTC38 from pTC35 by point mutating RHO1 
using site-directed mutagenesis. A similar site directed mutagenesis protocol was 
used to introduce the G12V mutation into CDC42. TRO996+TCO101 were used 
for CDC42 PCR amplification and it was cloned into pBT1 to create pTC34. Then 
TCO76+TCO77 were used to introduce the G12V mutation to CDC42 to result in 
pTC37 which expresses PENO1-CDC42G12V. pTC37 and pTC38 were linearized with 
MscI and transformed into SC5314.  
To create the strain that has GFPCRIB (Cdc42-Rac1 interactive binding 
motif) to probe the localization of GTP-Cdc42, RAC1 was disrupted in SC5314 
using C. albicans CRISPR-Cas9. This was to exclude GFPCRIB binding with 
Rac1. Primers TCO38+TCO39 were annealed to generate a RAC1 sgRNA flanked 
with BsmbI, which were then ligated with the deletion construct pV1393 [45] to 
create the plasmid pTC18. TCO40+TCO41 were used to generate the repair 
template that spanned the Cas9 cut site in order to introduce 3 stop codons to 
prevent RAC1 expression and a new HindIII cut site to allow quick genotyping of 
the transformants. pTC18 was digested with KpnI and SacI, and the larger 
fragment was transformed into both SC5314 and cho1Δ/Δ together with repair 
template. TCO51+TCO52 were used for colony PCR to test if the repair template 
had integrated into the Cas9 cut site. The positive rac1Δ/Δ transformant was then 
transformed with linearized pTC029. The pTC029 plasmid was created from 
pExpArg-pADH1CRIBGFP [46] by cutting it with NotI and ligating it with a Candida-
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adapted hygromycin B resistance marker amplified with primers TCO92/TCO93 
from pRB436 (a gift from Dr. Richard Bennett). CRISPR/Cas9 was also utilized to 
knock out MKC1 and PKC1 in the strains of interests. TCO32+TCO33 and 
TCO44+TCO45 were used to generate the sgRNA for MKC1 and PKC1, 
respectively. TCO34+TCO35, TCO46+TCO47 were used to create the repair 
templates for MKC1 and PKC1 with EcoRI and BglII introduced, respectively. 
TCO28+TCO29 and TCO49+TCO50 were used for colony PCR on transformants 
respectively to check if the repair template integrated into the Cas9-cut region.   
To generate strains that have GFPRID (Rho1 Interactive Domain) to probe 
the localization of GTP-Rho1, each strain was transformed with pTC033. The 
pTC033 plasmid consists of pExpArg-pACT1GFPRID [46] with a SAT1 marker 
cloned into the Not I restriction site following amplification with TCO15+TCO16. 
The pTC033 plasmid was linearized with StuI and transformed into the strains of 
interest.  
 
Western blotting  
Cells were grown overnight in liquid YPD at 30°C, diluted to an OD600 of 0.2 in 
fresh YPD medium and allowed to grow for 3 hours. For the STE11ΔN467 strain 
under the MAL2 promoter regulation, cells were grown overnight in liquid YPM at 
30°C and diluted back to OD600 of 0.1 into fresh YPM medium and grown to log 
phase. Cells were pelleted by centrifugation and resuspended in 250μl phosphate 
buffered saline (PBS) supplemented with protease inhibitor cocktail (PMSF, 
leupeptin, and pepstatin (RPI, Corp., Mount Prospect), complete Protease Inhibitor 
tablet and PhosStop Phosphatase Inhibitor tablet (Roche Diagnostics GmbH, 
Mannheim, Germany). An equal volume of 150-212μm acid-washed beads (Sigma 
Aldrich, MO, USA) was added to each tube. Cells were mechanically disrupted in 
a Biospec Mini-BeadBeater (Bio Spec Product Inc., USA) with 6 rounds of 1min 
homogenization at 4°C and 1min intervals for each cycle. Samples were 
centrifuged at 5,000×rpm for 10 min at 4°C, the supernatant was collected, and 
the protein concentration was quantified using the Bradford protein assay (Bio-Rad 
Laboratories Inc., USA). Extracts were heated for 3 min at 95°C, and equal 
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amounts of protein from each sample were separated on an SDS-12% 
polyacrylamide gel. Separated proteins were transferred onto a polyvinylidene 
difluoride (PVDF) membrane with a Hoefer MiniVE vertical electrophoresis unit 
(Amersham Biosciences Inc., USA). Membranes were blocked in blocking buffer 
(LI-COR biosciences Inc., USA) at room temperature for 1hour and subsequently 
incubated overnight at 4°C with Anti-phospho-p44/p42 MAPK (Thr202/Tyr204) 
antibody at a 1:2000 dilution (Cell Signaling Technology, Inc., USA) to detect 
phosphorylated Mkc1 and Cek1 MAPKs. The expression of total Mkc1 was 
detected with the primary antibody against total Mkc1. The expression of total 
Cek1 was measured with an antibody to total Cek1. The secondary antibody 
against Phospho-p44/42 Ab, Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–
rabbit IgG (H+L) conjugate (green, 1:10,000 dilution; LI-COR Biosciences) 
incubated in the dark followed by extensive washing and quantitation using an 
Odyssey IR imaging system (LI-COR Biosciences). Phosphorylated and total 
proteins levels were quantitated using ImageJ (National Institutes of Health, 
Bethesda, MD). As a control protein, tubulin was detected with rat anti-tubulin 
primary antibody (Bio-Rad Laboratories Inc., USA) at a 1:1000 dilution and IRDye 
680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000 dilution; LI-COR Biosciences).  
 
Pull-down assay for active Cdc42 
Cells were grown in YPD to log phase, and pelleted by centrifugation, and re-
suspended in Lysis/Binding/Wash buffer, provided by Active Cdc42 Pull-Down and 
Detection Kit (Thermo Fisher Scientific) with protease inhibitors cocktail (PMSF, 
leupeptin, and pepstatin) (RPI, Corp., Mount Prospect) and complete phosphatase 
inhibitor tablet (Roche Diagnostics GmbH, Mannheim, Germany), and cells were 
disrupted with acid-washed glass beads (Sigma-Aldrich Co. LLC., USA) in a 
Biospec Mini-Bead Beater with 6 rounds of 1min homogenization at 4°C and 1min 
interval for each cycle. The protein concentration was quantified using the Bradford 
protein assay (Bio-Rad Laboratories Inc., USA).  
1,500 μg of total protein were used for the pull-down procedure following 
the instruction from Active Cdc42 Pull-Down and Detection Kit (Thermo Fisher 
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Scientific). 50ul of the pull-down samples containing active Cdc42 were separated 
by SDS-PAGE, transferred to PVDF with the Hoefer MiniVE vertical 
electrophoresis unit (Amersham Biosciences Inc., USA), and detected with mouse 
monoclonal anti-Cdc42 antibody at a 1:250 dilution (Cytoskeleton Inc., USA), 
followed by secondary detection with IRye800CW goat anti–mouse IgG (H+L) 
conjugate (1:10,000; LI-COR biosciences). As a control protein, tubulin was 
detected with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA) 
and IRDye 680RD Goat-anti-Rat IgG (H+L) (LI-COR biosciences). Densitometry 
quantification of Cdc42 bands was performed with ImageJ (National Institutes of 
Health, Bethesda, MD). 
 
Immunofluorescent imaging of β (1,3)-glucan exposure 
This procedure was done as described in [13] with minor modification. C. albicans 
cells were grown overnight in YPD or YPM medium at 30°C. Mouse anti-β (1,3)-
glucan antibody (Biosupplies Australia Pty Ltd., Australia) at a 1:800 dilution was 
used as the primary antibody, and a goat anti-mouse antibody conjugated to Cy3 
(Jackson ImmunoResearch Inc., USA) at 1:300 dilution was used as secondary 
antibody. For imaging, Candida cells were resuspended in 100 μL of PBS and 
visualized with LEICA DM5500B epi-fluorescent microscope with Hamamatsu 
Orca-ER CCD digital camera (Model#C4742-80-12AG). The pictures were taken 
through Leica Application Suite AF (Advanced Fluorescence) software.  
 
Fluorescence imaging  
For imaging GFP-Cdc42 expressed under the MET3 promoter, Candida cells were 
cultured overnight in SD minimal medium plus 1mM ethanolamine at 30°C, diluted 
to an OD600 of 0.2 in the fresh SD medium and allowed to grow for about 4-5 hours 
to reach the OD600 of 0.6-0.8. Cells carrying the CRIB-GFP or GFP-RID constructs 
(the expression of each is under the constitutive ADH1 and ACT1 promoters, 
respectively), were cultured in YPD medium. The overnight culture at 30°C was 
diluted back to an OD600 of 0.2 in fresh YPD medium and grown for 3 hours to 
reach log phase. 1mL of cells was collected and re-suspended in 100μl of PBS. 
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3μl of samples were mounted on the slide and observed under Leica DM RXA epi-
fluorescent microscope with Leica DFC365FX CCD camera (Vashaw Scientific, 
Inc.). The pictures were taken through Leica Application Suite (LAS) V4.4 software.  
  
Flow cytometry 
To stain the STE11ΔN467 strain (PMAL promoter) and its controls, overnight cultures 
in YPM or YPD were collected and blocked in PBS plus 3% bovine serum albumin 
(BSA, Thermo Fisher Scientific, USA) for 30mins. Primary and secondary antibody 
incubations occurred on ice in PBS plus 3% BSA for 1.5 h and 20mins, 
respectively.  Soluble human Dectin-1–Fc (sDectin-1-Fc) [8] at 16.5 μg/ml was 
used to detect exposed β (1,3) glucan and mouse anti-Als3 antibody with 1:800 
dilution was used for staining Als3 on hyphal cells. The Donkey anti-human IgG 
(H+L) Alexa Fluor 488 (Jackson Immuno Research) and goat anti-mouse antibody 
conjugated to R-Phycoerythrin (R-PE) were used as secondary antibodies, 
respectively.  
To stain exposed β (1,3)-glucan on CDC42G12V cells, overnight cultures 
were collected, and mouse anti-β (1,3)-glucan antibody at a 1:800 dilution and 
rabbit anti-mouse IgG (H+L) Alexa Fluor 488 (Jackson Immuno Research) were 
utilized as primary and secondary antibodies, respectively. 5ul of eBioscienceTM 
propidium iodide dye (Thermos fisher) was then added to the solution for the 
live/dead staining and incubated for 5min at room temperature.  
To stain β (1,3)-glucan in Candida cells with MKC1 deleted, the overnight 
culture was incubated with mouse anti-β (1,3)-glucan antibody at a 1:800 dilution 
as primary antibody and followed by goat anti-mouse antibody conjugated to R-
Phycoerythrin (R-PE) at 1:300 dilution (Jackson ImmunoResearch) as a 
secondary antibody. The staining process for RHO1Q67L strains was the same 
except that the overnight cultures were diluted back to OD600 at 0.1 and the log 
phage cells were collected after 3hrs growth for staining.  
For all of the above conditions, after staining, cells were processed by 
washing five times with PBS, and samples were resuspended in 500μl of FACS 
buffer (PBS, 1% serum, 0.1% sodium azide) for flowcytometry in a FACSCalibur 
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LSR II flow cytometer (Becton Dickinson). Singlets were gated by using a forward 
scatter area (FSC-A) versus side scatter area (SSA) plot, followed by forward 
scatter width (FSC-W) versus forward scatter area (FSC-A) density plot, as well as 
a side scatter width (SSC-W) versus side scatter area (SSC-A) plot to exclude 
clumping cells. We further compare the PE fluorescence intensity from the P3 
singlets population in different Candida cells. Flow cytometry data were obtained 
for 100,000 gated events per strain and experiments were performed in triplicate 
and analyzed using FlowJo software package with version 10.11 (FlowJo LLC, 
OR, USA).  
 
Enzyme-linked immunosorbent assay (ELISA) of TNF-α 
RAW264.7 macrophages were plated the day prior at 5×105/well in a 24-well plate. 
To activate STE11ΔN467 expression under PMAL regulation, STE11ΔN467 mutant cells 
were grown at YPM. Overnight cultures were washed and diluted to an OD600 of 
1.25 in 5ml PBS/well in a 6-well plate for UV-kill. To do this, the 6-well plate was 
placed in the Spectrolinker XL-1000 UV Crosslinker (Spectroline Inc., USA) and 
the ENERGY mode was set to 100,000 µJ/cm2. The UV-killing process was 
repeated 5 times. UV-killed Candida cells were then added to the RAW264.7 
macrophages and coincubated at a 1:10 ratio for 4 h at 37°C and 5% CO2. The 
supernatant of each well was collected and filtered through a syringe filter with 
0.2µm pore size (Millipore Sigma, US) to exclude the macrophage debris. The 
ELISA kit instructions from the manufacturer (R&D Systems) were followed. Each 
sample has three individual wells, and the statistical analysis was performed by 
using Two-way analysis of variance ANOVA (GraphPad Prism, v7.04 software).  
 
Results 
C. albicans cho1Δ/Δ exhibits activated MAPKs 
Given the strong cell wall phenotypes seen in cho1Δ/Δ, we hypothesized that this 
mutant might exhibit increased activation of cell wall signaling pathways such as 
Cek1 and Mkc1 MAP kinase cascades. As shown in Figure 2. 2A, Western blots 
with the Phospho-p42/44 antibody, that labels the phosphorylated (activated) 
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forms of both Cek1 and Mkc1, revealed that these kinases were constitutively 
phosphorylated in cho1Δ/Δ compared to wild-type and other test strains. No 
significant difference was found between the psd1Δ/Δpsd2Δ/Δ mutant 
(synthesizes PE from PS) and wild-type (Figure 2. 2A). This indicates that 
disruption of the PS synthase specifically up-regulates the activity of both cell wall 
MAPK cascades. Similar trends were also seen under hyphal induction conditions. 
When cells were sub-cultured in RPMI 1640 medium (induces filamentation [47]), 
cho1Δ/Δ exhibited greater phosphorylation of Cek1 and Mkc1 than wild-type and 
other test strains (Figure 2. 2B). Collectively, these results indicate that loss of 
Cho1 activates the Cek1 and Mkc1 MAPK pathways. 
 
Activation of the Cek1 pathway causes β (1,3)-glucan masking 
Galán-Díez et al. observed that a cek1Δ/Δ homozygous deletion mutant exhibits β 
(1,3)-glucan exposure in C. albicans [15]. In contrast, Li et al. reported that Cek1-
inducing conditions, such as incubation with N-acetylglucosamine (GlcNAc) in the 
media, causes increased β (1,3)-glucan exposure in C. albicans [48]. To further 
investigate if activation of the Cek1 pathway increases exposure of β (1,3)-glucan 
in C. albicans yeast-form cells, we constructed a strain that expresses a hyper-
active allele of STE11 (STE11Δ467) under the regulation of the maltose promoter 
(PMAL2). Deletion of 467 N-terminal amino acids, including the inhibitory domain of 
Ste11, hyper-activates this kinase [43]. Ste11 is upstream of Cek1 and activates it 
via sequential phosphorylation through Hst7 (Figure 2. 1). Expression of the 
STE11∆N467 allele in YP maltose (YPM) media results in greater phosphorylation 
of Cek1 compared to growth of this strain in YPD (represses STE11ΔN467 
expression) (Figure 2. 3A). The STE11ΔN467 expressing strain exhibited greater β 
(1,3)-glucan exposure in YPM than YPD when stained with anti-β (1,3)-glucan 
antibody (Figure S.2. 1).   
 The Cek1 pathway is involved in inducing the yeast-to-hyphae transition. A 
small subset of cells forms filaments in the hyper-activated STE11ΔN467 strain in 
YPM, and hyphae exhibit β (1,3)-glucan unmasking more readily than yeast-form 




Figure 2. 2. Cek1 and Mkc1 MAPKs exhibit increased activation in cho1Δ/Δ yeast cells 
compared to wild-type.  
(A) Proteins from yeast-form cells growing in log phase in YPD media were extracted and Western 
blotting was performed with anti-phospho-p44/42 antibody to detect Phospho-Mkc1 and Phospho-
Cek1. Anti-Mkc1 was used for total Mkc1, anti-Cek1 for total Cek1, and anti-tubulin as a loading 
control. Graphs of quantification by Image J of the phosphorylated forms of each kinase are 
expressed as a percent of the wild-type control after being normalized to the total kinase blot for 
each respective MAP kinase and the tubulin loading controls for each gel. Quantification is based 
on three biological replicates. The statistical analysis was performed by using One-way ANOVA *, 
p=0.0308. ***, p=0.0005. (B) Western blotting was performed on extracts from cells grown as 
hyphae in RPMI media and probed with antibodies detecting Phospho-Cek1 and Phospho-Mkc1 
as well as the tubulin loading control. 
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unmasking, we used flow cytometry with a second hyphal-specific probe to gate 
out hyphal cells while measuring β (1,3)-glucan exposure. In particular, we stained 
strains with soluble Dectin-1 (sDectin-1) protein which binds with exposed β (1,3)-
glucan and anti-Als3 antibody, which stains the hyphal-specific protein Als3. Thus, 
Als3 staining was used as a marker to gate out hyphae by flow cytometry allowing 
us to focus on yeast-form cells. This double staining revealed that wild-type yeast-
form cells expressing hyper-activated Ste11 (STE11ΔN467) in YPM have 
significantly increased unmasking compared to yeast cells in YPD (Figure 2. 3B); 
compare the 1st quadrants (Q1) of the plots of STE11Δ467 grown in both YPM and 
YPD (bottom two plots).   
β-1,3-glucan exposure is more intense at bud scars, which presented the 
possibility that the higher glucan exposure in STE11ΔN467-YPM is associated with 
more bud scars provided that maltose increases growth rate. In fact, a growth 
curve demonstrated that both wild-type and STE11ΔN467 cells cultured in YPM grew 
slightly better compared to corresponding strains in YPD culture (Figure S.2. 2). 
However, when we co-stained cells with β (1,3)-glucan antibody and calcofluor 
white, a dye that stains the chitin that is normally concentrated at the bud scar [49], 
the exposed β (1,3)-glucan in STE11ΔN467 is scattered along the cell periphery, 
whereas the calcofluor white staining is constricted to the division sites (e. g. bud 
scars), revealing little overlap (Figure S.2. 3). Furthermore, STE11ΔN467 and wild-
type have similar growth rates in YPM (Figure S.2. 2), but STE11Δ467 has 
significantly elevated β (1,3)-glucan unmasking in this medium (Figure 2. 3B and 
C). Conversely, the strains have similar rates of growth and β (1,3)-glucan 
exposure in YPD (Figure 2. 3B and C), a condition where Cek1 is not hyperactived 
(Figure 2. 3A). Moreover, wild-type replicates more rapidly in YPM than YPD, but 
β (1,3)-glucan exposure is comparable for wild-type in both media (Figure 2. 3B). 
Altogether, these data indicate that hyperactivation of the Cek1 pathway leads to 
increased β (1,3)-glucan exposure that is not based on increased numbers of bud 
scars. 
The correlation between increased β (1,3)-glucan exposure and enhanced 
immune responses such as upregulated tumor necrosis factor alpha (TNF-α) 
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secretion has been studied intensively [12-14, 17, 50, 51]. Exposed β (1,3)-glucan 
is recognized by the receptor Dectin-1 on the surface of immune cells including 
macrophages and neutrophils, and this recognition activates the host immune 
response for fungal clearance including the secretion of TNF-α [12]. To determine 
if the increased β (1,3)-glucan exposure in the STE11ΔN467 strain is 
immunologically relevant, we performed an enzyme-linked immunosorbent assay 
(ELISA) to quantify TNF-α secretion from RAW264.7 macrophages exposed to this 
strain. As seen in Figure 2. 3D, TNF-α secretion was significantly upregulated 
when the Cek1 MAPK pathway was hyper-activated (STE11ΔN467 in YPM). It 
should be considered when examining the data in Figure 2. 3D that production of 
TNF-α is reduced in all strains that were grown in YPM, including wild-type and 
cho1ΔΔ. Thus, while the increase in TNF-α of cultures of STE11∆N467 grown in 
YPM is ~35% greater than that in YPD, the increase of STE11∆N467 over wild-type, 
both grown in YPM, is 2-fold. Thus, increased β (1,3)-glucan exposure in the 
STE11∆N467 strain increases proinflammatory responses from macrophages.  
 
CHO1 disruption upregulates Cdc42 activity in C. albicans  
The above results indicate that hyper-activation of Ste11 can cause unmasking, 
and since the Cek1 MAPK pathway, which acts downstream of Cdc42 [18], is 
constitutively activated in cho1Δ/Δ, this suggests that Cdc42 activity might be 
upregulated in cho1Δ/Δ (Figure 2. 1). To test this possibility, Cdc42 activity was 
measured by monitoring the amount of active Cdc42 (GTP-bound) in cells. GTP-
bound Cdc42 was isolated using agarose beads coated with Cdc42/Rac1 
interactive binding (CRIB) domain [46]. As seen in Figure 2. 4A, the concentration 
of GTP-bound Cdc42 in cho1Δ/Δ is higher than that in the other two strains. This 
confirms our hypothesis that cho1Δ/Δ has a higher concentration of active Cdc42 
than wild-type. Thus, Cho1 or its biochemical product PS may impact Cdc42 
activity negatively in wild-type cells, although the regulation may be indirect.  
 We then compared the localization of active Cdc42 in cho1Δ/Δ and wild-
type by using a CaCRIB-GFP probe [46]. This motif binds with both Cdc42 and 
Rac1 GTPases. As seen in Figure 2. 4B, both wild-type and cho1Δ/Δ cells have 
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Figure 2. 3. Hyperactive Ste11 (STE11ΔN467) causes significant increases in β (1,3)-glucan exposure and TNF-α secretion.  
(A) The Cek1 MAPK is hyper-activated by transforming wild-type cells with a hyperactive allele of STE11 (PMAL-STE11ΔN467), which is induced 
by adding maltose as a carbon source. (B) Both wild-type and STE11ΔN467 expressing cells were cultured overnight (16hrs) in YPD or YPM 
individually and then were doubly stained. The Y-axis represents staining with soluble Dectin-1-Fc (sDectin-1-Fc) that binds to exposed β 
(1,3)-glucan, and the X-axis represents anti-Als3 antibody, which binds to the hyphal-specific protein Als3. Flow cytometry was performed 
to quantify β (1,3)-glucan exposure from the yeast-form population (Q1: sDectin-1 single positive staining; Q2: sDectin-1 & Als3 double 
positive staining; Q3: Als3 single positive staining; Q4: double negative staining). Gates were established with an unstained control where 
97% of unstained cells gated within Q4. Gating strategies are further described in the Methods. (C) Left graph: Comparison of β (1,3)-glucan 
exposure from the yeast-form population of STE11ΔN467 versus that of wild-type, both of which are cultured in YPM. *, p=0.0289. Right graph: 
β (1,3)-glucan exposure was compared between these two strains when grown in YPD medium. (D) Expression of STE11ΔN467 significantly 
induces TNF-α secretion after growing in YPM overnight. RAW264.7 macrophages were challenged with various C. albicans stains. C. 
albicans strains were grown in YPD or YPM, washed, UV-inactivated, and then add to the macrophages for 4hrs. The macrophage 
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similarly localized active Cdc42 with the CRIB-GFP probe concentrated at the 
growth sites (buds). CRIB-GFP can bind both Rac1 and Cdc42, so to measure 
Cdc42 localization alone, we disrupted RAC1 in both wild-type and cho1Δ/Δ by 
using a C. albicans CRISPR-Cas9 system [45]. Both rac1Δ/Δ and cho1Δ/Δ 
rac1Δ/Δ mutant cells have a similar pattern of CRIB-GFP localization during 
budding growth compared to wild-type and cho1Δ/Δ (Figure 2. 4B and C). This 
suggests that active Cdc42 is found in its normal localization in cho1Δ/Δ cells. 
These results were in potential contrast to those for Cdc42 in a S. cerevisiae 
cho1Δ mutant, where PS disruption causes impaired Cdc42 polarization [52]. 
However, in this study, Fairn et al. used a GFP-Cdc42 construct to examine 
localization, which visualizes total Cdc42 rather than just active Cdc42. Therefore, 
we examined localization of total GFP-Cdc42 in C. albicans cho1Δ/Δ to determine 
how total Cdc42 responds to PS deficiency (Figure 2. 5A). In the wild-type and 
reintegrated strains (cho1Δ/Δ::CHO1), Cdc42 is localized to the plasma membrane 
and internal membranes, and accumulates in bud necks and bud tips. The 
cho1Δ/Δ mutant has impaired polarization of GFP-Cdc42 to bud necks and tips. 
There is an overall decrease in plasma membrane binding of GFP-Cdc42, and 
instead GFP-Cdc42 accumulates in the cytoplasm. Approximately 80% of wild-
type yeast cells have polarized Cdc42 localization, while only 20% of cho1Δ/Δ cells 
show polarized localization (Figure 2. 5B). This result indicates that CHO1 is 
necessary for the proper localization of total GFP-Cdc42 in C. albicans.  
We next examined the mechanism by which PS may impact GFP-Cdc42 
localization to buds and bud necks. PS is the most abundant anionic phospholipid 
of the plasma membrane, and it is largely restricted to the inner leaflet [52, 53]. A 
C-terminal polybasic region in some Rho-family small GTPases is a crucial domain 
for lipid interaction, where several positively charged amino acid residues promote 
plasma membrane localization and have been suggested to do so via electrostatic 
interactions with negatively charged phospholipids including PS [54, 55]. To 
elucidate if this domain is crucial for localization of Cdc42 in C. albicans, we 
constructed a GFP-Cdc42 mutant where the four C-terminal lysines were mutated 
to glutamines (GFP-Cdc42K183-187Q) and observed its localization in C. albicans
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Figure 2. 4. Cdc42 activity is upregulated in cho1Δ/Δ compared to wild-type. 
(A) GTP-Cdc42 was pulled-down with beads conjugated with GST-CRIB, which specifically binds with active GTP-Cdc42/Rac1. Cdc42 that 
was pulled down was then detected via Western blotting with anti-Cdc42 antibody. The amount of total Cdc42 in the extract was also probed 
as a control. The GTP-Cdc42/Total-Cdc42 ratio is expressed as a percentage of wild-type. (B) CaCRIB-GFP localization is not altered upon 
CHO1 deletion. The CaCRIB-GFP probe was transformed into Candida strains to investigate the active GTP-Cdc42 localization. The scale 
bar represents 10μm. (C) Cells from Figure 2. 4B were analyzed by microscopy for the number that exhibited CaCRIB-GFP localization to 
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wild-type cells. As shown in Figure 2. 5A, most of the GFP-Cdc42K183-187Q was 
associated with endomembrane structures instead of the plasma membrane. Of 
note, the preferential accumulation of GFP-Cdc42 seen in the buds of normal wild-
type yeast was absent in the mutated Cdc42K183-187Q protein. This indicates that 
the C-terminal polybasic region of Cdc42p is important for association of total GFP-
Cdc42 with plasma membrane. However, this does not show if the C-terminal 
domain is regulating localization by directly interacting with PS, although that is 
one possibility.   
In contrast, as observed in Figure 2. 4, GTP-bound unmodified Cdc42 is still 
able to associate with the bud necks and tips in the absence of CHO1, indicating 
that active Cdc42 can still localize to the appropriate places in the cell. The 
discrepancy we see between total GFP-Cdc42 localization and localization of 
GTP-bound native Cdc42 could be caused by the GFP or reflect differences 
between total versus active Cdc42 populations.   
 
Activation of Cdc42 activity contributes to cell wall unmasking 
The above results indicate that the GTPase Cdc42 has increased activation in 
cho1Δ/Δ (Figure 2. 4). To further investigate if this up-regulated Cdc42 activity 
contributes to β (1,3)-glucan exposure, we constructed a mutant strain that 
ectopically expresses a CDC42 hyperactive allele (CDC42G12V) in wild-type. 
Introduction of CDC42G12V decreases the intrinsic GTPase activity, therefore 
increasing the proportion of Cdc42 in an active GTP-bound state [18]. Cells 
overexpressing CDC42G12V exhibited decreased proliferation in YPD liquid and 
poor growth on YPD agar plates [32]. Similarly, a hyper-activated CDC42G12V 
mutant was dominant lethal in S. cerevisiae [56]. Our strain is viable, but does 
exhibit growth defects, so we measured β (1,3)-glucan exposure in the CDC42G12V 
mutant by staining with anti-β (1,3)-glucan antibody, but also co-stained cells with 
propidium iodide to control for cell-viability. Propidium iodide staining revealed that 
the overnight CDC42G12V culture contained fewer live cells compared to wild-type 
(Figure S.2. 4A). However, within the live cell populations for both strains, there 




Figure 2. 5. Cho1 is essential for GFP-Cdc42 polarization at the plasma membrane.  
(A) GFP-Cdc42 localization is examined for each strain by microscopy. The red arrows indicate the fluorescence concentrated at the bud 
tips or bud necks. The scale bar represents 5μm. (B) Quantification of the degree of polarization of GFP-Cdc42 in Candida cells. A 
minimum of 50 cells was counted for each strain and the imaging experiment was repeated three times. The statistical analysis was 
carried out by One-way ANOVA. ****, p<0.0001. 
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compared to wild-type (Figure S.2. 4B). This suggests that increased Cdc42 
activity causes β (1,3)-glucan masking, with the caveat that CDC42G12V is clearly 
having pleiotropic effects. 
 
The Rho1-associated signaling pathway does not have a clear role in 
causing β (1,3)-glucan exposure  
Our data indicate that the Cek1 pathway can cause β (1,3)-glucan exposure when 
hyper-activated, and this may help explain the increased β (1,3)-glucan exposure 
seen in the cho1Δ/Δ mutant. However, the Mkc1 pathway is also upregulated in 
cho1Δ/Δ (Figure 2. 2), and we wanted to determine if activation of this pathway 
plays a role in β (1,3)-glucan exposure as well. First, both MKC1 alleles were 
disrupted via the C. albicans CRISPR-cas9 system [45] in wild-type and cho1Δ/Δ. 
Western blotting was performed to confirm that Mkc1 was not expressed in the 
mutants with both MKC1 alleles disrupted (Figure S.2. 5). Immunostaining with 
anti-β (1,3)-glucan antibody on wild-type, cho1Δ/Δ, mkc1Δ/Δ and 
cho1Δ/Δmkc1Δ/Δ strains showed that deletion of MKC1 did not rescue the β (1,3)-
glucan exposure phenotype in the cho1Δ/Δ mutant (Figure 2. 6). In fact, flow 
cytometry demonstrated that the mkc1Δ/Δcho1Δ/Δ double mutant cells exhibited 
increased levels β (1,3)-glucan exposure compared to cho1Δ/Δ (Figure 2. 6B). 
This suggests that Mkc1 MAPK probably plays a role in sustaining cell wall 
organization when CHO1 is disrupted.  
 Pkc1 acts as a signaling module to connect Rho1 to the Mkc1 MAPK 
cascade [25-27]. We deleted one PKC1 allele in cho1Δ/Δ, and this did not 
suppress the β (1,3)-glucan exposure phenotype (Figure S.2. 6). 
Attempts to make a complete cho1Δ/Δ pkc1Δ/Δ double mutant failed. This does 
not completely test for a role for Pkc1 in unmasking but is consistent with those 
above indicating that increased activation of the Mkc1 pathway does not cause β 
(1,3)-glucan exposure.  
 We then examined if Rho1 might play a role in increased β (1,3)-glucan 
exposure in cho1Δ/Δ. Total, but not active, Cdc42 is mis-localized in the cho1Δ/Δ  




Figure 2. 6 Deletion of MKC1 in cho1Δ/Δ does not diminish β (1,3)-glucan exposure.  
(A) Cells were stained with primary anti-β (1,3)-glucan antibody and Cy3-conjugated secondary antibody and imaged by epi-fluorescent 
microscopy. The scale bar indicates 10μm.  (B) Flow cytometry was carried out to quantify β (1,3)-glucan exposure. Cells were incubated 
with primary anti-β (1,3)-glucan antibody and PE-conjugated secondary antibody. The statistical analysis was carried out by doing One-way 
ANOVA analysis. *, P=0.0485; **, P=0.0024. 
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This was achieved using a probe for active Rho1, that consists of a GFP tagged 
C. albicans Pkc1 Rho Interactive Domain (GFP-RID) [46]. In wild-type and 
cho1Δ/Δ::CHO1, GFP-RID is localized to the growth sites (i.e. buds and sites of 
cell division) (Figure 2. 7), however the signal in cho1Δ/Δ is delocalized. This 
suggests that the Rho1 cell wall remodeling system might be re-localized when 
Cho1 is disrupted. Rho1 also has multiple lysines on its extreme C-terminus, 
similar to Cdc42, thus its mislocalization in cho1Δ/Δ could be affected for similar 
reasons as observed for total GFP-Cdc42 (Figure 2. 5). Due to the lack of GFP-
Rho1, we have not examined GFP-Rho1 to find the exact localization of total Rho1 
in cho1Δ/Δ. The increased activation of Mkc1 in cho1Δ/Δ suggests that its 
upstream regulator, Rho1, might exhibit a similar increase in activation. To test if 
up-regulated Rho1 can cause β (1,3)-glucan exposure, we constructed a strain 
that ectopically expresses a hyperactive allele of RHO1Q67L in wild-type. 
Introduction of the RHO1Q67L allele decreases the ability of Rho1 to cleave GTP to 
GDP, therefore increasing the level of GTP-Rho1 [25]. As shown in Figure 2. 8A 
and B, hyper-activated RHO1Q67L did cause a significant increase in cell wall 
unmasking compared to wild-type, but not as great as that seen with STE11∆N467.   
However, examination of MAPK phosphorylation revealed that active Cek1 was 
unexpectedly upregulated along with active Mkc1 (Figure 2. 8C). Thus, the β (1,3)-
glucan exposure in the RHO1Q67L strain could be due at least in part to Cek1 
activation rather than Mkc1 (Figure 2. 8C).   
 
Discussion 
Previously, our lab showed that the enzyme for synthesizing PS, Cho1, plays a 
role in controlling β (1,3)-glucan exposure [13]. The homozygous PS synthase 
knockout mutant, cho1Δ/Δ, exhibits increased β (1,3)-glucan exposure compared 
to wild-type [13]. However, the mechanism by which cho1Δ/Δ displays the β (1,3)-
glucan exposure phenotype was unclear.  
 In this report, we identify two MAPK signaling pathways (Cek1 and Mkc1) 
that are activated in the cho1Δ/Δ mutant (Figure 2. 2), and we hypothesized that 




Figure 2. 7. Active GTP-Rho1 is de-localized in cho1Δ/Δ.  
(A-C) GFP-RID localization was used as proxy for active (GTP-bound) Rho1 in cells and was 
analyzed by epifluorescent microscopy. (D) Quantification of the degree of polarization of GTP-
Rho1 in Candida cells. A minimum of 50 cells were counted for each strain and this repeated three 





Figure 2. 8. Hyper-activated Rho1 causes β (1,3)-glucan exposure.  
(A-B) Candida cells were stained for β (1,3)-glucan exposure as described in Figure 2. 6. The scale 
bar represents 10μm. ***, p=0.0003.  (C) Western blotting was performed to examine the effect of 
expressing hyperactive RHO1Q67L on the regulation of downstream MAPKs activities. Phospho-
p44/42 antibody was used to detect Phospho-Cek1 and Phospho-Mkc1 and anti-tubulin, anti-Mkc1, 
and anti-Cek1 antibodies were used as controls.  
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MAPK signal transduction cascades are essential pathways for C. albicans 
adaptation to the host environment [35, 57]. Cek1 and Mkc1 are major MAPK 
pathways in this organism that play roles in cell wall regulation. The Mkc1-
associated pathway is primarily responsible for cell wall integrity, while the Cek1-
mediated signaling cascade is important for cell wall construction and hyphal 
formation [19, 58-60].  
 
Cdc42-Cek1 MAPK pathway activation can increase β (1,3)-glucan exposure 
We tested the hypothesis that one or both of these pathways can cause β (1,3)-
glucan exposure in cho1Δ/Δ by determining if they could contribute to this 
phenotype independently of loss of PS. We found confirming evidence for the Cek1 
pathway. In particular, a hyperactive form of Ste11 (STE11ΔN467), the MAPKKK that 
activates Cek1 (Figure 2. 1), stimulates significant β (1,3)-glucan exposure in 
yeast-form cells compared to wild-type cells (Figure 2. 3). This confirms an 
assertion that β (1,3)-glucan can be unmasked in Cek1 inducing conditions [48]. 
The cells with STE11∆N467-induced unmasking also exhibit more TNF-α secretion 
from the macrophages (Figure 2. 3D).  
Ste11 is downstream of the small GTPase Cdc42 (Figure 2. 1), which has 
been well-studied in C. albicans [18, 32, 46, 61]. Cdc42 is involved in cellular 
proliferation and bud emergence and activates the downstream protein kinase 
Cst20 [32], which also controls the activation of the Cek1 MAPK cascade including 
Ste11 [15, 18, 58]. To control accurate cellular function, Cdc42 cycles between an 
active GTP-bound and inactive GDP-bound state [61]. By performing pull-downs 
of GTP-Cdc42 with CaCRIB-GST and Western blotting, we have evidence that the 
level of active GTP-Cdc42 is higher in cho1Δ/Δ compared to wild-type (Figure 2. 
4A). This might be responsible for the increased activation of the downstream 
Ste11-associated cascade. We did not test to see if disruption of CEK1 in the 
cho1Δ/Δ strain would decrease β (1,3)-glucan exposure because cek1Δ/Δ also 
exhibits more exposed β (1,3)-glucan than wild-type [15], and this would be 
uninterpretable.   
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Possible roles of PS in regulating Cdc42 activity and localization 
The impact of PS on β (1,3)-glucan exposure is likely indirect, but may be occurring 
through its role in regulating Cdc42. The loss of PS correlates with increased 
Cdc42 activity, which in turn can lead to activation of the Cek1 pathway, which 
does cause β (1,3)-glucan exposure when activated (Figure 2. 3). However, the 
mechanism by which loss of PS causes Cdc42 activation is currently unclear, but 
possibilities are discussed below. 
PS may impact Cdc42 activity indirectly by regulating the GTPase activating 
proteins (GAPs) for Cdc42. These GAPs act as repressors of Cdc42 activity. 
Previous investigations identified that PS stimulates the GAP activity of Rga1 and 
Rga2 toward Cdc42 in S. cerevisiae [62]. Given that C. albicans cho1Δ/Δ lacks PS 
[16], this may result in less inhibition of the GAP activity, and in turn results in less 
inhibition of Cdc42 activity. 
Alternatively, there are data indicating that PS can control the localization 
of a subpopulation of Cdc42. For example, we found that GFP-tagged Cdc42 is 
mislocalized in C. albicans cho1Δ/Δ. Moreover, mutating the C-terminal lysines to 
glutamine in GFP-Cdc42 led to mislocalization of GFP-Cdc42K183-187Q in wild-type 
cells (Figure 2. 5). This is similar to what has been observed in S. cerevisiae, where 
Cdc42 localization is affected by both PS and the basic lysine residues at the C-
terminal domain of Cdc42 [52, 55]. However, in contrast to this, the localization of 
active GTP-Cdc42 in C. albicans, as measured by CaCRIB-GFP (binds to GTP-
Cdc42/Rac1) appears to be focused in the bud necks and tips like wild-type (Figure 
2. 4B). Therefore, PS might control only a subpopulation of Cdc42 localization. It 
is also possible that GFP-Cdc42 does not fully represent endogenous Cdc42 in its 
activated state. 
The mechanism by which PS controls Cdc42 localization in C. albicans 
remains to be fully elucidated. One model suggests that Cdc42 localization is 
controlled in part through the interaction between the negatively charged PS head 
group and the lysines at the C-terminus of Cdc42 (Figure 2. 5). However, this is 
only a model at this point and remains to be tested, as the impact of PS on GFP-
Cdc42 may be indirect. These lysines may interact with another protein that is 
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required to localize Cdc42 that itself is impacted by PS. In addition, the correct 
localization of active Cdc42 in cho1Δ/Δ indicates that other factors, perhaps GEFs 
or GAPs, play an important role in Cdc42 localization, independently of PS (Figure 
2. 4). 
 
Activation of the Mkc1 MAPK pathway does not appear to be sufficient to 
cause unmasking  
The other MAPK pathway upregulated in cho1Δ/Δ is the Mkc1 pathway (Figure 2. 
1 and Figure 2. 2). We tested for its role in cho1Δ/Δ-dependent β (1,3)-glucan 
exposure by generating a cho1Δ/Δmkc1Δ/Δ double mutant, and this did not 
diminish β (1,3)-glucan exposure (Figure 2. 6). Moreover, we disrupted one allele 
of the upstream kinase Pkc1, and this also did not diminish β (1,3)-glucan exposure 
(Figure S.2. 6). Finally, a hyperactive GTP-bound form of Rho1 (RHO1Q67L) was 
generated, and it did lead to modest β (1,3)-glucan exposure compared to wild-
type, however surprisingly it also led to increased phosphorylation of Cek1 as well 
as Mkc1 (Figure 2. 8), thus the increase may be caused by Cek1 upregulation.   
An alternative role for Mkc1 may be to diminish β (1,3)-glucan exposure in 
stress conditions. For example, the mkc1Δ/Δ mutant did not exhibit enhanced β 
(1,3)-glucan exposure compared to wild-type, but the cho1Δ/Δ mkc1Δ/Δ double 
mutant exhibited greater β (1,3)-glucan exposure than cho1Δ/Δ alone. This 
coupled with the mislocalization of active Rho1 in cho1Δ/Δ (Figure 2. 7), may 
indicate that Mkc1 is activated to compensate for cell wall disfunction that is 
caused by the cho1Δ/Δ mutation, perhaps even due to upregulated Cek1. 
Surprisingly, our results with the Mkc1 pathways relationship to PS contrast 
with what is observed for the orthologous pathway in S. cerevisiae. In baker yeast, 
PS has been shown to be necessary for the activation of the C. albicans Mkc1 
homolog Slt2 in S. cerevisiae [22, 63]. However, we observed that loss of PS 
synthase in C. albicans causes increased Mkc1 activity (Figure 2. 2), suggesting 
that there are fundamental differences in the manner through which the Mkc1-
associated cascade is regulated in pathogenic versus non-pathogenic yeasts. This 
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report also sets the stage for better understanding how the phospholipid PS 
synthase influences GTPase activity and localization in this pathogenic organism.  
 
Conclusions 
Candida albicans is able to diminish its detection by innate immune cells through 
masking of β (1,3)-glucan in the inner cell wall with an outer layer of heavily 
glycosylated mannoproteins (mannan) [12, 64, 65]. Once exposed, this glucose 
polymer antigen can be detected by Dectin-1, a C-type signaling lectin found on 
host immune cells [10, 11]. However, it usually takes several days after infection 
before β (1,3)-glucan is exposed to the immune system [64]. Therefore, if the β 
(1,3)-glucan exposure process could be induced more rapidly, the immune 
responses would be expected to improve and clear fungal pathogens more 
effectively [12, 64, 66-68]. 
Identification of specific pathways that contribute to β (1,3)-glucan exposure 
when activated could help elucidate future drug targets that can induce β (1,3)-
glucan exposure to improve immune response. Thus, compounds that specifically 
activate Cek1 may be useful in this regard. If such compounds were combined with 
the current azole class of antifungals, which act statically, and immune detection 
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Prototrophic wild type [69] 
YLC337 SC5314 cho1Δ/Δ [16] 
SED022 YLC337 cho1Δ/Δ::CHO1 [13] 
YLC375 SC5314 psd1Δ/Δ psd2Δ/Δ [16] 
TC001 SC5314 Wild-type PMET3-GFP-CDC42 This study 
TC002 YLC337 cho1Δ/Δ PMET3-GFP-CDC42 This study 
TC003 SED022 cho1Δ/Δ::CHO1 PMET3-GFP-
CDC42 
This study 
TC004 YLC375 psd1Δ/Δpsd2Δ/Δ PMET3-GFP-
CDC42 
This study 
TC005 SC5314 mkc1Δ/Δ This study 
TC006 SC5314 Wild-type PMET3-GFP-
CDC42K183-187Q 
This study 
TC007 SC5314 rac1Δ/Δ This study 
TC011 SC5314 Wild-type PMAL-STE11ΔN467 This study 
TC033 YLC337 cho1Δ/Δrac1Δ/Δ This study 
TC034 YLC337 cho1Δ/Δmkc1Δ/Δ This study 
TC046 SC5314 Wild-type GFP-RID This study 
TC064 TC033 cho1Δ/Δrac1Δ/Δ CRIBGFP This study 
TC071 YLC337 cho1Δ/Δ GFPRID This study 
TC072 SED022 cho1Δ/Δ::CHO1 GFPRID This study 
TC073 TC007 rac1Δ/Δ CRIBGFP This study 
TC078 SC5314 Wild-type PENO1-CDC42G12V This study 
TC083 SC5314 Wild-type PENO1-RHO1Q67L This study 
TC107 SC5314 Wild-type PKC1/pkc1Δ This study 
TC110 YLC337 cho1Δ/Δ PKC1/pkc1Δ This study 
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Strain Name Description Source 
pYLC314 CaNAT-PMET3, ampR [41] 
pTC001 CaNAT-PMET3-GFP-CDC42, ampR, This study 
pYLC146 FLP-CaNAT, chloraR This study 





pTC009 pExpArg-pADH1CRIBGFP+HYGR This study 
pTC014 CaNAT-PMET3-GFP-CDC42K183-187Q, ampR This study 
pV1393 FLP-CAS9-CaNAT-SNR52p-sgRNA, ampR [45] 
pTC015 pV1393 CaMKC1-sgRNA, ampR This study 
pTC018 pV1393 CaRAC1-sgRNA, ampR This study 
pTC019 CaNAT-PMAL, ampR, This study 
pTC020 pTC019 CaSTE11ΔN467, ampR This study 





pTC033 pExpArg-pACT1GFPRID+NATR This study 
pTC034 pBT1 CaCDC42, ampR This study 
pTC035 pBT1 CaRHO1, ampR This study 
pTC037 pBT1 CaCDC42G12V, ampR This study 
pTC038 pBT1 CaRHO1Q67L, ampR This study 
pTC041 pYLC146 CaPKC1-KO, chloraR This study 
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Table S.2. 3. Primers used in this study 
Name Sequence Description 
TCO1 GATTGTGGCTCATAGTAAC Primer-F to check if pTC1/pTC14 integrated into pMET3 locus 
TCO2  AGTAGCATCACCTTCACCT Primer-R to check if pTC1/pTC14 integrated into pMET3 locus 
TCO8 AAAAGAGCTCAAAAGTATAGGATAAAACATAAT Primer-R for CaRHO1 amplification with SacI flanking  
TCO15 AAAGCGGCCGCCGTCAAAACTAGAGAATAATAAG Primer-F to amplify SAT1 resistance gene with NotI flanking  
TCO16 AAAGCGGCCGCGACCACCTTTGATTGTAAA Primer-R to amplify SAT1 resistance gene with NotI flanking  
TCO28 TATATTATGGCAGATCCGTAA Primer-R at CaMKC1+23bp for colony PCR to detect if the MKC1 repair template integrated into the chromosome 
TCO29 AACCCATCTACAGTCTCAAA Primer-R at CaMKC1+1097 for colony PCR to detect if the MKC1 repair template integrated into the chromosome 
TCO32 ATTTGAGAACCCCGACGAAAATGCTG  Primer-F at CaMKC1+602 to amplify MKC1 SgRNA 
TCO33 AAAACAGCATTTTCGTCGGGGTTCTC Primer-R at CaMKC+621 to amplify MKC1 SgRNA 
TCO36 AAAACTGCAGTTGATATTTTTGTCTAGTACC Primer-F at CaMAL2-543 to amplify MAL2 promoter 
TCO37 AAAACTGCAGTGTAGTTGATTATTAGTTAAAC Primer-R at CaMAL2-1 to amplify MAL2 promoter 
TCO38 ATTTGAACCAATCAAATTAGGATTAG Primer-F at CaRAC1 to amplify RAC1 SgRNA 
TCO39 AAAACTAATCCTAATTTGATTGGTTC Primer-R at CaRAC1 to amplify RAC1 SgRNA 
TCO42 AAAAGGATCCATGGATTCGAGATCCATAAT Primer-F to amplify CaSTE11ΔN467 with BamHI flanking  
TCO43 AAAAGGATTCCTCGAGGGAAATAACTACTA Primer-R to amplify CaSTE11ΔN467 with BamHI flanking  
TCO44 ATTTGAGTCGAAAATAAGTATTCCGG Primer-F at CaPKC1 to amplify PKC1 SgRNA 
TCO45 AAAACCGGAATACTTATTTTCGACTC Primer-R at CaPKC1 to amplify PKC1 SgRNA 
TCO48 AAGACACGGTATAAAAATGG Primer-F at pMAL2 region of pTC19 to check if pTC19 reintegrated into the chromosome  
TCO49 ACAAGTTGTCAATGATATTAG Primer-F for colony PCR to detect if the PKC1 repair template integrated into the chromosome 
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Table S.2. 3. Continued 
Name Sequence Description 
TCO50 ATCACTTGAAGGAGATACTG Primer-R for colony PCR to detect if the PKC1 repair template integrated into the chromosome 
TCO51 AGCATTAAATCAGTCGTAGT Primer-F at CaRAC1+7bp for colony PCR to detect if the RAC1 repair template integrated into the chromosome 
TCO52 TCTTTTCTTACCAGTACCAG Primer-R at CaRAC1+675bp for colony PCR to detect if the RAC1 repair template integrated into the chromosome 
TCO57 TTTCCACAATCAAACATCCAA Primer-R at CaSTE11
ΔN467 region of pTC19 to check if pTC19 
reintegrated into the chromosome  
TCO59 AAAAGGTACCTACAAGAAAGTAAAGCCAAAG Primer-F at CaPKC1-501bp to amplify CaPKC1 promoter with KpnI flanking  
TCO60 AAAACTCGAGATTGGAATTACACTGATCTC Reverse primer at CaPKC1-1bp to amplify CaPKC1 promoter with XhoI flanking  
TCO62 AAAAGAGCTCGATACAAATAGAGAAGTTTCC Primer-R at +700bp of CaPKC1 3'NTR to amplify CaPKC1 terminator with SacI flanking  
TCO63 GCAATAGTAAGTAGCGAATAA Primer-F at CaPKC1-688 to check if the linearized pTC41 integrated into chromosome 
TCO72 AAAAGCGGCCGCATGGTTAACGGTCCAGCTGA Primer-F for CaRHO1 amplification with NotI flanking  
TCO74 ATTATGGGATACTGCTGGTCTAGAAGATTATGATAGATTAA Primer-F for point mutation of CaRHO1R67L 
TCO75 TTAATCTATCATAATCTTCTAGACCAGCAGTATCCCATAAT Primer-R for point mutation of CaRHO1R67L 
TCO76 TGTGTTGTTGTCGGTGATGTTGCCGTTGGTAAAACTTGCT Primer-F for point mutation of CaCDC42G12V 
TCO77 AGCAAGTTTTACCAACGGCAACATCACCGACAACAACACA Primer-R for point mutation of CaCDC42G12V 
TCO92 AAAGCGGCCGCTCGATATTGCTAGAGGCAAA Primer-F to amplify Hygromycin resistant gene 
TCO93 AAAGCGGCCGCATTTTATGATGGAATGAATGG Primer-R to amplify Hygromycin resistant gene 
TCO101  AAAAGCGGCCGCATGCAAACTATAAAATGTGTTG Primer-F to amplify CaCDC42 with NotI flanking  
TCO110 AAAAGCGGCCGCTGATTAAAGTAGATATATAATAATA Primer-F at +1bp of CaPKC1 3'NTR to amplify CaPKC1 terminator with NotI flanking  
TCO988 AAAAGGATCCATGTCTAAAGGTGAAGAATTA Primer-F to amplify EGFP with BamHI flanking  
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Table S.2. 3. Continued 
Name Sequence Description 
TRO989 AAAAGGATTCTTTGTACAATTCATCCATAC Primer-R to amplify EGFP with BamHI flanking  
TRO993 TTGGTGATGGTCCAGTCTTGT Primer-F at the EGFP region of pTC1 to check if EGFP and CDC42 ligated in a correct orientation 
TRO994 CAGAACACTCAACATACTTGACAGC Primer-R at CaCDC42+463bp to check if EGFP and CDC42 ligated in a correct orientation 
TRO995 AAAAGAGCTCGCAGCTGCAGCTGCAGCTGCAGCTCAAACTATAAAATGTGTTGT Primer-F to amplify Cdc42 with SacI flanking  
TRO996 AAAAGAGCTCTGATTTATATTATGTCTAGAGT Primer-R to amplify CaCDC42 with SacI flanking  
JCO95 GATTATTAGTTAAACCACTGC Primer-R at pMAL2 of pTC41 to check if the linearized pTC41 integrated into chromosome  
BTO30 AAAAGGATTCAGGTCTGTCATATTTCTATC Primer-F to amplify ENO1 promoter  
BTO31 AAAAGCGGCCGCGTTGTAATATTCCTGAATTATC Primer-R to amplify ENO1 promoter  
JCO165 AAAGAATTCCGTCAAAACTAGAGAATAATAAAG Primer-F to amplify pMET3-SAT1 
JCO166 AAAGAATTCGTTTTCTGGGGAGGGTATTT Primer-R to amplify pMET3-SAT1 
TCO34 CTTAAAATTTGTGACTTTGGTTTAGCAAGAGGGTTTTCTGAGAACCCCTAAGAATAAGCTT CaMKC1-F for crispr-cas9 repair template  
TCO35 CCCTGTACCATCTGGTGGCAACATACTCTGTCATAAACTATTAAGCTTATTCTTAGGGGTTCT CaMKC1-R for crispr-cas9 repair template 
TCO40 GTTTTTGATAATTATTCAGCCTCAGTTATGATTGATGGCGAACCAATCTAATAAGGATAAGCTT CaRAC1-F for crispr-cas9 repair template 
TCO41 GTCTTAATCTATCATATTCTGATTGACCAGCGGTATAAGCTTATCCTTATTAGATTGGTT CaRAC1-R for crispr-cas9 repair template 
TCO46 AGATTCAATTTATGTTGCAATATTTGGAATTCAAACTCCAGATCTAAAATAAGTAATCCTAA CaPKC1-F for crispr-cas9 repair template 
TCO47 CCATCCATAAGATAAAGATGAGACAATTTTTTATTGGCTTAGGATTACTTATTTTAGATCT CaPKC1-R for crispr-cas9 repair template 
 81 
 
Figure S.2. 1. STE11ΔN467 exhibited significantly increased β (1,3)-glucan exposure compared 
to wild-type cells.  
Overnight cultures of Candida cells were incubated with anti-β (1,3)-glucan primary antibody and 
PE-conjugated secondary antibody, followed by flow cytometry to quantify the fluorescence 
intensity. Data represent three biological replicates. The statistical analysis was done by One-way 





Figure S.2. 2. Growth curves were measured to determine the growth rate of strains in YPD 
vs YPM.  
Cells were grown overnight in YPD, diluted back to 0.1 OD600 and transferred to fresh YPD or 
YPM. A growth curve was performed with three replicates per condition, and plotted based on the 
growth rate of different strains measured in 48 hrs. The growth at each time-point between YPD 
and YPM cultures of STE11ΔN467 were compared by Two-way ANOVA (****, p<0.0001; *, 
p=0.0286).  The same comparison was made between wild-type YPD and YPM culture (####, 





Figure S.2. 3. The exposed β (1,3)-glucan in STE11ΔN467 YPM cells was not restricted to bud 
scars.  
Overnight cultures of wild-type and STE11ΔN467 grown in YPM were co-stained with anti-β (1,3)-
glucan antibody and Cy3 secondary to visualize exposed β (1,3)-glucan and calcofluor white to 
visualize chitin.  
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Figure S.2. 4. CDC42G12V increases β (1,3)-glucan exposure, but also reduces the viable cell 
population.  
(A) Propidium iodide staining was performed to quantify the live cells in Candida strains. (B) β (1,3)-
glucan exposure in live (gated for propidium iodide negative cells) wild-type and CDC42G12V 




Figure S.2. 5. MKC1 was knocked out in C. albicans via CRISPR-Cas9.  
Western blotting was performed using anti-Mkc1 antibody to confirm the absence of MKC1 in the 
MKC1 knockout mutants compared to wild-type (WT) and other strains. Tubulin was probed with 




Figure S.2. 6. Deleting one PKC1 allele in cho1Δ/Δ did not rescue β (1,3)-glucan exposure.  
One PKC1 allele was deleted through SAT1-flipper method. Cells were then stained with anti-β 
(1,3)-glucan primary antibody and phycoerythrin (PE)-conjugated secondary antibody. The 
statistical analysis was carried out by doing One-way ANOVA. 
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CHAPTER III: Hyperactivation of Cek1 Attenuates 
Virulence in Candida albicans  
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Candida albicans is among the most prevalent opportunistic human fungal 
pathogens and is an important source of mortality, particularly in immune-
compromised patients. The ability to mask the immunogenic polysaccharide β 
(1,3)-glucan from immune detection via an outer layer of heavily mannosylated 
proteins is a key virulence factor of C. albicans. We previously reported that 
hyperactivation of the Cek1 Mitogen Activated Protein Kinase (MAPK) pathway 
promotes β (1,3)-glucan exposure and enhances detection of cells by 
macrophages. In this communication, we report a novel upstream regulator of 
Cek1 activation and characterize the impact of Cek1 activity on fungal virulence. 
Lrg1 encodes a GTPase activating protein (GAP) homolog that has been reported 
to inhibit the GTPase Rho1. We find that disruption of LRG1 causes Cek1 
hyperactivation and β (1,3)-glucan unmasking, but when GTPase activation is 
measured for a panel of cellular small GTPases, the lrg1Δ/Δ mutant exhibits 
increased activation of the GTPases Cdc42 and Ras1, but not Rho1 or Rac1. 
Unmasking and Cek1 activation in lrg1Δ/Δ can be blocked by inhibition of the 
Ste11 MAPKKK, indicating that Lrg1 acts through the canonical Cek1 MAPK 
cascade. In order to determine how Cek1 hyper-activation specifically impacts 
virulence, a doxycycline repressible hyperactive Ste11ΔN467 was generated in C. 
albicans and was found to induce production of the pro-inflammatory cytokine 
TNF-α from murine macrophages. This in vitro phenotype correlates with 




Candida spp. species are the fourth most common cause of bloodstream 
infections, and the leading causes of invasive fungal infections in hospitalized 
patients in the United States [1]. Despite the presence of several effective 
antifungals, the mortality rate of these infections still exceeds 40% [1]. Current anti-
fungal drugs for Candida include polyenes, azoles, and echinocandins, however 
mortality rates are unacceptably high even after accounting for limitations like drug 
resistance or toxicity. This suggests that other therapeutic approaches need to be 
used in conjunction with anti-infectives. One approach is to improve the residual 
immune response of patients to these pathogens [2-4]. This could be improved by 
making fungal pathogens more visible to the immune system’s sensory cells. The 
fungal cell wall is a major focus for this as it is the main interface between the 
immune system and the fungus [5].  
The C. albicans cell wall is composed of three major layers, where the outer 
layer is enriched for glycosylated proteins (mannan), and the inner layer consists 
of chitin, β (1,6)-glucan and the highly immunogenic β (1,3)-glucan. Fungal 
pathogens have a diversity of mechanisms to manipulate cell wall architecture to 
mask pro-inflammatory β (1,3)-glucan epitopes from host recognition. In 
Histoplasma capsulatum, α-glucan serves a masking function by concealing the β-
glucan, while the Eng1 exoglucanase hydrolyzes β-(1,3)-glycosyl bonds and 
removes exposed β-glucans not covered by α-glucan [6, 7]. Aspergillus fumigatus 
Uge3 regulates the biosynthesis of galactosaminogalactan, a polymer that covers 
hyphal β-glucan from immune detection [8]. In C. albicans, β (1,3)-glucan is 
masked by the outer layer of mannan. In this organism, certain genetic mutations, 
treatment with the cell wall inhibitor caspofungin, or damage by neutrophils can 
expose C. albicans β (1,3)-glucan [9-11]. This exposure facilitates recognition by 
host immune cells through receptors like Dectin-1, and therefore launches immune 
responses more efficiently and rapidly, including induction of pro-inflammatory 
cytokines like tumor necrosis factor (TNF)-α for anti-fungal clearance [12]. The 
importance of β (1,3)-glucan exposure and resultant enhancement of immune 
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detection is becoming better appreciated in medical mycology and may lead to 
discoveries that will improve adjunctive therapy approaches [9, 11, 13-16].  
We previously identified that the activated GTPase Rho1 (RHO1Q67L) 
exhibited β (1,3)-glucan unmasking in C. albicans [17]. The most well-known 
contribution of Rho1 in this organism is to maintain sophisticated cell wall 
architecture through regulating several downstream effectors including the β (1,3)-
glucan synthase Fks1, protein kinase C (Pkc1), and the cell wall integrity MAPK 
cascade containing Mkc1 [18, 19]. To function accurately, Rho1 serves as a 
molecular switch by cycling between active GTP-bound and inactive GDP-bound 
state [20]. The regulatory proteins of GTPases generically include guanosine 
exchange factors (GEFs), which stimulate GTP to be loaded onto the enzyme and 
keep it in the active GTP-bound state, and GTPase-activating proteins (GAPs), 
which promote the hydrolysis of GTP and convert the enzyme into the inactive 
GDP-bound state [21-24]. In C. albicans, Lrg1 is proposed to act as the Rho1 GAP 
based on the evidence that lrg1Δ/Δ mutant and hyper-activated RHO1Q67L mutants 
both induce hyphal formation individually and ScLrg1 is a GAP for ScRho1 in 
Saccharomyces cerevisiae, suggesting that Lrg1 negatively regulates Rho1 
activity [25, 26]. However, GAP activity towards Rho1 in vitro has not been 
evaluated in C. albicans [25]. 
Cdc42 is also an essential GTPase in C. albicans, and it is required for cell 
viability, polarized growth, yeast-to-hyphal morphogenesis etc. [27, 28]. Like other 
GTPases, CaCdc42 activity is regulated by GAPs negatively and the GEFs 
positively [23]. The activated Cdc42 turns on downstream effectors including PAK 
kinase Cst20, which further initiates hyphal formation by mediating Cek1 MAPK 
cascade signaling [17, 27]. The Cek1 MAPK cascade, comprised of Ste11-Hst7-
Cek1, is primarily responsible for gene transcription involved in morphogenesis, 
cell wall stress adaption, and cell growth [17, 29-31]. In C. albicans, Cek1 has been 
reported to respond to several GTPases including Cdc42, Rho1, Ras1, and Rac1, 
although most of this data is genetic in nature [17, 32, 33]. Here, we demonstrate 
for the first time that in C. albicans, Lrg1 negatively controls Cdc42 and Ras1 
activity in vivo, but not Rho1 or Rac1. Moreover, activation of Cek1 downstream of 
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lrg1Δ/Δ occurs through the canonical Ste11 MAPKKK. Furthermore, we reveal that 
hyperactivation of Cek1 by a Ste11ΔN467 allele compromises fungal virulence in the 
mouse model of systemic infection.  
 
Methods 
Strains and growth media 
All the strains and plasmids in this study are described in Table S.3. 1 and Table 
S.3. 2, respectively. Primers used in this study were described in Table S.3. 3. The 
media used to culture strains was yeast extract-peptone-dextrose (YPD) medium 
(1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher Scientific)) [34]. 
YPM medium (1% yeast extract, 2% peptone, and 2% maltose (Thermo Fisher 
Scientific)) was used to flip out SAT1-flipper which is under the control of maltose 
(MAL2) promoter. Doxycycline (Sigma-Aldrich, USA) was added with the working 




To generate the LRG1 reintegrated strain, primers TCO68 and TCO69 were used 
to amplify the LRG1 open reading frame (ORF) and 200bp of terminator as a SacI-
NotI fragment, which was cloned into the pBT1 vector [35] between the constitutive 
ENO1 promoter and the SAT1 selective marker. The resultant pTC7 was cut with 
MscI and the linearized fragment was transformed to the lrg1Δ/Δ competent cells 
by electroporation to create the TC14 mutant. The transformation method has 
been described in [36]. 
To generate the homozygous deletion of STE11, the same protocol was 
utilized as described in [37] with minor modification. ~500 bp of 5’ promoter and 3’ 
terminator flanking the STE11 ORF were amplified as KpnI-XhoI and NotI-SacI 
fragments, by using the primers TCO155+TCO156 and TCO157+TCO158, 
respectively. These two fragments were cloned to the corresponding ends of the 
SAT1-flipper plasmid pSFS2A, respectively [38]. The resulting plasmid pTC71 was 
digested with KpnI and SacI, and the larger fragment was transformed into lrg1Δ/Δ. 
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The nourseothricin-resistant transformants were further cultured in YPM medium 
containing maltose as a carbon source to induce caFLP expression, which is under 
MAL2 promoter regulation. Successful deletion of one STE11 allele was confirmed 
by PCR with the primers TCO159+JCO95. To delete the second STE11 allele in 
the resultant Candida strain TC41, primers TCO162+TCO163 were used to 
amplify the tetracycline-repressing promoter PtetOFF with the template of plasmid 
pWTF1 [39]. The PtetOFF N-terminal was flanked by 60bp of homology to the STE11 
promoter and the C-terminal was flanked by 60 bp of homology to the STE11 open 
reading frame (ORF) located at 1402 -1461 bp. The PCR product was gel-purified 
(Qiagen Inc., Germany), and transformed into the competent Candida TC41 cells, 
and plated on YPD plates with 2mg/ml hygromycin B. The primers 
TCO181+TCO57 were utilized for colony PCR to confirm if the pWTF1 fragment 
replaced the N-terminal 1401bp of STE11 ORF on the chromosome. 
To generate the Candida strain which expresses the doxycycline regulated 
PtetOFF–STE11ΔN467, primers TCO162+TCO163 were utilized as mentioned above 
to amplify the tetracycline-repressing promoter from the template of plasmid 
pWTF1 [39]. The PCR product was transformed to the wild-type DAY286 
competent cells, and then plated on the YPD plates with 2mg/ml hygromycin B. 
TCO168+TCO169 were used to check if pWTF1 was integrated into the 
chromosome.  
To generate the GST-RID-6×His construct, primers TCO139+TCO140 were 
used to amplify the RID domain located at 1111-1908bp of the CaPKC1 ORF as a 
BamHI-SalI fragment by using C. albicans genomics DNA as template, which was 
then cloned into the expression vector pGEX to create pTC55. The resultant 
plasmid was transformed into competent E. coli BL21 cells for high protein 
expression. Primers TCO165+TCO92 were used to amplify a Candida-adapted 
hygromycin B resistance marker from pRB436 as a NotI-XbaI fragment. The PCR 
product was ligated to the corresponding sites in pYGS1244 [24], in which Rho1 
was tagged with 6×myc at the N-terminus. The resultant pTC73 was transformed 
into the Candida strains of interest.  
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To tag the N-terminus of Rac1 with GFP, TCO170+TCO175 were used to 
amplify the RAC1 ORF flanked by RsrII and Mlu, from genomic DNA extracted 
from the C. albicans DAY286 strain. The PCR product was digested and inserted 
into the corresponding locus of the plasmid pTC33 to replace the RID domain. 
TRO993 was used for sequencing to check if the RAC1 was ligated into the 
plasmid in the correct orientation. The resultant plasmid pTC76 was linearized by 
StuI restriction enzyme, followed by electroporation into Candida competent cells. 
The positive transformants selected on YPD with nourseothricin were further 
screened for GFP fluorescence by performing microscopy with a LEICA DM5500B 
epi-fluorescent microscope with a Hamamatsu Orca-ER CCD digital camera 
(Model#: C4742-80-12AG).  
To generate the hyperactive RAS1G13V allele, primers TCO185+TCO186 
were used to PCR amplify the RAS1G13V allele from the genome of the Ca79 strain 
[40].and introduce NotI and SacI restriction sites. The PCR product was digested 
and ligated into the plasmid pBT1. TCO185 was used for sequencing to check if 
the RAS1G13V allele was inserted with the correct orientation. The resultant plasmid 
pTC78 was linearized with BglII and transformed to the C. albicans competent cells 
of interest. The positive colonies were selected on YPD plates with nourseothricin 




To measure Rho1 activity, we first generated a GST-RID-6×His (Rho1 Interactive 
Domain) construct that binds with GTP-Rho1 and expressed it in E. coli BL21 
strain. The overnight culture was diluted to 1:100 ratio in fresh LB medium and 
grown to OD600 0.6-0.9. IPTG (Sigma-Aldrich) was added to the final concentration 
of 5mM to induce GST-RID expression at 20°C for 20hrs. The culture was pelleted 
by centrifugation and resuspended into cell lysis buffer (50mM Tris-HCl, 500mM 
NaCl, 30mM Imidazole, 400ul of 0.25mM PMSF (phenylmethylsulfonyl fluoride), 
100ul of BME, 10mM MgCl2, and 1 protease inhibitor tablet (Roche Diagnostics 
GmbH, Mannheim, Germany)) was agitated by sonication (Sonic Dismembrator 
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F550 Ultrasonic Homogenizer, Fisher Scientific). The liquid was centrifuged for 1hr 
at 17,000rpm at 4°C. The protein is soluble and was thus located in the 
supernatant. The solution was then slowly run through a Ni-NTA column (QIAGEN 
Inc., Germany) for binding, and the beads were then gently washed with wash 
buffer (50mM Tris-HCl, PH8.0, 500mM NaCl, 30mM imidazole) to remove the 
nonspecific binding protein. To elute out the His-tagged protein, 6 rounds of 250ul 
of elution buffer (the same as wash buffer except with 300mM imidazole) was 
added. The eluted fractions were then run through a PD-10 column (GE 
Healthcare) to remove the imidazole. The product was applied to an Amicon ultra 
0.5ml-centrifugal filter unit (Merck KGaA, Darmstadt, Germany) to concentrate the 
protein. 
 
Western Blotting  
Western Blotting was performed as previously described [17]. To detect the 
phosphorylation of Cek1 and Mkc1 MAPKs, rabbit anti-Phospho-p44/42 antibody 
(Cell Signaling Technology, Inc., USA) at 1:2,000 dilution was utilized. The 
expression of total Mkc1 was detected with the primary rabbit-anti-total Mkc1 Ab 
at a 1:1000 dilution. The expression of total Cek1 was measured with a rabbit-anti-
total Cek1 Ab at a 1:1000 dilution. The secondary antibody against Phospho-
p44/42 Ab, Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–rabbit IgG (H+L) 
conjugate (green, 1:10,000 dilution; LI-COR Biosciences). Tubulin was detected 
as a control with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA) 
at a 1:1000 dilution and IRDye 680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000 
dilution; LI-COR Biosciences).  
 
Pull-down assay for active GTPases  
GTPase activity assay was performed as previously described [17]. The procedure 
of cell wall disruption and protein concentration determination followed the above-
mentioned Western Blotting protocol. To detect Cdc42 activity, 1,500 μg of total 
protein was used for the pull-down procedure following the instruction from the 
Active Cdc42 Pull-Down and Detection Kit (Thermo Fisher Scientific, USA). The 
 96 
same kit was used to pull down the active GTP-bound GFP-tagged-Rac1 (See 
Strain Construction), since the GST-Pak1 provided in the kit can also bind with 
active Rac1. GTPase Ras1 activity was evaluated following the protocol from the 
Active Ras1 Pull-Down and Detection Kit (Thermo Fisher Scientific, USA). To pull-
down the active GTP-bound c-myc-tagged Rho1 (See Strain Construction), the 
Active Rho Pull-Down and Detection Kit (Thermo Fisher Scientific, USA) was 
purchased and the instruction was followed, except that the purified GST-
Rhotekin-RBD peptides provided in the kit was replaced with the purified GST-
RID-6×His that we generated (See Protein Purification above) for optimized 
binding capacity between GTP-Rho1 and the RID domain.  
The antibody used to detect Cdc42 was rabbit polyclonal anti-S. cerevisiae 
Cdc42 (kindly sent by Dr. Doug Kellogg at University of California, Santa Cruz). 
The antibody to detect Ras1 was mouse monoclonal anti-Ras1 antibody (Anti-Ras, 
clone RAS10, Millipore Sigma, USA) with the working concentration at 1.5µg/ml. 
The antibody for c-myc-Rho1 detection was mouse anti-c-Myc Monoclonal 
Antibody (9E10) (Thermo Fisher Scientific, USA) at 1:1000 dilution. The rabbit anti-
GFP antibody was used for the GFP tagged-Rac1 detection (Sigma Inc., USA). 
The antibody to recognize the loading control tubulin was rat anti-tubulin (Bio-Rad 
Inc., USA). The secondary antibody included IRye800CW goat anti–mouse IgG 
(H+L) conjugate (1:10,000; LI-COR biosciences), IRye800CW goat anti-rabbit 
IgG(H+L) conjugate (1:10,000; LI-COR biosciences), and IRye600RD goat anti-rat 
IgG(H+L) conjugate (1:10,000; LI-COR biosciences). Densitometry quantification 
of active GTP-bound GTPases versus the total GTPases input bands was 
performed with ImageJ (National Institutes of Health, Bethesda, MD). 
 
Immunofluorescent imaging of β (1,3)-glucan exposure 
To stain the lrg1Δ/Δ mutant, Candida cells were grown overnight in YPD at 30 °C. 
The culture was collected and processed to immunostaining. The staining and 




To stain the STE11ΔN467 strain under the regulation of PtetOFF promoter over-time, 
overnight cultures in YPD with doxycycline were diluted back to 0.2, and cells were 
collected after 1h, 2h, 4h and 6h grown in the fresh YPD medium without 
doxycycline. To stain the lrg1Δ/Δ mutant, overnight culture in YPD was collected 
for immunostaining. The staining protocol and gating strategy was followed as 
described in [17]. Flow cytometry data were obtained for 100,000 gated events per 
strain and experiments were performed in triplicate, and the data were analyzed 
using FlowJo software package with version 10.11 (FlowJo LLC, OR, USA).  
 
Enzyme-linked immunosorbent assay (ELISA) of TNF-α 
To activate Ste11ΔN467 expression under the PtetOFF regulation, the PtetOFF-
STE11ΔN467 mutant was grown in YPD without doxycycline overnight. RAW264.7 
murine macrophages were in used in this assay. ELISA kit instructions (R&D 
Systems, USA) were followed. Each sample has three individual wells, and the 
statistical analysis was performed by using Two-way analysis of variance ANOVA 
(GraphPad Prism, v7.04 software).  
 
Mouse model  
Outbred male ICR mice were used in this study. C. albicans wild-type DAY286 and 
PtetOFF–STE11ΔN467 strains were cultured overnight at 30°C in 50ml YPD with 0.5 
µg/ml of doxycycline to repress Ste11ΔN467 expression. The overnight culture was 
counted via hemocytometer and diluted to 107 cells/ml. The diluted fungal cells 
were plated on YPD plate to test the viability. Mice were injected via the lateral tail 
vein with 0.1 ml of the fungal cells. Mice were given drinking water either co-
supplemented with 2 mg/ml doxycycline plus 5% sucrose to cover the bitter taste 
of the antibiotics [41] or given 5% sucrose water alone. Mice were monitored 
closely for 21 days for signs of illness. For the fungal burden counting experiment, 
mice were sacrificed 4 days post infection. Kidneys were harvested, homogenized 
and serial diluted in water, and plated on YPD plate. The plates were incubated at 
30°C for 2 days to determine cfu per gram of kidney.   
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Ethics statement 
All mouse model experiments in this study were performed under an animal 
protocol (1083) that was approved by the University of Tennessee Institutional 
Animal Care and Use Committee (IACUC) and followed the ethical guidelines set 
forth by the National Institute of Health (NIH) for the ethical treatment of animals. 
 
Results  
The lrg1Δ/Δ mutation causes β (1,3)-glucan exposure in C. albicans   
Lrg1 homologs impact several cell wall-related functions in fungi (e.g. cell wall 
integrity, cell fusion, and morphogenesis) [25, 26, 42, 43]. In S. cerevisiae, Lrg1 
stimulates the intrinsic GTPase activity of Rho1, and therefore converts Rho1 to 
its inactive, GDP-bound state [26, 42, 43]. We previously showed that hyperactive 
Rho1 exposes β (1,3)-glucan in the cell wall, but appeared to act through the Cek1 
MAPK rather than Mkc1 [17]. Since Lrg1 has been described as the Rho1 GAP in 
C. albicans, we hypothesized that disruption of LRG1 would cause β (1,3)-glucan 
exposure. To this end, we performed immunofluorescence staining with anti-β 
(1,3)-glucan antibody to examine if the lrg1Δ/Δ mutant exhibits increased β (1,3)-
glucan exposure. As shown in Figure 3. 1A, β (1-3)-glucan is noticeably more 
exposed in lrg1Δ/Δ cells than in wild-type or the complemented strain, where Lrg1 
expression is under the regulation of constitutive promoter PENO1. Flow cytometry 
confirms that lrg1Δ/Δ has significantly increased levels of β (1,3)-glucan 
unmasking compared to control strains (Figure 3. 1B). This reveals that Lrg1 acts 
as a repressor of cell wall β (1,3)-glucan unmasking in C. albicans.  
 
LRG1 disruption up-regulates the Cek1 MAPK activity 
Several MAPKs pathways are involved in the regulation of cell wall architecture in 
C. albicans [29, 44], and improper activation of the Cek1 MAPK by upstream 
GTPases such as Cdc42 or Rho1 causes β (1,3)-glucan exposure [17]. Lrg1 is a 
proposed Rho1 GAP in C. albicans [25], which should upregulate Mkc1 and 
possibly Cek1. To this purpose, we performed Western blotting to detect the 
activated (phosphorylated) forms of Cek1 and Mkc1 in C. albicans. As seen in 
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Figure 3. 1. Lrg1 represses β (1,3)-glucan unmasking in C. albicans.  
(A) Cells cultured overnight in YPD medium were stained with anti-β (1,3)-glucan antibody and 
Cy3-conjugated secondary antibody. Cells were imaged by epi-fluorescent microscopy. (B) Cells 
were stained with anti-β (1,3)-glucan antibody and Phycoerythrin (PE) –conjugated secondary 
antibody. Flow cytometry was performed to quantify β (1,3)-glucan exposure in different Candida 
cells. The statistical analysis was performed by doing One-way ANOVA. ****, p<0.0001 
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Figure 3. 2, lrg1Δ/Δ does not visibly increase the intensity of phosphorylated Mkc1, 
but instead Cek1 was hyper-phosphorylated up to 15-fold compared to wild-type. 
This indicates that Lrg1 represses the activity of Cek1 instead of Mkc1 in C. 
albicans, and this might be responsible for the cell wall exposure in the lrg1Δ/Δ 
mutant. 
 
 LRG1 disruption hyper-activates the small GTPases Cdc42 and Ras1 
The small GTPase Cdc42 sits upstream of Cek1, and is essential for many cellular 
functions, including cellular polarized growth and bud emergence in C. albicans 
[27, 45]. Regulation of the GTP/GDP-binding state controls the Cdc42 activation 
state [27]. Given that Cdc42 is known to control Cek1 MAPK activity in C. albicans, 
we hypothesized that the lrg1Δ/Δ disruption activates Cek1 through Cdc42. To test 
this, we measured Cdc42 activity by quantifying the amount of GTP-bound active 
Cdc42 in vivo. As seen in Figure 3. 3A and B, the concentration of GTP-bound 
Cdc42 was clearly up-regulated compared to that of wild-type DAY286 and the 
reintegrated strain. Thus, this suggests that Lrg1 controls Cdc42 activity negatively 
in C. albicans. Cdc42 has been shown to control Cek1 phosphorylation in this 
organism [17], so LRG1 disruption-dependent Cek1 hyper-activation may be 
mediated by Cdc42.  
There is a possibility that Lrg1 impacts other Cek1-associated GTPases. To 
address this, we measured the activity of the GTPase Rac1, which has been 
implied to function upstream of Cek1 [33]. Rac1 activity was assessed by pulling 
down the activated GTP-bound GFP-tagged Rac1. The Cdc42/Rac1 interactive 
binding (CRIB) protein used in the Cdc42 pull-down assay were used as the probe 
to isolate GTP-bound Rac1, while GFP antibody was utilized to detect the amount 
of GFP-Rac1 specifically. As shown in Figure S.3. 1, the level of GTP-bound GFP-
Rac1 in the lrg1Δ/Δ mutant is reduced compared to that of wild-type. This suggests 
that Rac1 and Cdc42 might work antagonistically when Lrg1 is disrupted in C. 
albicans.   
Ras1 is an important GTPase for filamentation and controls the cyclic AMP 
signaling cascade and protein kinase A. It has been suggested to act upstream of 
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Figure 3. 2 .The Cek1p MAPK is hyper-phosphorylated in lrg1Δ/Δ cells compared to wild-
type  
(A). Proteins were isolated from Candida cells sub-cultured 3 hrs into log phases after grown 
overnight in YPD at 30°C. Western blotting was performed with anti-phospho-p44/42 antibody, 
which stains both phosphorylated Mkc1 and Cek1, as well as anti-Mkc1 and -Cek1 antibodies, 
which stain total Mkc1 and Cek1 proteins, respectively. Phospho-MAPKs signal was expressed as 
a percent of wild-type (WT) control after being normalized to the tubulin loading control. (B). The 
P-Mkc1 bands were quantified and normalized based on the total Mkc1 bands and tubulin. (C). The 
P-Cek1 bands were quantified and normalized based on the total Cek1 bands and tubulin. The 
graphs in both cases were based on quantification of 3 blots, and statistical analysis was performed 
by doing one-way ANOVA. ****, p<0.0001 
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Cek1 in C. albicans [32]. Since Cek1 is hyper-active in the lrg1Δ/Δ mutant (Figure 
3. 2), it is reasonable to evaluate if Ras1 activity is upregulated when LRG1 is 
disrupted. We performed pull-down assay to isolate active GTP-Ras1 by using its 
downstream effector Raf1 as a probe. The ratio of GTP-Ras1 to total Ras1 is 
significantly higher in lrg1Δ/Δ than that in other strains, indicating that LRG1 
disruption induces Ras1 activity (Figure 3. 3C and D). To biochemically test if Ras1 
can cause Cek1 hyperactivation, we performed Western blotting on the PMAL-
RAS1G13V mutant (hyperactive allele) with Phospho-p44/42 antibody recognizing 
the phosphorylated Cek1 and Mkc1. Unexpectedly, as seen in Figure 3. 3E, 
hyperactivated Ras1G13V does not induce Cek1 activation under the inducing 
conditions of using maltose as the carbon source. Similar results were seen in the 
RAS1G13V mutant under the constitutive promoter PENO1 (Figure S.3. 2). These 
results indicate that in C. albicans Ras1 is not activating Cek1 downstream of the 
lrg1Δ/Δ mutation.   
 
Lrg1 does not act as the Rho1 GAP in C. albicans  
In S. cerevisiae, Lrg1 represses Rho1, and this has been implied by genetic data 
in C. albicans, therefore, we measured Rho1 activity in the lrg1Δ/Δ mutant. Due to 
lack of a commercial reagent to pull down active GTP-Rho1, we expressed and 
purified a GST-tagged Rho1 interactive domain (RID) protein specific for C. 
albicans GTP-Rho1 [46]. Due to lack of available commercial CaRho1 antibody, 
CaRho1 was tagged with the c-myc epitope tag for the Western blot detection [24]. 
However, as shown in Figure 3. 3F and G, the lrg1Δ/Δ mutant does not contain a 
higher concentration of GTP-Rho1 compared to wild-type. GTPγS is a non-
hydrolysable substrate for these GTPases and therefore acts as positive control to 
evaluate if our reagents work. The lack of an induction of Rho1 activity in the 
lrg1Δ/Δ mutant suggests that Lrg1 does not act as the Rho1 GAP in C. albicans. 
 103 
Figure 3. 3. Lrg1 inhibits the activity of GTPases Cdc42 and Ras1, but not Rho1.  
(A). GTP-Cdc42 was pulled-down by glutathione beads conjugated with glutathione S-transferase (GST)-PAK1, which specifically binds active GTP-
Cdc42/Rac1. Western blotting was performed on the isolated GTP-Cdc42 portion with anti-Cdc42 antibody and tubulin was used as loading control. 
(B). The GTP-bound Cdc42/Total-Cdc42 ratio compared to WT was calculated. The densitometry of active GTP-Cdc42 band and total Cdc42 band 
was quantified by Image J based on 2 blots. *, p=0.0261. (C). The active GTP-Ras1 was pulled down by using the Ras1 binding domain (RBD) 
within Raf1 as a probe, followed by Western blotting using anti-Ras1 antibody to evaluate the amount of active Ras1. (D). The ratio of GTP-bound 
Ras1/Total-Ras1 compared to WT was calculated as shown in B. ***, P=0.0006. (E). Western blotting was performed with anti-P-p44/42 antibody to 
assess the phosphorylation of Cek1 in the hyperactive RAS1G13V mutant under the regulation of maltose promoter. (F). The active c-myc-tagged 
Rho1 was isolated by incubating with the purified GST-RID protein. The mixture was incubated with glutathione beads. Western blotting was 
performed with anti-c-myc antibody to demonstrate the amount of GTP-bound Rho1 in the pulled-down portion. Total Rho1 was determined by 
performing Western blotting on the total protein extract. (G). The ratio of GTP-bound Rho1/Total-Rho1 compared to WT was calculated as shown in 
B. NS, no significance. 
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Figure 3. 3 Continued 
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Ste11 disruption blocks Cek1 hyper-phosphorylation and β (1,3)-glucan 
exposure in lrg1Δ/Δ 
Our results indicate that Lrg1 negatively controls Cek1 phosphorylation through 
Cdc42 (Figure 3. 3), but it is was not clear if the pathway acts through the canonical 
Cek1 MAPK cascade. Therefore, we next elucidated which upstream kinase 
participates in this signal transduction pathway. The Ste11 MAPKKK sits at the top 
of the Cek1 MAPK module, therefore we disrupted STE11 in lrg1Δ/Δ to determine 
if this would prevent Cek1 activation. One STE11 allele was deleted in lrg1Δ/Δ 
using SAT1-flipper [37]. However, we could not disrupt the second STE11 allele in 
lrg1Δ/Δ. Thus, we replaced the second allele with the hyperactive STE11ΔN467 
allele under the regulation of tetracycline-repressible promoter (PtetOFF-
STE11ΔN467). This resulted in an lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 strain, 
indicating that STE11 is not essential in the lrg1Δ/Δ background, but may be 
difficult to recover from transformation conditions. The lrg1Δ/Δste11Δ/Δ::Ptet-OFF-
STE11ΔN467 mutant was treated with 0.5µg/ml of doxycycline overnight to repress 
STE11 expression, followed by sub-culture in fresh YPD medium ±doxycycline for 
3 hours. Western blotting was performed to measure Cek1 and Mkc1 activation.
 As seen in Figure 3. 4A, failure to express Ste11 in lrg1Δ/Δ 
(lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 +doxycycline) blocks Cek1 phosphorylation. 
This result indicates that Lrg1 negatively controls Cek1 activity through Ste11. We 
next investigated if β (1,3)-glucan exposure can be suppressed in lrg1Δ/Δ when 
Ste11 expression is repressed. The overnight cultured Candida cells 
(±doxycycline) were stained with anti-β (1,3)-glucan antibody, and then measured 
by flow cytometry to quantify the unmasking. As seen in Figure 3. 4B, inhibition of 
Ste11 expression by adding doxycycline (lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 
+doxycycline) completely blocked β (1,3)-glucan unmasking. This indicates that 
hyper-activation of the Cek1 MAPK pathway is responsible for exposing β (1,3)-




Figure 3. 4. Disruption of LRG1 causes Cek1 over-activation through Ste11 MAPKKK  
A. One STE11 allele was deleted in lrg1Δ/Δ using the well-established SAT1-flipper method. The second STE11 allele was replaced by the 
PtetOFF-STE11ΔN467 allele. The Candida cells were treated with 0.5µg/ml of doxycycline overnight at 30°C, followed by sub-culture in fresh 
YPD medium for 3 hours at 30°C into log phase with or without doxycycline. Western blotting was performed with the anti-P-p44/42 antibody. 
B. The Candida cells were cultured overnight with or without doxycycline, followed by immunofluorescent staining with anti-β (1,3)-glucan 
antibody and PE-conjugated secondary antibody. The stained cells were measured by flow cytometry for the quantification of β (1,3)-glucan 
exposure. Strains were tested three times with 2 technical replicates each time, and statistical analysis was performed by doing one-way 
ANOVA. ****, p<0.0001. *, p=0.0142.
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Cells with a lrg1Δ/Δ mutation or expressing the hyperactive STE11ΔN467 allele 
induce TNF-α secretion from RAW264.7 macrophages 
The relationship between the increased β (1,3)-glucan exposure and more TNF-α 
secretion has been studied intensively [9, 11, 13, 15, 17, 30]. Due to the strong β 
(1,3)-glucan exposure exhibited by lrg1Δ/Δ (Figure 3. 1), we performed enzyme-
linked immunosorbent assays (ELISAs) to study if unmasking in lrg1Δ/Δ correlates 
with increased TNF-α production. As seen in Figure 3. 5A, loss of LRG1 
significantly up-regulates TNF-α secretion released from RAW264.7 murine 
macrophages. The cho1Δ/Δ mutant in Figure 3. 5A served as a positive control, 
which has shown to cause upregulation of TNF-α production compared to the wild-
type SC5314 strain [11, 15, 17]. Cek1 is hyperactivated in multiple conditions 
associated with β (1,3)-glucan exposure including caspofungin treatment [47], 
cho1Δ/Δ [11], hyperactivation of Cdc42, [17], and lrg1Δ/Δ (Figure 3. 1 and Figure 
3. 2). Furthermore, hyperactivation of Cek1 via an activated allele of STE11 
(STE11ΔN467) causes unmasking [17]. We suspect that this hyperactivation of Cek1 
will lead to decreased virulence. Many of the mutants we have described such as 
hyperactive Cdc42 or Rho1, lrg1Δ/Δ, or cho1Δ/Δ have pleotropic effects, which 
makes it challenging to assess specific roles in virulence. However, the 
STE11ΔN467 mutation causes a more specific upregulation of Cek1 activation [17]. 
 Thus, to test this in vivo, we overexpressed STE11ΔN467 from the 
doxycycline repressible promoter (PtetOFF) [39], so we could then use this in the 
mouse model of infection and turn the gene on or off in the host after infection. We 
transformed the PtetOFF-STE11ΔN467 allele into the wild-type Candida strain DAY286 
cells and confirmed that in the absence of doxycycline Cek1 is hyperactivated 
(Figure S.3. 3), but in the presence of the drug the strain behaved like wild-type. 
Previous overexpression experiments with STE11ΔN467 using the PMAL2-
STE11ΔN467 construct showed hyperactivation of Cek1, but not Mkc1, however 
when we upregulated STE11ΔN467 with the PtetOFF-STE11ΔN467 construct, we 
observed stronger hyperactivation of Cek1 and Mkc1. This may be because a 
strong enough activation of Cek1 causes a compensatory activation of Mkc1 [17], 
although this is not certain.   
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 Immunofluorescent staining of the PtetOFF-STE11ΔN467 strain for β (1,3)-
glucan exposure indicates that when cultured in YPD medium overnight without 
doxycycline, the mutant exhibits significantly increased β (1,3)-glucan exposure 
(Figure S.3. 4). To evaluate the correlation between β (1,3)-glucan exposure 
exhibited by STE11ΔN467 expression from the PtetOFF promoter and TNF-α secretion, 
we performed ELISAs on overnight cultures of wild-type DAY286 and the PtetOFF-
STE11ΔN467 strain in the presence or absence of doxycycline. As seen in Figure 3. 
5B, when Ste11ΔN467 is induced in the PtetOFF-STE11ΔN467 strain (-doxycycline), 
TNF-α production is significantly up-regulated from RAW246.7 macrophages. 
 
Hyperactivation of Cek1 results in decreased fungal virulence in vivo 
We predict that due to increased unmasking, activation of PtetOFF-STE11ΔN467 in 
mice will lead to a loss of virulence. To test this, wild-type and PtetOFF-STE11ΔN467 
strains were cultured in YPD overnight with doxycycline to repress Ste11ΔN467 
expression, and then injected into the tail vein of outbred ICR mice. The mice 
injected with the PtetOFF-STE11ΔN467 strain and provided with doxycycline 
succumbed to fungal infection in ~10 days. This is similar to mice injected with 
wild-type ±doxycycline. However, mice infected with PtetOFF-STE11ΔN467 without  
doxycycline (where STE11ΔN467 is overexpressed), survived significantly longer 
than mice in the other groups (Figure 3. 6).   
 Furthermore, when mice were sacrificed at day 4 post-infection, mice 
infected with PtetOFF-STE11ΔN467 minus doxycycline exhibited (2.43±1.07) ×102 cfu 
g-1 kidney, while the mice infected with the same strain with doxycycline exhibited 
(2.51±0.65) ×104 cfu g-1 of kidney (Figure 3. 7). Thus, there was a decrease of ~ 2 
logs (P=0.0006) in kidney fungal burden when the gene was expressed. A growth 
curve in vitro demonstrated that wild-type and STE11ΔN467 had a similar growth 
pattern without doxycycline, and addition of doxycycline did increase the cell 
division rate modestly from 90 minutes to ~103 minutes in early log phase, 
however, the strain rapidly catches up to wild-type, suggesting only a temporary 




Figure 3. 5. LRG1 disruption significantly induces TNF-α secretion.  
(A). C. albicans cells were grown in YPD overnight at 30°C, UV-inactivated, and then co-cultured 
with RAW264.7 macrophages for 4hrs. The RAW264.7 macrophage supernatant was collected 
and filtered through a 0.22µm syringe filter to remove cell debris. The filtrates were assayed by 
ELISA to quantify the TNF-α production. Samples were tested in triplicate three times for an n of 9. 
The statistical analysis was done by one-way ANOVA. ****, P<0.0001. (B). C. albicans wild-type 
and PtetOFF-STE11ΔN467 strains were cultured overnight in YPD at 30°C, plus or minus doxycycline. 
The UV-kill, incubation with macrophages RAW264.7, filtration and ELISA procedures were the 




Figure 3. 6. Activated Cek1 leads to attenuated fungal virulence in the mouse model of systemic infection.  
C. albicans strains wild-type (DAY286) and PtetOFF-STE11ΔN467 were cultured overnight at 30°C with doxycycline to repress Ste11ΔN467 
expression. The overnight culture was diluted to 106 cells/ml, and 100 µl of the suspension were injected into the lateral tail vein of outbred 
ICR mice. Mice were given 2 mg/ml of sucrose in their drinking water either without doxycycline or with doxycycline to repress Ste11ΔN467 




Figure 3. 7. Ste11 hyper-activation causes decreased kidney fungal burden in the mouse 
model of systemic infection.  
C. albicans strains wild-type DAY286 and PtetOFF-STE11ΔN467 were cultured overnight at 30°C with 
doxycycline to repress Ste11ΔN467 expression. The overnight culture was diluted to 107 cells/ml, and 
100 µl of the suspension was injected to the lateral tail vein of outbred ICR mice. Mice were given 
sucrose drinking water either with doxycycline to repress Ste11ΔN467 expression in vivo or given 
sucrose water alone. The mice were sacrificed 4 days post-infection and the kidneys from each 
mouse were taken and homogenized. The homogenates were diluted to 10-3 by performing serial 
dilution. 1 ml of the diluted homogenates from each dilution were plated on the YPD plates and 
cultured in 30°C for two days. The colony forming unit was counted on each plate. Eight mice were 
tested for each strain. ***, p=0.0006; ****, p<0.0001.  
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that β (1,3)-glucan exposure driven by PtetOFF-STE11ΔN467 activates the host 
immunity more efficiently, which further clears the fungal pathogen more rapidly. 
 
Discussion  
Previously our lab determined that hyper-activation of Cek1 promotes β (1,3)-
glucan exposure in response to loss of phosphatidylserine synthase [17]. This 
process involves the activation of the GTPase Cdc42 which positively regulates 
Cek1 MAPK activity [17]. In this communication, we characterized a novel 
upstream regulator of Cek1 by identifying that the Lrg1 GAP negatively regulates 
Cek1 activity. Lrg1 acts through the GTPase Cdc42, but not the GTPase Rho1, 
which has been reported as a target of Lrg1 in the literature. Lrg1 disruption 
stimulates significantly increased β (1,3)-glucan unmasking, which further induces 
a higher level of TNF-α secretion from murine macrophages. 
 
The Lrg1-Cdc42 cascade modulates Cek1 MAPK activity via Ste11 in C. 
albicans 
In S. cerevisiae, Lrg1 has been shown to interact with the activated form of Rho1 
and act as GAP [26, 48]. However, there are discrepancies concerning the 
negative regulation of other GTPases by Lrg1 in different studies. Roumanie et. al. 
found that Lrg1 acts as GAP for two other GTPases, Rho2 and Cdc42 by 
performing spectroscopic measurement in vitro based on 7-methyl-6-
thioguanosine (MESG)/phosphorylase system [49]. In contrast, Fitch et al. found 
Lrg1 is a Rho1-specific GAP in vitro by measuring the amount of Rho1 bound with 
[α-32P]-labeled GDP or GTP, after stimulation with purified Lrg1 [26]. Regarding 
the effect of Lrg1 on Rho1-mediated cell wall processes, Lrg1 is reported to 
negatively regulate glucan synthase activity, whilst controversy appears on its role 
in activation of the cell wall integrity Mkc1 pathway [42, 48]. These opposing results 
could be due to the different backgrounds of S. cerevisiae strains used. In 
Neurospora crassa, Lrg1 was shown to serve as a Rho1-specific GAP and impact 
several downstream pathways of Rho1 [43]. In C. albicans, the lrg1Δ/Δ mutant 
increases hyphal formation and biofilm development, which are phenotypes 
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shared with a RHO1Q67L gain of function mutant. However, in this study there was 
no biochemical evidence to demonstrate that Lrg1 acts as Rho1 GAP [25, 50].  
In this communication, we provided evidence that in C. albicans loss of Lrg1 
increases β (1,3)-glucan masking (Figure 3. 1), and this is likely mediated by hyper-
activated Cek1 (Figure 3. 2). Our results also suggest that Lrg1 does not act as a 
Rho1 GAP in C. albicans. Lrg1 does not show Rho1 inhibitory activity in vivo, nor 
does it inhibit Rac1 activity (Figure 3. 3 and Figure S.3. 1). Instead, Lrg1 exhibits 
repression of the activities of both Cdc42 and Ras1, as indicated by significant 
induction of both GTPase activities in vivo in the lrg1Δ/Δ mutant (Figure 3. 3). The 
unexpected results imply signal rewiring occurs in the pathogenic C. albicans 
versus the non-pathogenic S. cerevisiae. Ras1 plays pivotal roles in fungal 
morphogenesis, and as a result contributes to virulence [32]. Loss of RAS1 causes 
defects in yeast-to-hyphal transition, which nonetheless can be restored by 
overexpressing signaling component in the Cek1 pathway in the ras1Δ/Δ mutant 
[32]. Although this suggests that Ras1 might be upstream of Cek1, we cannot rule 
out the possibility that Cek1 and Ras1 act in a parallel manner. Our western blot 
result shows that hyperactive RAS1G13V mutant does not display Cek1 
overactivation (Figure 3. 3E and Figure S.3. 2), suggesting that hyperactivation of 
Ras1 is not sufficient to induce Cek1 phosphorylation, and that these two proteins 
are not in a linear signaling cascade.  
 The Ste11 MAPKKK is a well-known upstream regulator of Cek1 activity 
and the hyperactivated STE11ΔN467 mutant causes β (1,3)-glucan exposure in C. 
albicans [17]. Here we show that Ste11 is also involved in the Lrg1-dependent 
Cek1 hyperactivation, given that disruption of STE11 rescues both β (1,3)-glucan 
exposure and Cek1 hyper-phosphorylation in the lrg1Δ/Δ mutant (Figure 3. 4). 
Given the established effect of Cdc42 on Cek1 activation [17], our results indicate 
that Lrg1 negatively modulates Cek1 activity via the GTPase Cdc42 (Figure 3. 8).  
 
β (1,3)-glucan exposure compromises fungal virulence  
Several cell wall defective mutants have exhibited attenuated fungal virulence in 
the mouse model of systemic infection, including the phosphatidylserine synthase  
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Figure 3. 8. A model shows that Lrg1 acts as a molecular switch regulating Cek1 activity 
negatively via the GTPase Cdc42.  
(A). Lrg1 disruption turns on GTPase Cdc42 activity in vivo, which is represented by higher level of 
GTP-bound Cdc42. This further phosphorylates/activates the canonical downstream Ste11-Hst7-
Cek1 cascade. Hyperactivated Cek1 is shown in this study to stimulate β (1,3)-glucan exposure 
and compromise fungal virulence. (B). Lrg1 is speculated to act as GTPase Cdc42 GAP, which 
stimulates its intrinsic GTPase activity. Cdc42 is therefore favorably disposed to GDP-bound state 
to suppress Cek1 phosphorylation.
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mutant (cho1Δ/Δ), ace2Δ/Δ, cek1Δ/Δ, kre5 Δ/Δ, phr1 Δ/Δ [11, 15, 30, 51, 52]. 
However, all these mutants display pleotropic phenotypes. Therefore, it is hard to 
differentiate the effect of β (1,3)-glucan exposure versus the role that other types 
of defects play on fungal virulence. Also, β (1,3)-glucan of the mutants is exposed 
even before the fungal cells are injected into the mouse tail. This raises a problem 
that the mutants with β (1,3)-glucan exposed might be recognized and cleared by 
the immune systems more rapidly, even before the systemic infection is 
established.  
 In this communication, we made the PtetOFF-STE11ΔN467 mutant that 
addressed the above-mentioned disadvantages. Ste11 sits upstream and 
specifically regulates Cek1 activity in C. albicans [53]. The truncated STE11ΔN467 
mutant without the N-terminal inhibitory domain displays great induction of Cek1 
activity and higher level of β (1,3)-glucan exposure [17]. The PtetOFF promoter can 
be further used to control Ste11ΔN467 expression, by adding/removing the inhibitor 
doxycycline as needed. The STE11ΔN467 mutant when induced to hyper-activate 
Cek1 has decreased virulence in vivo, reflected by significantly greater mouse 
survival over 21 days compared to other control groups, and an ~100 fold 
decreased in fungal burdens in mouse kidneys (Figure 3. 6 and Figure 3. 7). This 
suggests that the exposed β (1,3)-glucan might contribute to the attenuated fungal 
virulence, due to its higher visibility to immune receptors via Dectin-1 potentially. 
Regardless of the mechanism, virulence is compromised, thus hyperactivation of 
Cek1 via a variety of different pathways may be useful for improving immune 




1. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The 
epidemiology and attributable outcomes of candidemia in adults and children 
hospitalized in the United States: a propensity analysis. Clinical infectious diseases 
: an official publication of the Infectious Diseases Society of America. 
2005;41(9):1232-9. doi: 10.1086/496922. PubMed PMID: 16206095. 
2. Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk 
FL. Immune defence against Candida fungal infections. Nat Rev Immunol. 
2015;15(10):630-42. doi: 10.1038/nri3897. PubMed PMID: 26388329. 
3. Cheng SC, Joosten LA, Kullberg BJ, Netea MG. Interplay between Candida 
albicans and the mammalian innate host defense. Infection and immunity. 
2012;80(4):1304-13. doi: 10.1128/IAI.06146-11. PubMed PMID: 22252867; 
PubMed Central PMCID: PMCPMC3318407. 
4. Casadevall A, Pirofski LA. Adjunctive immune therapy for fungal infections. 
Clinical infectious diseases : an official publication of the Infectious Diseases 
Society of America. 2001;33(7):1048-56. doi: 10.1086/322710. PubMed PMID: 
11528579. 
5. Gow NAR, Latge JP, Munro CA. The Fungal Cell Wall: Structure, 
Biosynthesis, and Function. Microbiology spectrum. 2017;5(3). doi: 
10.1128/microbiolspec.FUNK-0035-2016. PubMed PMID: 28513415. 
6. Rappleye CA, Eissenberg LG, Goldman WE. Histoplasma capsulatum 
alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. 
Proceedings of the National Academy of Sciences of the United States of America. 
2007;104(4):1366-70. doi: 10.1073/pnas.0609848104. PubMed PMID: 17227865; 
PubMed Central PMCID: PMCPMC1783108. 
7. Garfoot AL, Shen Q, Wuthrich M, Klein BS, Rappleye CA. The Eng1 beta-
Glucanase Enhances Histoplasma Virulence by Reducing beta-Glucan Exposure. 
MBio. 2016;7(2):e01388-15. doi: 10.1128/mBio.01388-15. PubMed PMID: 
27094334; PubMed Central PMCID: PMCPMC4850272. 
8. Gravelat FN, Beauvais A, Liu H, Lee MJ, Snarr BD, Chen D, et al. 
Aspergillus galactosaminogalactan mediates adherence to host constituents and 
conceals hyphal beta-glucan from the immune system. PLoS pathogens. 
2013;9(8):e1003575. doi: 10.1371/journal.ppat.1003575. PubMed PMID: 
23990787; PubMed Central PMCID: PMCPMC3749958. 
9. Wheeler RT, Kombe D, Agarwala SD, Fink GR. Dynamic, morphotype-
specific Candida albicans beta-glucan exposure during infection and drug 
treatment. PLoS pathogens. 2008;4(12):e1000227. doi: 
10.1371/journal.ppat.1000227. PubMed PMID: 19057660; PubMed Central 
PMCID: PMC2587227. 
10. Hopke A, Nicke N, Hidu EE, Degani G, Popolo L, Wheeler RT. Neutrophil 
Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and 
Altered Immune Recognition. PLoS pathogens. 2016;12(5):e1005644. doi: 
10.1371/journal.ppat.1005644. PubMed PMID: 27223610; PubMed Central 
PMCID: PMC4880299. 
11. Davis SE, Hopke A, Minkin SC, Jr., Montedonico AE, Wheeler RT, 
Reynolds TB. Masking of beta(1-3)-glucan in the cell wall of Candida albicans from 
 117 
detection by innate immune cells depends on phosphatidylserine. Infection and 
immunity. 2014. doi: 10.1128/IAI.01612-14. PubMed PMID: 25114110. 
12. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage 
recognition of Candida albicans yeast but not filaments. Embo Journal. 
2005;24(6):1277-86. doi: 10.1038/sj.emboj.7600594. PubMed PMID: 
WOS:000228327000018. 
13. Hopke A, Brown AJP, Hall RA, Wheeler RT. Dynamic Fungal Cell Wall 
Architecture in Stress Adaptation and Immune Evasion. Trends in microbiology. 
2018;26(4):284-95. doi: 10.1016/j.tim.2018.01.007. PubMed PMID: 29452950; 
PubMed Central PMCID: PMC5869159. 
14. Wester MJ, Lin J, Neumann AK. A computational model for regulation of 
nanoscale glucan exposure in Candida albicans. PloS one. 
2017;12(12):e0188599. doi: 10.1371/journal.pone.0188599. PubMed PMID: 
29232689; PubMed Central PMCID: PMC5726713. 
15. Hasim S, Allison DP, Retterer ST, Hopke A, Wheeler RT, Doktycz MJ, et al. 
beta-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with 
Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity. 
Infection and immunity. 2017;85(1). doi: 10.1128/IAI.00601-16. PubMed PMID: 
27849179; PubMed Central PMCID: PMC5203643. 
16. Sherrington SL, Sorsby E, Mahtey N, Kumwenda P, Lenardon MD, Brown 
I, et al. Adaptation of Candida albicans to environmental pH induces cell wall 
remodelling and enhances innate immune recognition. PLoS pathogens. 
2017;13(5):e1006403. doi: 10.1371/journal.ppat.1006403. PubMed PMID: 
28542528; PubMed Central PMCID: PMC5456412. 
17. Chen T, Jackson JW, Tams RN, Davis SE, Sparer TE, Reynolds TB. 
Exposure of Candida albicans beta (1,3)-glucan is promoted by activation of the 
Cek1 pathway. PLoS genetics. 2019;15(1):e1007892. doi: 
10.1371/journal.pgen.1007892. PubMed PMID: 30703081. 
18. Qadota H, Python CP, Inoue SB, Arisawa M, Anraku Y, Zheng Y, et al. 
Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan 
synthase. Science. 1996;272(5259):279-81. PubMed PMID: 8602515. 
19. Delley PA, Hall MN. Cell wall stress depolarizes cell growth via 
hyperactivation of RHO1. The Journal of cell biology. 1999;147(1):163-74. 
PubMed PMID: 10508863; PubMed Central PMCID: PMC2164985. 
20. Kondoh O, Tachibana Y, Ohya Y, Arisawa M, Watanabe T. Cloning of the 
RHO1 gene from Candida albicans and its regulation of beta-1,3-glucan synthesis. 
Journal of bacteriology. 1997;179(24):7734-41. PubMed PMID: 9401032; PubMed 
Central PMCID: PMC179736. 
21. Gulli MP, Jaquenoud M, Shimada Y, Niederhauser G, Wiget P, Peter M. 
Phosphorylation of the Cdc42 exchange factor Cdc24 by the PAK-like kinase Cla4 
may regulate polarized growth in yeast. Mol Cell. 2000;6(5):1155-67. PubMed 
PMID: 11106754. 
22. Hope H, Bogliolo S, Arkowitz RA, Bassilana M. Activation of Rac1 by the 
guanine nucleotide exchange factor Dck1 is required for invasive filamentous 
growth in the pathogen Candida albicans. Molecular biology of the cell. 
 118 
2008;19(9):3638-51. doi: 10.1091/mbc.E07-12-1272. PubMed PMID: 18579689; 
PubMed Central PMCID: PMCPMC2526690. 
23. Grahl N, Demers EG, Lindsay AK, Harty CE, Willger SD, Piispanen AE, et 
al. Mitochondrial Activity and Cyr1 Are Key Regulators of Ras1 Activation of C. 
albicans Virulence Pathways. PLoS pathogens. 2015;11(8):e1005133. doi: 
10.1371/journal.ppat.1005133. PubMed PMID: 26317337; PubMed Central 
PMCID: PMC4552728. 
24. Yang SL, Zeng G, Chan FY, Wang YM, Yang D, Wang Y. Sac7 and Rho1 
regulate the white-to-opaque switching in Candida albicans. Scientific reports. 
2018;8(1):875. doi: 10.1038/s41598-018-19246-9. PubMed PMID: 29343748; 
PubMed Central PMCID: PMCPMC5772354. 
25. Xie JL, Grahl N, Sless T, Leach MD, Kim SH, Hogan DA, et al. Signaling 
through Lrg1, Rho1 and Pkc1 Governs Candida albicans Morphogenesis in 
Response to Diverse Cues. PLoS genetics. 2016;12(10):e1006405. doi: 
10.1371/journal.pgen.1006405. PubMed PMID: 27788136; PubMed Central 
PMCID: PMC5082861. 
26. Fitch PG, Gammie AE, Lee DJ, de Candal VB, Rose MD. Lrg1p Is a Rho1 
GTPase-activating protein required for efficient cell fusion in yeast. Genetics. 
2004;168(2):733-46. doi: 10.1534/genetics.104.028027. PubMed PMID: 
15514049; PubMed Central PMCID: PMC1448843. 
27. Ushinsky SC, Harcus D, Ash J, Dignard D, Marcil A, Morchhauser J, et al. 
CDC42 is required for polarized growth in human pathogen Candida albicans. 
Eukaryotic cell. 2002;1(1):95-104. PubMed PMID: 12455975; PubMed Central 
PMCID: PMC118047. 
28. Bassilana M, Hopkins J, Arkowitz RA. Regulation of the Cdc42/Cdc24 
GTPase module during Candida albicans hyphal growth. Eukaryotic cell. 
2005;4(3):588-603. doi: 10.1128/EC.4.3.588-603.2005. PubMed PMID: 
15755921; PubMed Central PMCID: PMCPMC1087799. 
29. Roman E, Correia I, Salazin A, Fradin C, Jouault T, Poulain D, et al. The 
Cek1-mediated MAP kinase pathway regulates exposure of-1,2 and-1,2-
mannosides in the cell wall of Candida albicans modulating immune recognition. 
Virulence. 2016;7(5):558-77. doi: 10.1080/21505594.2016.1163458. PubMed 
PMID: WOS:000380007500011. 
30. Galan-Diez M, Arana DM, Serrano-Gomez D, Kremer L, Casasnovas JM, 
Ortega M, et al. Candida albicans beta-glucan exposure is controlled by the fungal 
CEK1-mediated mitogen-activated protein kinase pathway that modulates immune 
responses triggered through dectin-1. Infection and immunity. 2010;78(4):1426-
36. doi: 10.1128/IAI.00989-09. PubMed PMID: 20100861; PubMed Central 
PMCID: PMCPMC2849429. 
31. Roman E, Alonso-Monge R, Gong Q, Li D, Calderone R, Pla J. The Cek1 
MAPK is a short-lived protein regulated by quorum sensing in the fungal pathogen 
Candida albicans. FEMS yeast research. 2009;9(6):942-55. doi: 10.1111/j.1567-
1364.2009.00545.x. PubMed PMID: 19656200. 
32. Leberer E, Harcus D, Dignard D, Johnson L, Ushinsky S, Thomas DY, et al. 
Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and 
 119 
cAMP signalling pathways in the pathogenic fungus Candida albicans. Molecular 
microbiology. 2001;42(3):673-87. PubMed PMID: 11722734. 
33. Hope H, Schmauch C, Arkowitz RA, Bassilana M. The Candida albicans 
ELMO homologue functions together with Rac1 and Dck1, upstream of the MAP 
Kinase Cek1, in invasive filamentous growth. Molecular microbiology. 
2010;76(6):1572-90. doi: 10.1111/j.1365-2958.2010.07186.x. PubMed PMID: 
20444104. 
34. Cassilly CD, Maddox MM, Cherian PT, Bowling JJ, Hamann MT, Lee RE, 
et al. SB-224289 Antagonizes the Antifungal Mechanism of the Marine 
Depsipeptide Papuamide A. PloS one. 2016;11(5):e0154932. doi: 
10.1371/journal.pone.0154932. PubMed PMID: 27183222; PubMed Central 
PMCID: PMC4868317. 
35. Tams RN, Cassilly CD, Anaokar S, Brewer WT, Dinsmore JT, Chen YL, et 
al. Overproduction of Phospholipids by the Kennedy Pathway Leads to 
Hypervirulence in Candida albicans. Front Microbiol. 2019;10:86. doi: 
10.3389/fmicb.2019.00086. PubMed PMID: 30792701; PubMed Central PMCID: 
PMCPMC6374345. 
36. De Backer MD, Maes D, Vandoninck S, Logghe M, Contreras R, Luyten 
WH. Transformation of Candida albicans by electroporation. Yeast. 
1999;15(15):1609-18. doi: 10.1002/(SICI)1097-0061(199911)15:15<1609::AID-
YEA485>3.0.CO;2-Y. PubMed PMID: 10572258. 
37. Reuss O, Vik A, Kolter R, Morschhauser J. The SAT1 flipper, an optimized 
tool for gene disruption in Candida albicans. Gene. 2004;341:119-27. doi: 
10.1016/j.gene.2004.06.021. PubMed PMID: 15474295. 
38. Chen Y-L, Montedonico AE, Kauffman S, Dunlap JR, Menn F-M, Reynolds 
TB. Phosphatidylserine synthase and phosphatidylserine decarboxylase are 
essential for cell wall integrity and virulence inCandida albicans. Molecular 
microbiology. 2010;75(5):1112-32. doi: 10.1111/j.1365-2958.2009.07018.x. 
39. Lai WC, Sun HF, Lin PH, Ho Lin HL, Shieh JC. A new rapid and efficient 
system with dominant selection developed to inactivate and conditionally express 
genes in Candida albicans. Current genetics. 2016;62(1):213-35. doi: 
10.1007/s00294-015-0526-6. PubMed PMID: 26497136. 
40. Feng QH, Summers E, Guo B, Fink G. Ras signaling is required for serum-
induced hyphal differentiation in Candida albicans. Journal of bacteriology. 
1999;181(20):6339-46. PubMed PMID: WOS:000083006500016. 
41. Tremblay P, Meiner Z, Galou M, Heinrich C, Petromilli C, Lisse T, et al. 
Doxycycline control of prion protein transgene expression modulates prion disease 
in mice. Proceedings of the National Academy of Sciences of the United States of 
America. 1998;95(21):12580-5. PubMed PMID: 9770528; PubMed Central 
PMCID: PMCPMC22873. 
42. Lorberg A, Schmitz HP, Jacoby JJ, Heinisch JJ. Lrg1p functions as a 
putative GTPase-activating protein in the Pkc1p-mediated cell integrity pathway in 
Saccharomyces cerevisiae. Molecular genetics and genomics : MGG. 
2001;266(3):514-26. doi: 10.1007/s004380100580. PubMed PMID: 11713681. 
43. Vogt N, Seiler S. The RHO1-specific GTPase-activating protein LRG1 
regulates polar tip growth in parallel to Ndr kinase signaling in Neurospora. 
 120 
Molecular biology of the cell. 2008;19(11):4554-69. doi: 10.1091/mbc.E07-12-
1266. PubMed PMID: 18716060; PubMed Central PMCID: PMC2575149. 
44. Roman E, Alonso-Monge R, Miranda A, Pla J. The Mkk2 MAPKK Regulates 
Cell Wall Biogenesis in Cooperation with the Cek1-Pathway in Candida albicans. 
PloS one. 2015;10(7):e0133476. doi: 10.1371/journal.pone.0133476. PubMed 
PMID: 26197240; PubMed Central PMCID: PMC4509911. 
45. Bassilana M, Arkowitz RA. Rac1 and Cdc42 have different roles in Candida 
albicans development. Eukaryotic cell. 2006;5(2):321-9. doi: 10.1128/EC.5.2.321-
329.2006. PubMed PMID: 16467473; PubMed Central PMCID: PMC1405900. 
46. Corvest V, Bogliolo S, Follette P, Arkowitz RA, Bassilana M. Spatiotemporal 
regulation of Rho1 and Cdc42 activity duringCandida albicansfilamentous growth. 
Molecular microbiology. 2013;89(4):626-48. doi: 10.1111/mmi.12302. 
47. Wheeler RT, Fink GR. A Drug-Sensitive Genetic Network Masks Fungi from 
the Immune System. PLoS pathogens. 2006;2(4):e35. doi: 
10.1371/journal.ppat.0020035. 
48. Watanabe D, Abe M, Ohya Y. Yeast Lrg1p acts as a specialized RhoGAP 
regulating 1,3-beta-glucan synthesis. Yeast. 2001;18(10):943-51. doi: Doi 
10.1002/Yea.742. PubMed PMID: WOS:000169965500007. 
49. Roumanie O, Weinachter C, Larrieu I, Crouzet M, Doignon F. Functional 
characterization of the Bag7, Lrg1 and Rgd2 RhoGAP proteins from 
Saccharomyces cerevisiae. FEBS letters. 2001;506(2):149-56. PubMed PMID: 
11591390. 
50. Seneviratne CJ, Zeng G, Truong T, Sze S, Wong W, Samaranayake L, et 
al. New "haploid biofilm model" unravels IRA2 as a novel regulator of Candida 
albicans biofilm formation. Scientific reports. 2015;5:12433. doi: 
10.1038/srep12433. PubMed PMID: 26202015; PubMed Central PMCID: 
PMCPMC5378891. 
51. Ballou ER, Avelar GM, Childers DS, Mackie J, Bain JM, Wagener J, et al. 
Lactate signalling regulates fungal beta-glucan masking and immune evasion. 
Nature microbiology. 2016;2:16238. doi: 10.1038/nmicrobiol.2016.238. PubMed 
PMID: 27941860. 
52. Ghannoum MA, Spellberg B, Saporito-Irwin SM, Fonzi WA. Reduced 
virulence of Candida albicans PHR1 mutants. Infection and immunity. 
1995;63(11):4528-30. PubMed PMID: 7591097; PubMed Central PMCID: 
PMCPMC173646. 
53. Cheetham J, Smith DA, da Silva Dantas A, Doris KS, Patterson MJ, Bruce 
CR, et al. A single MAPKKK regulates the Hog1 MAPK pathway in the pathogenic 
fungus Candida albicans. Molecular biology of the cell. 2007;18(11):4603-14. doi: 
10.1091/mbc.E07-06-0581. PubMed PMID: 17804815; PubMed Central PMCID: 
PMC2043575. 
54. Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for 
orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 
and E. coli pyrF mutations. Mol Gen Genet. 1984;198(2):179-82. PubMed PMID: 
6394964. 
 121 
55. Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in 
Candida albicans. Genetics. 1993;134(3):717-28. PubMed PMID: 8349105; 




Table S.3. 1. C. albicans strains used in this study 




Prototrophic wild type [54] 
YLC337 SC5314 cho1Δ/Δ [38] 










TC14 lrg1Δ/Δ lrg1Δ/Δ:: PENO1-LRG1 This study 
TC41 lrg1Δ/Δ lrg1Δ/Δste11Δ/STE11 This study  
TC48 TC41 lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 This study  
TC128 DAY286 DAY286 with 6×myc-Rho1  This study  
TC131 lrg1Δ/Δ lrg1Δ/Δ with 6×myc-Rho1 This study  
TC132 lrg1Δ/Δ::R lrg1Δ/Δ:: R with 6×myc-Rho1 This study 
TC147 DAY286 DAY286+PtetOFF-STE11ΔN467 This study 
TC44 DAY286 DAY286 with GFP-Rac1 This study  
TC158 lrg1Δ/Δ lrg1Δ/Δ with GFP-Rac1 This study  
CAF2-1 SC5314 URA3/ura3::imm434  
IRO1/iro1::imm434 
[55] 
Ca79 CAF2-1 RAS1/RAS1/PMAL2-RAS1G13V [40] 
TC159 DAY286 DAY286+PENO1-RAS1G13V-1 This study  




Table S.3. 2. Plasmids used in this study 
Strain Name Description Source 
pYLC146  FLP-CaNAT, chloraR  This study 
pBT1 CaNAT-PENO1, ampR  [35] 





pTC33 pExpArg-pACT1GFPRID+NATR [17] 
pTC55 pGEX+RIDHIS in DH5α, ampR This study 
pTC57 pGEX+RIDHIS in BL21, ampR This study 
pTC71 pYLC146+STE11-KO, chloraR This study 
pYGS1244 TetO-Myc-RHO1-UTR*-TetR/CIP10U [24] 
pTC73 pYGS1244+HYGROR This study  
pTC76 pExpArg-pACT1GFPRAC1+NATR This study  
pTC78 pENO1+CaRAS1G13V, ampR This study  
pWTF1 PtetOFF+HYGROR [39] 
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Table S.3. 3. Primers used in this study 
Name Sequence Description 
TCO57 TTTCCACAATCAAACATCCAA Primer-R sits at the C-terminus of STE11 to check if PTETOFF- STE11ΔN467 
is replaced the 2nd allele of STE11 in TC41 
TCO69 AAAAGCGGCCGCATGAAGCATTCGTTTGATAC Primer-F to amplify CaLRG ORF and Terminator 
TCO68 AAAAGAGCTCGGTTTAGATTAAGCAGAGTT Primer-R to amplify CaLRG ORF and Terminator 
TCO92 AAAGCGGCCGCTCGATATTGCTAGAGGCAAA Primer-F to amplify Hygromycin resistance B gene with NotI flanking 
TCO93 AAAGCGGCCGCATTTTATGATGGAATGAATGG Primer-R to amplify Hygromycin resistance B gene with NotI flanking 
TCO139 AAAAGGATCCTTAGAACCAGGTGGTCAAAT Primer-F to amplify RID domain located at 1111-1908bp of CaPKC1 
ORF flanking with BamHI 
TCO140 AAAAGTCGACCCGACGTCTAGTAGAAGGA Primer-R to amplify RID domain located at 1111-1908bp of CaPKC1 
ORF flanking with SalI 
TCO155 AAAAGGTACCGATGAACAGGTATTAGTATCA Primer-F to amplify 500bp of CaSTE11 promoter with KpnI flanking 
TCO156 AAAACTCGAGGACTGTTTGTTAGATTTGAGT Primer-R to amplify 500bp of CaSTE11 promoter with XhoI flanking 
TCO157 AAAAGCGGCCGCCCATTAATTATGTCGAAACAA Primer-F to amplify 500bp of CaSTE11 terminator with NotI flanking 
TCO158 AAAAGAGCTCCAAGTAGGTTCACTGTAGAT Primer-R to amplify 500bp of CaSTE11 terminator with SacI flanking 





Primer -F to amplify tetracycline-repressing promoter flanking by 60-mer 




Primer -R to amplify tetracycline-repressing promoter flanking by 60-mer 
homology of STE11 ORF located at 1402-1461bp 
TCO181 CTACTCGATTGAGTAATAGA Primer-F sits at PminiOP4 of pWTF1 to check if pWTF1 replaced the 
STE11 promoter and the N-terminal 467 aa. 
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Table S.3. 3. Continued 
Name Sequence Description 
TCO57 TTTCCACAATCAAACATCCAA Primer-R sits at the C-terminal of STE11 to check if pWTF1 replaced the 
STE11 promoter and the N-terminal 467 aa. 
TCO165 AAATCTAGAATTTTATGATGGAATGAATGG Primer-R to amplify Hygronyocin B resistance gene with XbaI flanking 
TCO168 CTGTTCTTTCATGGTATTCT Primer-F sits at -117bp of the STE11 promoter to check if PTETOFF- 
STE11ΔN467 was integrated into the chromosome 
TCO169 ACTGATTTATTCAATTGATGG Primer-R sits within the pTDH3 of pWTF, and is to check if PTETOFF- 
STE11ΔN467 was integrated into the chromosome 
TCO170 AAAACGGACCGTGTACCCATACGATGTCCCAGA
CTACGCAATGAGAAGCATTAAATCAGTCGTAG 
Primer-F to amplify RAC1 ORF with RsrII flanking 
TCO175 AAAAACGCGTCCCATGATTATAATATAGTACATT
TTTTAGCTCTC 
Primer-R to amplify RAC1 ORF with MluI flanking 
TRO993 TTGGTGATGGTCCAGTCTTGT Primer-F at the EGFP region of pTC76 to check if EGFP and RAC1 
ligated in a correct orientation 
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Figure S.3. 1. Loss of Lrg1 decreases GTPase Rac1 activity. 
(A) Active GTP-bound GFP-tagged Rac1 was pulled-down using GST-CRIB as a probe, followed 
by Western blotting with anti-GFP antibody. The amount of total Rac1 was also detected from whole 
cell lysates by using anti-GFP antibody. (B). The GFP-Rac1 band in the pull-down lanes was 





Figure S.3. 2. The hyperactive Ras1G13V does not display Cek1 phosphorylation. 
The RAS1G13V mutant under regulation of constitutively expressing enolase promoter was cultured 
overnight in YPD at 30 °C and diluted back to OD600 at 0.2 for 3 hours growth. Cells were collected, 




Figure S.3. 3. Cek1 MAPK is hyper-phosphorylated when the PtetOFF-STE11ΔN467 construct is 
induced.  
The PtetOFF-STE11ΔN467 strain was cultured overnight in YPD medium at 30°C in the presence of 
doxycycline, washed with PBS, diluted back to 0.2 and grown for 3 hours into log phase. Western 
blotting was performed on the Candida cell extracts to evaluate the activation state of MAPKs. 
Phospho-p44/42 antibody was used as the primary antibody to detect the level of phosphorylated 
Cek1 and Mkc1 MAPKs. The lrg1Δ/Δ mutant was used as a control. The overnight lrg1Δ/Δ culture 




Figure S.3. 4. An overnight culture of PtetOFF-STE11ΔN467 exhibits increased β (1,3)-glucan 
exposure when induced.  
The PtetOFF-STE11ΔN467 strain was cultured overnight in YPD medium at 30°C in the presence or 
absence of doxycycline. The overnight culture was stained with anti-β (1,3)-glucan antibody and 
PE-conjugated secondary antibody. Flow cytometry was then performed to quantify the level of β 




Figure S.3. 5. The growth rate of different Candida strains was measured to determine if 
hyperactivation of Cek1 MAPK affects cellular growth.  
Cells were grown overnight in YPD at 30°C plus doxycycline, diluted back to OD600 of 0.1 and 
transferred to fresh YPD with or without doxycycline. A growth curve was generated with three 
replicates for each condition. The growth rate of STE11ΔN467 at each timepoint without (w/o) 
doxycycline was compared with that of wild-type under the same condition by using Two-way 
ANOVA (**, p=0.0024; ****, p<0.0001).  
  
 131 
CHAPTER IV: Genetic Analysis of Genes Expressed 




This chapter is part of a manuscript that includes Chapter III that we are preparing 
to submit.  
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A full molecular model to explain β (1,3)-glucan exposure has not yet been 
developed, although a growing body of data indicates it correlates with cell wall 
repair processes. Activation of Cek1 is consistent with this. To investigate how 
Cek1 activation could contribute to this, the gene expression profile controlled by 
hyperactive Cek1 needs to be determined. To achieve this goal, we utilized the 
Cek1-hyperactivating mutant (PtetOFF-STE11ΔN467), where the N-terminus inhibitory 
domain of Ste11 is deleted, and the C-terminus is under the regulation of the 
tetracycline repressible promoter. We found that the STE11ΔN467 mutant displays a 
statistically significant increasing β (1,3)-glucan unmasking 4 hours after sub-
culturing into conditions without doxycycline. Total RNA was thus extracted from 
wild-type and PtetOFF-STE11ΔN467 strains based on timing parameter. The RNA 
samples were sequenced via the Illumina MiSeq platform, and 109 genes were 
identified to be differentially expressed more than 2-fold in STE11ΔN467 inducing 
condition compared to other control conditions. These genes are enriched for cell 
wall construction/repair, including chitin production, and the β-glucan biosynthesis 
process. Several signal transduction genes were also found to be expressed 
differentially. Of note, the Cek1-regulated transcription factor Cph1, required for 
hyphal development, is induced ~9-folds under Cek1-inducing condition. This 
suggests that Cph1 might be the downstream effector mediating cell wall 
unmasking induced by Cek1 hyperactivation. Moreover, Cek1 is induced to be 
hyper-phosphorylated when treated with the anti-fungal caspofungin, and 
disruption of CPH1 decreases the level of β (1,3)-glucan exposure caused by the 
drug. This highlights the significance of Cek1-Cph1 in cell wall remodeling for 
therapeutic applications. Our data also provides groundwork to further assess 
potential cell wall proteins causing β (1,3)-glucan exposure when 




Cek1 is a well-known MAP kinase involved in cell wall biogenesis, morphological 
alterations, and fungal virulence [1-5]. Disruption of CEK1 attenuates hyphal 
development on certain agar media when mannitol is used as the carbon source, 
or on glucose media while the nitrogen source is limited. The cek1Δ/Δ mutation 
also adversely affects the serum-induced mycelial colony diameters and growth 
rate [1] and compromises fungal virulence in the mouse mastitis and systemic 
infection models [1, 2].  
Recently, Cek1 activity was identified to be key to controlling β (1,3)-glucan 
exposure. Loss of Cek1 causes exposure of certain cell wall components, including 
β (1,3)-glucan, α (1,2)- and β (1,2)-mannosides, via transcriptionally regulating a 
significant number of cell wall biogenesis genes (PGA13, IHD1, etc.) and stress 
response genes (HSP21, DDR48, etc.) [6, 7]. The cek1Δ/Δ mutant stimulates the 
host immune response more effectively compared to the wild-type, via a dectin-1 
receptor-dependent fungal recognition mechanism [7]. This mutant is also better 
recognized by the galectin‑3 receptor, a member of β‑galactoside‑binding protein 
family [8]. On the other hand, we previously identified that hyper-activated Cek1 
promotes β (1,3)-glucan exposure [9]. Like cek1Δ/Δ, the mutant containing Cek1 
hyperactivation is recognized more effectively by murine macrophages than wild-
type, and fungal virulence is attenuated in the mouse model of systemic infection 
(Figure 3. 5, Figure 3. 6, and Figure 3. 7). However, the genetic mechanisms 
causing β (1,3)-glucan exposure in this mutant are unknown.  
Cek1 has two downstream transcription factors Cph1 and Ace2, where 
Cph1 impacts hyphal growth and white-opaque switching and Ace2 affects cell 
wall glycosylation [1, 8]. Disruption of ACE2 was reported to cause severe β (1,3)-
glucan exposure [10]. Conversely, transcriptional upregulation of ACE2 is thought 
to be responsible for increased β (1,3)-glucan masking driven by lactate treatment 
[10]. This is possibly due to the regulation of Ace2 on homeostasis of cell wall 
glycostructure in order to cover the glucan layer underneath [8]. Cph1 is also 
involved in C. albicans cell wall construction [11-13]. The CPH1 over-expressing 
mutant exhibit pseudo-filament formation under yeast growth condition, and 
 135 
several transcriptionally upregulated cell wall genes driven by Cph1 
hyperexpression under this condition were also induced in a wild-type strain grown 
under hyphal-culturing condition [13]. Given that C. albicans hyphae intrinsically 
display a higher level of β (1,3)-glucan exposure, it is possible that Cph1 
overexpression under yeast condition might drive cell wall to transition to a hyphal-
like structure. Altogether, this indicates that the cell wall dysfunction resulted from 
Cek1 activity imbalance might be mediated through these two downstream 
effectors transcriptionally.  
To determine the genetic profile induced by Cek1 hyperactivation which 
might result in β (1,3)-glucan exposure, we performed RNA-seq on the PtetOFF-
STE11ΔN467 mutant which has been confirmed to hyper-activate Cek1 when 
induced (Figure S.3. 3). Our transcriptome analysis identified a group of genes that 
are enriched for cell wall synthesis and responses to chemicals/stress and are 
increased in expression by more than 2-fold in the hyperactive Cek1 mutant 
compared to control groups. The transcription factor Cph1 is among them and is 
up-regulated ~9-fold, which might impact cell wall architecture.    
 
Methods 
Strains and plasmids  
All the strains in this chapter were described in Table S.4. 1.  
 
Growth conditions  
The media used to culture Candida cells was yeast extract-peptone-dextrose 
(YPD) medium (1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher 
Scientific)) [14]. Doxycycline (Sigma-Aldrich, USA) was added at the working 
concentration of 0.5 µg/mL as the repressor for the tetracycline-repressing 
promoter. 
 
Western blotting  
To extract proteins from PtetOFF-STE11ΔN467 mutant, the strain was cultured 
overnight in the presence of doxycycline, and sub-cultured in fresh YPD 
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±doxycycline and grown for 4 hours to mid-log phase. To extract proteins from 
Candida cells being treated with caspofungin, the wild-type DAY286 cells were 
cultured without caspofungin overnight, and then transferred to in the fresh YPD 
medium without the drug for 3 hours into log phase. Then, a ½ MIC of caspofungin 
(63ng/ml) was added to the culture for further incubation for 30min, 1 hr and 2 hrs. 
Western Blotting was performed as previously described [9].  
To detect the phosphorylation of Cek1 and Mkc1 MAPKs, rabbit anti-
Phospho-p44/42 antibody (Cell Signaling Technology, Inc., USA) at 1:2000 dilution 
was utilized. The expression of total Mkc1 was detected with the primary rabbit-
anti- Mkc1 Ab at a 1:1000 dilution (provided by Dr. Jesus Pla at Universidad 
Complutense de Madrid, Spain). The expression of total Cek1 was measured with 
a rabbit-anti- Cek1 Ab at a 1:1000 dilution (a gift from Dr. Mira Edgerton at The 
State University of New York). The secondary antibody for Phospho-p44/42 Ab, 
Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–rabbit IgG (H+L) conjugate 
(green, 1:10,000 dilution; LI-COR Biosciences). Tubulin was probed as a control 
with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA) at a 1:1000 
dilution and IRDye 680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000 dilution; LI-COR 
Biosciences) as a secondary antibody.  
 
Flow cytometry 
To stain the STE11ΔN467 strain under the regulation of PtetOFF promoter over-time, 
overnight cultures in YPD with doxycycline were diluted back to 0.2, and cells were 
collected after 1hr, 2hrs, 4hrs and 6hrs grown in the fresh YPD medium without 
doxycycline. To stain Candida cells treated with caspofungin, the overnight culture 
without the drug was sub-cultured for 3 hours. The staining protocol and gating 
strategy was followed as described in [9]. Flow cytometry data were obtained for 
100,000 gated events per strain and experiments were performed in triplicate, and 
the data were analyzed using the FlowJo software package with version 10.11 




The RNA extraction protocol was modified from [15]. 15 ml of yeast overnight 
culture were collected and washed 3 times with PBS. 750 µl of TES buffer (Tris-Cl 
(10 mM, pH 7.6), EDTA (10 mM), Sodium dodecyl sulfate (SDS) (0.5%, w/v)), 
which was prepared with RNAse-free water (RPI, Corp. USA) and 750 µl of acid 
phenol at pH 4.5 (Thermo Fisher, USA) were added to the pellet and an equal 
volume of 150-212μm acid-washed glass beads (Millipore-Sigma, USA) were 
added to each tube. Cells were mechanically disrupted in a Biospec Mini-
BeadBeater (Bio Spec Product Inc., USA) with 4 rounds of 1 min homogenization 
at 4°C and 2 min intervals for each cycle on ice. Samples were placed in a 65°C 
heat block for 30min and vortexed thoroughly every 10mins. The mixture was 
centrifuged for 5 min at 13,000 ×rpm at room temperature, and the aqueous layer 
was transferred to a fresh tube containing 700 µl of acid phenol at pH 4.5 and spun 
for 5 mins. The aqueous layer was transferred and washed twice with 600 µl of 
neutral pH phenol (Thermo Fisher, USA), followed by washing with 600 µl of 
chloroform until the interface was clean.  The supernatant was further transferred 
to the tube containing 150 µl of 3M sodium acetate, followed by adding 1 ml 100% 
ethanol, and the mixture was placed in -80°C freezer overnight to precipitate the 
nucleic acid out of solution. The pellet was collected by centrifugation at 
13,000×rpm at 4°C for 10mins, and further washed with 500 µl of 70% ice-cold 
ethanol. The pellet was dried at room temperature and resuspended in 100 µl of 
RNase-free water. DNA was removed by using Turbo DNA-free kit (Thermo Fisher, 
USA) following manufacturer’s instructions. 
RNA Samples were analyzed by the 2100 series bioanalyzer (Agilent 
Technologies, USA) for quality at the University of Tennessee Genomics Core, 
followed by cDNA library preparation and sequencing. Barcoded cDNA libraries 
were prepared with a TruSeq Stranded mRNA Sample Preparation Illumina kit 
according to manufacturer’s specifications (Illumina, Inc., USA). The libraries’ 
qualities were validated by bioanalyzer (Agilent Technologies, USA), and then 
arranged on a flow cell from the MiSeq reagent kit v3 (150×cycle) (Illumina, Inc., 
USA), and sequenced on the Illumina MiSeq M04398 machine.  
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Bioinformatic Analysis 
All the operations were performed on CLC Genomics Workbench v.12.0 software 
(Qiagen, Germany). Trimming was performed with a quality score limit set as 0.01 
and ambiguity set as 0. The read length to be discarded is set to below 50. The 
hits were mapped to the assembly 22 of the C. albicans reference strain SC5314 
[16]. Genome annotations were performed using the corresponding GFF file and 
annotated with the GFF file tool which is available on CLC Genomics Workbench 
v.12.0 software. The mapping parameters for mismatch cost, insertion cost, 
deletion cost, length fraction, and similarity fraction used at default values, which 
were 2, 3, 3, 0.8, 0,8, respectively. Expression values for each gene were 
calculated from unique gene reads (maximum number of hits for a read is set to 1) 
and normalized by gene length and sequencing depth yielding the expression 
value of transcripts per million (TPM). To determine if gene expression values are 
correct, the TPM reads of five housekeeping genes (TEF1, ACT1, TUB1, ENO1, 
and PMA1) were evaluated to calculate the average for each condition, which was 
further plotted as shown in [17]. To identify differentially expressed genes between 
treatment and control, P-values of individual genes were adjusted for false 
discovery rate (FDR), and genes with an FDR adjusted p-value < 0.05 in the 
treatment group were considered differentially expressed.  Expression values 
exceeding a factor of 2 (fold change), either higher or lower than that in control 
were considered of significantly different expression.  
 
Results 
The PtetOFF-STE11ΔN467 mutant displays increased β (1,3)-glucan over-time  
To investigate how Cek1 activation could contribute to β (1,3)-glucan exposure, 
the gene expression profile resulting from hyper-activated Cek1 was measured. 
First, we determined the parameters for this experiment. The PtetOFF-STE11ΔN467 
strain ±doxycycline was compared to the isogenic wild-type in identical conditions. 
To determine the time-point when the STE11ΔN467 mutant starts to display β (1,3)-
glucan exposure, we cultured Candida cells overnight with doxycycline to repress 
Ste11ΔN467 expression, followed by dilution into fresh YPD medium without 
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doxycycline to switch on STE11ΔN467 expression up to 6 hours. The Candida cells 
were then subjected to immunofluorescent staining by using anti-β (1,3)-glucan 
antibody, and subsequent flow cytometry to quantify the exposure level over time. 
As seen in Figure 4. 1A, the STE11ΔN467 mutant began to display statistically 
significant increased unmasking 4 hours sub-cultured in the medium without 
doxycycline. Interestingly, the time-point when unmasking became significant 
correlates well with the Western blotting results where Cek1 began to display 
increased phosphorylation after doxycycline was removed 4 hours (Figure 4. 1B). 
on this, we extracted total RNA from the wild-type and PtetOFF-STE11ΔN467 strains 4 
hours after sub-culturing into ±doxycycline conditions. 
 
β (1,3)-glucan exposure induced by hyper-activation of the Cek1 cascade 
correlates with upregulation of cell wall synthesis genes 
Based on these timing parameters, we extracted total RNA from the wild-type and 
PtetOFF-STE11ΔN467 strains 4 hours after sub-culturing into ±doxycycline conditions, 
with each condition represented by three biological replicates (12 total samples). 
RNA sequencing was performed using the Illumina MiSeq platform, which 
generated a total of 59 million 75bp paired-end reads from 12 libraries. A principal 
component plot (PCA) was created by using the RNA Analysis Package in CLC 
Genomics Workbench software to determine the variabilities between replicates 
Based and different treatment samples. As seen in Figure 4. 2, the two wild-type 
groups (±doxycycline) clustered tightly, suggesting that doxycycline does not 
cause undesired effect on wild-type. The PtetOFF-STE11ΔN467 strain was found in 
two distinct clusters based on the presence and absence of doxycycline, which 
both separated from wild-type. The STE11ΔN467 strain +doxycycline grouped away 
from wild-type and this may be because of basal expression of STE11ΔN467, which 
would explain the modest increase in TNF-α elicited by macrophages by these 
cells compared to wild-type, even in the presence of doxycycline (Figure 3. 5B). 
To be certain that the expression levels of genes overall were consistent, we 
examined 5 housekeeping genes that are known to have differential expression 
levels. We found that those housekeeping genes were highly consistent between  
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Figure 4. 1. The PtetOFF -STE11ΔN467 strain exhibits β (1,3)-glucan exposure in a time-
dependent manner in the absence of doxycycline.  
A. The STE11ΔN467 mutant was cultured overnight in YPD at 30°C in the presence or absence of 
doxycycline. Aliquots of the overnight culture (O/N+ and O/N-) were taken as 0 timepoint controls 
and stained with mouse anti-β (1,3)-glucan antibody and goat-anti-mouse PE-conjugated 
secondary antibody. An aliquot of the overnight PtetOFF-STE11ΔN467 culture treated with doxycycline 
was washed three times with PBS and diluted back to 0.2 in fresh YPD without doxycycline to 
switch on Ste11ΔN467 expression and was grown for 1hr, 2hrs, 4hrs, and 6hrs. Cells were collected 
at the indicated time points and stained as described above. All the stained cells were subject to 
the flow cytometer to quantify the β (1,3)-glucan exposure level. Samples were tested three times 
with 2 replicates each time. **, P<0.008. B. Cells were cultured as described in A, and then total 
protein was isolated, and Western blotting was performed to evaluate the MAPKs phosphorylation 
by using phospho-p44/42 antibody and total Cek1 and tubulin as controls.  
 141 
Figure 4. 2. PCA plot displays the clustering of samples within each group. 
PCA plot was created by using RNA Analysis Package in CLC Genomics Workbench software (V12.0) to determine the variabilities between 
replicates and different treatment samples.  
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Figure 4. 2. Continued  
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the samples (Figure 4. 3). In STE11ΔN467 inducing-condition (-doxycycline), 109 
genes are commonly regulated by a > 2-fold change in expression value, 
compared to the other three conditions (wild-type±doxycycline and STE11ΔN467 
+doxycycline) (Figure 4. 4A). Among the commonly regulated 109 genes, 16 
genes are down-regulated, and 93 genes are up-regulated (Figure 4. 4B). The 
commonly regulated genes were listed in Table S.4. 2. Although Cek1 activation 
is associated with hyphal formation, there are only a few genes that are 
conventional hyphal-specific proteins. A number of genes commonly associated 
with hyphal formation like members of the Als family and Ece1 are not upregulated. 
However, 13 genes that are involved in cell wall construction are upregulated 
(Figure 4. 4B and Table 4. 1). These genes are enriched for cell wall or extracellular 
genes (14% of upregulated genes were secreted genes compared to 5% secreted 
genes in the total Candida genome, indicating that there was 2× fold enrichment 
in cell wall genes in our data set). 26 genes are responsive to chemicals and stress, 
including OPY2 and RBT4 and 10 genes encode signal transduction proteins 
(CPP1, BUD5, RGA2, HAC1, WSC2, CPH1 etc.). In the category of down-
regulated genes, it is worth noting that Eng1 expression was decreased ~2 fold in 
the STE11ΔN467-inducing condition. Eng1 is an endo-β (1,3)-glucanase, which has 
been reported to keep glucan masked by removing the exposed β (1,3)-glucan in 
the fungal pathogen Histoplasma capsulatum. Altogether, these data suggest that 
the β (1,3)-glucan unmasking could be caused by Cek1 hyper-activation through 
inappropriate expression of cell wall repair machinery. 
In addition, our data suggest that Cph1 is likely responsible for these effects. 
Cek1 has two known downstream transcription factors, Cph1 and Ace2, but they 
display distinct profiles in our data. Cph1 is up-regulated 8.4-fold in STE11ΔN467 
yeast condition compared to that of wild-type. Cph1 is important for Candida 
albicans filament development on certain solid media [18] and is involved in the 
switching from white cells to the mating-competent opaque cells [19]. In contrast, 
Ace2, involved in cell wall glycosylation, morphogenesis and virulence [8, 20] does 
not display altered transcripts when Cek1 is hyperactivated. This indicates Cph1 
is likely the transcription factor responsive to Cek1-inducing condition.
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Figure 4. 3. Housekeeping genes expression was similar among different Candida strains.  
The TPM reads of five housekeeping genes (TEF1, ACT1, TUB1, ENO1, and PMA1) were used to 
calculate the average for each condition to determine if gene expression values are correct.  
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Figure 4. 4. Differentially expressed genes in STE11ΔN467-inducing condition are enriched for cell wall repair genes.  
(A). Venn diagram shows that 109 genes are differentially expressed in the PtetOFF-STE11ΔN467 mutant when Cek1 is induced (STE11 –
doxycycline) compared to the other three control groups (wild-type± and STE11+doxycycline). Genes with a false discovery rate (FDR) 
adjusted p-value < 0.05 were considered differentially expressed. (B). Heat-maps were generated for genes with expression values 
exceeding a factor of 2 (fold change) in STE11ΔN467 inducing condition (STE11 –doxycycline) compared to the other three controls 
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Figure 4. 4. Continued  
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Table 4. 1: Commonly regulated genes induced by STE11ΔN467 –doxycycline vs. Wild-type± 
and STE11ΔN467 +doxycycline 
Gene Ontology terms Names 
• Function  
Cell Wall Organization 
CEK1, CHS2, CPH1, CRH11, ENG1*, HAC1, HWP1, 
KRE6, PGA13, PGA31, RLM1, WSC2, XOG1 
Stress/Chemical Response 
BRG1, C1_03870C_A, C1_10710C_A*, C3_02290W_A, 
CEK1, CPH1, CPP1, DDR48, FGR41*, GPX1, HAC1, 
MDR1*, MEP1, OPY2, PMS1, RLM1, STE11, WSC2, 




Cell Wall and Extracellular Regions 
CRH11, CSH1, DDR48, ENG1*, HWP1, IFF11, KRE1, 
PGA13, PGA30, PGA31, XOG1, C4_01800W_A*, DAG7, 
FGR41*, RBT4,SAP7 




Cek1 activity is induced by caspofungin treatment 
β (1,3)-glucan exposure has been reported to correlate with activation of Cek1 
pathway under various conditions, such as phosphatidylserine synthase (Cho1) 
disruption and hyperactivation of the GTPases Cdc42 and Rho1 [9]. Caspofungin, 
an antifungal drug inhibiting β (1,3)-glucan biosynthesis, causes β (1,3)-glucan 
exposure even at sublethal condition [21]. However, the mechanism regarding β 
(1,3)-glucan exposure induced by caspofungin insult has not yet been discovered. 
Here we evaluated if the correlation between β (1,3)-glucan unmasking and Cek1 
phosphorylation holds true under caspofungin treatment. As shown in Figure 4. 5, 
the Cek1 MAPK is induced to be activated 30 mins after incubation with ½ MIC of 
caspofungin, and the induction increases over-time. This suggests that Cek1 
activation might contribute to β (1,3)-glucan exposure, at least partially, under the 
caspofungin insult. This further indicates that improper activation of Cek1 seems 
involved in cell wall remodeling in different situations. 
 
Discussion 
In this chapter, we provided the transcriptome analysis to address the genetic 
mechanism regarding β (1,3)-glucan exposure induced by Cek1 hyperactivation. 
Our RNA-Seq results reveal that several categories of genes are expressed 
differentially when Ste11-Cek1 are hyperactivated, and they include cell walls 
genes, signal transduction genes, and stress genes (Table S.4. 2). Cph1, one of 
two well-known downstream transcription factors that is phosphorylated/activated 
by Cek1, is significantly up-regulated in STE11ΔN467 inducing conditions. Cph1 is 
important for C. albicans filament development [18], and white-to-opaque 
switching [19]. The Cph1-overexpressing mutant under yeast conditions induces 
pseudo-hyphal structure, and several hyphal-specific genes are also induced 
transcriptionally [13]. Lowman et al. reported that C. albicans hyphal glucan 
exhibited a novel glucan structure, where hyphal glucan has a unique cyclical 
structure which intrinsically display higher levels of β (1,3)-glucan exposure and 
immunogenicity [11]. Our data shows that CPH1 is induced ~9 fold, and it is 




Figure 4. 5. Caspofungin treatment over-activates the Cek1 MAPK.  
C. albicans wild-type DAY286 strain was cultured at 30°C in YPD medium overnight. The next day 
the overnight culture was diluted back to OD600 of 0.2 in fresh YPD medium for 3 hours growth into 
the log phase, followed by ½ MIC of caspofungin treatment (+) for 30 min, 1 hr and 2hrs, 
respectively. The culture was collected and proceeded to the Western blotting procedure. The 
antibody to detect phosphorylated Cek1 was phospho-p44/42, which can also detect the 




structure even under yeast-conditions, and therefore display more glucan 
exposure. Alternatively, Cek1 is upregulated in response to caspofungin treatment 
and the changes in exposure may be related to aberrantly induced cell wall repair. 
 The cek1ΔΔ mutant displays β (1,3)-glucan exposure, hyper-sensitivity to 
agents that disturb the cell wall such as Congo red, and the N-glycosylation 
inhibitor tunicamycin [7, 22, 23]. This mutant also exhibits α (1,2)- and β (1,2)-
mannosides exposure, suggesting the glycostructure is defective upon CEK1 
disruption. This characteristic facilitates the immune recognition by the receptor 
galectin-3. Ace2, a second downstream transcription factor of Cek1, is required for 
cell wall glycosylation, and causes β (1,3)-glucan exposure when disrupted [8, 10]. 
Interestingly, Ace2 is not induced transcriptionally when Cek1 is hyperactivated. 
Thus, Cek1 may be able to deploy specific transcription factors for unique 
adaptation responses based on the nature of the insult. 
Cek1 activity is regulated tightly by multiple stimuli in C. albicans. Several 
conditions induce Cek1 phosphorylation, including disruption of the 
phosphatidylserine synthase Cho1[9], growth resumption from the overnight 
culture to fresh media [24], being treated with fungicidal salivary histatin 5 (Hst5) 
protein [25]. We found that Candida cells treated with caspofungin also exhibit 
Cek1 hyperphosphorylation in a time-dependent manner (Figure 4. 5). Given the 
correlation of Cek1 activation and resultant cell wall remodeling [9], this might 
explain, at least partially, the mechanism through which β (1,3)-glucan is 
unmasked stimulated by caspofungin. This indicates the significance of Cek1 
activity in regulating cell wall structure.  
Overall, our RNA-seq profile on the Cek1-overactivating mutant provides 
groundwork for further understanding the genetic mechanisms of β (1,3)-glucan 
exposure caused by this mutation. We hypothesize that differential expression of 
some of those genes cause β (1,3)-glucan exposure, including Cph1. Genetic work 
can be done by Cph1 overexpression to evaluate if the mutation leads to cell wall 
remodeling and increases immunogenicity. Several cell wall associated proteins 
are also of interest, including chitin synthases (Chs2, 3 and 8), given the correlation 
between increased chitin levels and β (1,3)-glucan exposure [26, 27]. The same 
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genetic strategy can be performed on these target genes by overexpression to 
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Table S.4. 2. Genes that were differentially regulated in STE11ΔN467 –doxycycline 








PBR1 Protein of unknown function; required for cohesion, adhesion, and 
RPMI biofilm formation; induced by alpha pheromone in white cells; 
fluconazole-induced; Spider biofilm induced 
1,269.77 1,276.88 333.46 
PGA13 GPI-anchored cell wall protein involved in cell wall synthesis; required 
for normal cell surface properties; induced in oralpharyngeal 
candidasis; Spider biofilm induced; Bcr1-repressed in RPMI a/a 
biofilms 
114.57 93.25 22.48 
C2_09880C_
A 
Putative protein of unknown function; Plc1-regulated; transcript 
induced by Mnl1 under weak acid stress; flow model, rat catheter, 
Spider biofilm induced 
59.07 32.66 14.68 
XOG1 Exo-1,3-beta-glucanase; 5 glycosyl hydrolase family member; affects 
sensitivity to chitin and glucan synthesis inhibitors; not required for 
yeast-to-hypha transition or for virulence in mice; Hap43-induced; 
Spider biofilm induced 
51.34 55.89 37.56 
C2_02220C_
A 
Protein of unknown function; F-12/CO2 early biofilm induced 47.72 46.24 18.21 
RBT4 Pry family protein; required for virulence in mouse systemic/rabbit 
corneal infections; not filamentation; mRNA binds She3, is localized to 
hyphal tips; Hap43-induced; in both yeast and hyphal culture 
supernatants; Spider biofilm induced 
40.37 31.85 43.55 
C7_02280W_
A 
Ortholog of C. parapsilosis CDC317: CPAR2_808370, C. dubliniensis 
CD36: Cd36_72070, Candida orthopsilosis Co 90-125: 
CORT_0C00800 and Candida albicans WO-1 : CAWG_05577 
39.92 43.07 19.01 
PGA31 Cell wall protein; putative GPI anchor; expression regulated upon 
white-opaque switch; induced by Congo Red and cell wall 
regeneration; Bcr1-repressed in RPMI a/a biofilms 
36.75 44.22 17.82 
SAP7 Pepstatin A-insensitive secreted aspartyl protease; self-processing; 
expressed in human oral infection; Ssn6p-regulated; role in murine 
intravenous infection; induced during, but not required for, murine 
vaginal infection; N-glycosylated 
36.55 16.76 14.56 
KRE1 Cell wall glycoprotein; beta glucan synthesis; increases glucan content 
in S. cerevisiae kre1, complements killer toxin sensitivity; caspofungin 
induced; Spider/rat catheter/flow model biofilm induced; Bcr1-
repressed in RPMI a/a biofilms 
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Ortholog of C. parapsilosis CDC317: CPAR2_808350, C. dubliniensis 
CD36: Cd36_72060, Candida orthopsilosis Co 90-125: 
CORT_0C00820 and Candida albicans WO-1 : CAWG_05575 
33.04 31.96 17.09 
DAG7 Secretory protein; a-specific, alpha-factor induced; mutation confers 
hypersensitivity to toxic ergosterol analog; fluconazole-induced; 
induced during chlamydospore formation in C. albicans and C. 
dubliniensis 
27.47 28.28 24.06 
FAV1 Protein with weak similarity to S. cerevisiae Fus2p; induced by alpha 
pheromone mating factor in MTLa/MTLa opaque cells 
23.68 36.82 8.76 
RBR1 Glycosylphosphatidylinositol (GPI)-anchored cell wall protein; required 
for filamentous growth at acidic pH; expression repressed by Rim101 
and activated by Nrg1; Hap43-induced 
21.41 28.04 5.53 
LDG3 Putative LDG family protein; F-12/CO2 early biofilm induced 20.45 23.8 11.02 
C6_02100W_
A 
Secreted potein; Hap43-repressed; fluconazole-induced; regulated by 
Tsa1, Tsa1B under H2O2 stress conditions; induced by Mnl1p under 
weak acid stress; Spider biofilm induced 
18.17 20.69 8.74 
C1_07040C_
A 
Pry family pathogenesis-related protein; oral infection upregulated 
gene; mutant has reduced capacity to damage oral epithelial cells 
16.15 13.23 13.55 
MRV8 Protein of unknown function; Spider biofilm induced 15.68 15.16 11.93 
PGA23 Putative GPI-anchored protein of unknown function; Rim101-
repressed; Cyr1-regulated; colony morphology-related gene regulation 
by Ssn6 
15.46 17.02 12.49 
CR_05330W_
A 
Protein of unknown function; Spider biofilm repressed 13.1 13 7.97 
C1_05970W_
A 
Putative adhesin-like protein; macrophage-induced gene 13.06 14.56 14.35 
HWP1 Hyphal cell wall protein; host transglutaminase substrate; opaque-, a-
specific, alpha-factor induced; at MTLa side of conjugation tube; 
virulence complicated by URA3 effects; Bcr1-repressed in RPMI a/a 
biofilms; Spider biofilm induced 
13.05 6.29 4.22 
IFF11 Secreted protein required for normal cell wall structure and for 
virulence; member of the IFF family; Hap43p-repressed gene 
12.7 17.03 9.93 
C4_04380C_
A 
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FAV2 Adhesin-like protein; induced by mating factor in MTLa/a opaque cells, 
in cyr1 null, in filaments; regulated by Nrg1, Rfg1, Tup1, Tec1, Efg1, 
Ntd80, Rob1, Brg1; induced in oralpharyngeal candidasis; Spider 
biofilm induced 
10.33 7.52 10.97 
C4_03500C_
A 
Protein of unknown function; regulated by Tsa1, Tsa1B in minimal 
media at 37 degrees C 
9.13 8.58 36.84 
KCH1 Ortholog of Kch1 a potassium transporter; mediates K+ influx and 
activates high-affinity Ca2+ influx system during mating pheromone 
response in S. cerevisiae; induced by alpha pheromone in SpiderM 
medium 
8.95 12.59 9.23 
ALK8 Alkane-inducible cytochrome P450; catalyzes hydroxylation of lauric 
acid to hydroxylauric acid; overproduction causes fluconazole 
resistance in WT and causes multidrug resistance in a cdr1 cdr2 
double mutant; rat catheter biofilm repressed 
8.84 7.53 4.37 
CPH1 Transcription factor; for mating, filamentation on solid media, 
pheromone-stimulated biofilms; in pathway with Ess1, Czf1; required 
with Efg1 for host cytokine response; regulates galactose metabolism 
genes; rat cathether biofilm repressed 
8.46 9.24 7.52 
C5_03440W_
A 
Protein of unknown function 7.98 8.3 6.92 
CPP1 VH1 family MAPK phosphatase; regulates Cst20-Hst7-Cek1-Cph1 
filamentation pathway; negatively regulates mating, represses yeast-
hyphal switch; required for virulence in mice; yeast-enriched; induced 
by alpha pheromone in SpiderM medium; 
6.7 8.03 6.9 
CSH1 Aldo-keto reductase; role in fibronectin adhesion, cell surface 
hydrophobicity; regulated by temperature, growth phase, benomyl, 
macrophage interaction; azole resistance associated; Spider biofilm 
induced; rat catheter biofilm repressed 
6.61 8.4 5.01 
C5_04940W_
A 
Maltase; induced during growth on sucrose; induced by alpha 
pheromone in SpiderM medium; early-stage flow model biofilm indced 
6.57 6.29 5.56 
STE11 Protein similar to S. cerevisiae Ste11p; mutants are sensitive to 
growth on H2O2 medium 
6.56 6.02 8.53 
C4_01330W_
A 
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PRM1 Putative membrane protein with a predicted role in membrane fusion 
during mating; Hap43p-repressed gene; protein induced during the 
mating process 
6.16 5.83 7.85 
CR_09930W_
A 
Protein of unknown function; induced by alpha pheromone in SpiderM 
medium 
5.99 5.11 4.88 
C6_04190C_
A 
Protein of unknown function; Spider biofilm induced 5.92 6.05 3.84 
CR_04770C_
A 
Ortholog of C. dubliniensis CD36 : Cd36_30140, C. parapsilosis 
CDC317 : CPAR2_204040, Candida tenuis NRRL Y-1498 : 
CANTEDRAFT_114703 and Debaryomyces hansenii CBS767 : 
DEHA2G22880g 
5.83 6.28 2.89 
PTR2 Oligopeptide transporter involved in uptake of di-/tripeptides; highly 
induced during chlamydospore formation in both C. albicans and C. 
dubliniensis 
5.73 5.02 2.27 
GFA1 Glucosamine-6-phosphate synthase, homotetrameric enzyme of 
chitin/hexosamine biosynthesis; inhibited by UDP-GlcNAc, FMDP, N-
acyl peptide, kanosamine-6-P; functional homolog of S. cerevisiae 
Gfa1p; Cagrowth-phase regulated; catalytic Cys 
5.65 7.04 4.98 
GST3 Glutathione S-transferase; expression regulated upon white-opaque 
switch; induced by human neutrophils; peroxide-induced; induced by 
alpha pheromone in SpiderM medium; Spider biofilm induced 
5.52 5.73 2.45 
C4_02260C_
A 
Protein of unknown function; repressed by prostaglandins; Hap43-
induced, Spider biofilm induced 
5.48 17.53 6.59 
CRH11 GPI-anchored cell wall transglycosylase, putative ortholog of S. 
cerevisiae Crh1p; predicted glycosyl hydrolase domain; similar to 
Csf4p and to antigenic A. fumigatus Aspf9; predicted Kex2p substrate; 
caspofungin-induced 
4.95 4.45 3.31 
WSC2 Putative cell wall integrity and stress response protein; mRNA binds 
She3; Spider biofilm induced 
4.74 5.31 2.99 
PGA58 Putative GPI-anchored protein; transcription is positively regulated by 
Tbf1p 
4.59 4.42 2.97 
MNN12 Predicted alpha-1,3-mannosyltransferase activity with a role in protein 
glycosylation 
4.25 4.88 3.61 
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Putative membrane protein; induced by alpha pheromone in SpiderM 
medium; Hap4-induced gene; Spider biofilm induced 
4.24 5.89 4.82 
C1_03870C_
A 
Predicted heme-binding stress-related protein; Tn mutation affects 
filamentous growth; induced during chlamydospore formation in C. 
albicans and C. dubliniensis; Spider biofilm induced 
4.23 4.46 4.99 
C6_00810C_
A 
Protein of unknown function; Hap43-repressed gene 4.21 2.98 3.56 
KAR4 Transcription factor; required for gene regulation in response to 
pheromones; ortholog of S. cerevisiae Kar4; role in karyogamy; 
opaque-specific, a-specific; induced by alpha factor 
4.21 3.62 2.99 
CR_00090C_
A 
Protein of unknown function; stationary phase enriched protein; 
induced upon yeast-hypha transition; benomyl or caspofungin 
induced; Hap43-repressed; Spider biofilm induced 
4.17 3.76 2.01 
OPY2 Predicted transmembrane protein; role in cell wall biogenesis; required 
for Cek1 phosphorylation; Spider biofilm induced 
4.14 4.11 2.81 
MNN14 Predicted alpha-1,3-mannosyltransferase activity with a role in protein 
glycosylation; Hap43-repressed; Spider biofilm induced 
4 3.91 2.57 
C2_05040C_
A 
Ortholog(s) have cellular bud neck, fungal-type vacuole localization 3.94 3.83 3.47 
C6_04420W_
A 
Protein of unknown function; GlcNAc-induced protein; Spider biofilm 
induced; rat catheter biofilm repressed 
3.94 2.64 2.84 
CHS8 Chitin synthase required for synthesis of long-chitin fibrils; 
nonessential; 8 or 9 membrane spanning regions; mRNA present in 
yeast and hyphae; induced during cell wall regeneration; flow model 
biofilm repressed 
3.65 3.74 2.66 
C1_11730W_
A 
Protein with SEL-1 like protein domain; early-stage flow model biofilm 
induced 
3.64 3.63 2.81 
CHS2 Chitin synthase; nonessential; required for wild-type chitin deposition 
in hyphae; transcript regulated during dimorphic transition; Chs1 and 
Chs2, but not Chs3, are inhibited by the protoberberine HWY-289; 
flow model biofilm repressed 
3.56 4.08 3.26 
PGA54 GPI-anchored protein; Hog1-repressed; induced in cyr1 or efg1 
mutant or in hyphae; colony morphology-related gene regulation by 
Ssn6; induced in RHE model; mRNA binds She3; regulated in Spider 
biofilms by Tec1, Egf1, Ntd80, Rob1, Brg1 
3.47 3.69 3.42 
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GPX1 Putative thiol peroxidase; rat catheter and Spider biofilm induced 3.42 3.75 2.03 
C7_02250W_
A 
Ortholog of C. dubliniensis CD36 : Cd36_72050, C. parapsilosis 
CDC317 : CPAR2_301140, Candida tenuis NRRL Y-1498 : 
CANTEDRAFT_135055 and Debaryomyces hansenii CBS767 : 
DEHA2E07678g 
3.35 4.17 2.87 
C1_07990C_
A 
Similar to cell-wall mannoproteins; induced in low iron; induced in cyr1 
homozygous null; regulated by osmotic and oxidative stress via Hog1; 
Spider biofilm induced 
3.25 3.7 3.17 
C2_10150W_
A 
Secreted protein; fluconazole-induced 3.1 2.84 2.92 
CR_07850W_
A 
Ortholog of C. dubliniensis CD36 : Cd36_33530, C. parapsilosis 
CDC317 : CPAR2_201980, Candida tenuis NRRL Y-1498 : 
CANTEDRAFT_134293 and Debaryomyces hansenii CBS767 : 
DEHA2A10164g 
3.1 2.65 2.03 
RLM1 Putative transcription factor; required for wild-type resistance to cell 
wall perturbation, caspofungin treatment; regulates caspofungin 
induction of PGA13 
3.07 3.23 2.31 
C1_04010C_
A 
Protein with a NADP-dependent oxidoreductase domain; transcript 
induced by ketoconazole; rat catheter and Spider biofilm induced 
2.99 3.89 2.27 
BUD5 Predicted GTP/GDP exchange factor for Rsr1; rat catheter biofilm 
induced 
2.91 3.18 2.1 
UAP1 UDP-N-acetylglucosamine pyrophosphorylase, catalyzes biosynthesis 
of UDP-N-acetylglucosamine from UTP and N-acetylglucosamine 1-
phosphate; functional homolog of S. cerevisiae Qri1p; alkaline 
upregulated 
2.9 4.31 3.82 
BRG1 Transcription factor; recruits Hda1 to hypha-specific promoters; Tn 
mutation affects filamentation; Hap43-repressed; Spider and flow 
model biofilm induced; required for Spider biofilm formation; Bcr1-
repressed in RPMI a/a biofilms 
2.85 4.05 2.76 
AXL2 Ortholog of S. cerevisiae Axl2; a plasma membrane protein involved in 
determination of budding pattern; O-glycosylated by Pmt4; mutant is 
viable 
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YKE2 Possible heterohexameric Gim/prefoldin protein complex subunit; role 
in folding alpha-tubulin, beta-tubulin, and actin; transcript induced by 
yeast-to-hypha switch; regulated by Nrg1, Tup1; Spider and flow 
model biofilm induced 
2.78 3.28 2.18 
C6_02210W_
A 
Protein of unknown function; oxidative stress-induced via Cap1; 
induced by alpha pheromone in SpiderM medium 
2.67 2.4 2.21 
CHS7 Protein required for wild-type chitin synthase III activity; similar to (but 
not functional homolog of) S. cerevisiae Chs7p, which effects ER 
export of Chs3p; induced cyr1 mutant hyphae and ras1 yeast-form 
cells; Spider biofilm induced 
2.58 2.6 2.68 
RGA2 Putative GTPase-activating protein (GAP) for Rho-type GTPase 
Cdc42; involved in cell signaling pathways controlling cell polarity; 
induced by low-level peroxide stress; flow model biofilm induced 
2.54 2.55 2.4 
MRV3 Ortholog of Candida albicans WO-1 : CAWG_04793 2.54 2.42 2.08 
C2_07790C_
A 
Protein of unknown function; induced by alpha pheromone in SpiderM 
medium 
2.53 3.05 2.97 
C7_01940C_
A 
Pheromone-regulated protein (Prm10) of S. cerevisiae; colony 
morphology-related gene regulation by Ssn6; induced by Mnl1 under 
weak acid stress; possibly essential gene, disruptants not obtained by 
UAU1 method; Spider biofilm induced 
2.53 2.37 2.26 
PMS1 Putative DNA mismatch repair factor; ortholog of S. cerevisiae PMS1 
which is an ATP-binding protein involved in DNA mismatch repair 
2.5 3.33 2.94 
C1_05440C_
A 
Protein of unknown function; flow model biofilm induced; Spider 
biofilm induced 
2.45 2.14 2.01 
DFI1 Cell-surface associated glycoprotein; promotes activation of Cek1 in a 
matrix-dependent manner; N-glycosylated; Spider biofilm induced 
2.43 2.63 2.28 
CR_09090C_
A 
Ortholog of C. dubliniensis CD36 : Cd36_34510, Candida tropicalis 
MYA-3404 : CTRG_05938 and Candida albicans WO-1 : 
CAWG_02183 
2.36 2.92 2.01 
C4_01420W_
A 
Ortholog of C. dubliniensis CD36 : Cd36_41430, Candida tropicalis 
MYA-3404 : CTRG_00187 and Candida albicans WO-1 : 
CAWG_03642 
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HGC1 Hypha-specific G1 cyclin-related protein involved in regulation of 
morphogenesis, biofilm formation; Cdc28-Hgc1 maintains Cdc11 S394 
phosphorylation during hyphal growth; required for virulence in mice; 
regulated by Nrg1, Tup1, farnesol 
2.29 3.29 2.56 
C3_02290W_
A 
Protein similar to S. cerevisiae Ydr282cp; transposon mutation affects 
filamentous growth; Hap43p-repressed gene 
2.25 2.18 2.61 
KRE6 Essential beta-1,6-glucan synthase subunit; change in mRNA length, 
not abundance, at yeast-hypha transition; alkaline induced by Rim101, 
on cell wall regeneration; Spider biofilm induced; Bcr1-repressed in 
RPMI a/a biofilms 
2.24 2.7 2.34 
HAC1 bZIP transcription factor; role in unfolded protein response and control 
of morphology; transcript undergoes atypical splicing at C terminus 
under ER stress; induced during mating and by caspofungin; mRNA 
binds She3; Spider biofilm induced 
2.12 2.32 2.59 
PTP2 Predicted protein tyrosine phosphatase; involved in regulation of MAP 
kinase Hog1 activity; induced by Mnl1 under weak acid stress; rat 
catheter and Spider biofilm induced 
2.11 2.22 2.45 
ENG1 Endo-1,3-beta-glucanase; ortholog of S. cerevisiae Dse4 needed for 
cell separation; caspofungin, fluconazole repressed; repressed by 
alpha pheromone in SpiderM medium; flow model biofilm induced; rat 
catheter biofilm repressed 
-2.09 -2.14 -2.79 
C7_01170C_
A 
Putative oxidoreductase; mutation confers hypersensitivity to toxic 
ergosterol analog; rat catheter and Spider biofilm induced 
-2.17 -4.89 -4.56 
C1_11990W_
A 
Putative cell wall adhesin-like protein; repressed in core caspofungin 
response and by alpha pheromone in SpiderM medium; transcript 
reduced in ace2 mutant; flow model, rat catheter and Spider biofilm 
repressed 
-2.22 -2.06 -3.17 
C2_06800C_
A 
Protein of unknown function; Spider biofilm induced -2.28 -2.94 -2.31 
C4_02080W_
A 
Protein with a mitochondrial carrier protein domain; possibly an 
essential gene, disruptants not obtained by UAU1 method; Spider 
biofilm repressed 
-2.35 -3.3 -3.21 
C1_10710C_
A 
Protein similar to S. cerevisiae Yor378w; MFS family transporter; 
transposon mutation affects filamentous growth; null mutants are 
viable; fungal-specific (no human or murine homolog) 
-2.52 -2.4 -2.35 
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Ortholog(s) have trans-aconitate 3-methyltransferase activity and 
cytosol localization 
-2.58 -4.53 -3.84 
TRP4 Predicted enzyme of amino acid biosynthesis; upregulated in biofilm; 
regulated by Gcn2p and Gcn4p; S. cerevisiae ortholog is Gcn4p 
regulated 
-2.59 -2.91 -2.15 
C4_01800W_
A 
Protein with a dienelactone hydrolase domain; Hap43-repressed gene -2.59 -2.9 -3.18 
FGR41 Putative GPI-anchored adhesin-like protein; transposon mutation 
affects filamentous growth; Spider biofilm repressed 
-2.68 -2.85 -2.71 
MEP1 Ammonium permease; Mep1 more efficient permease than Mep2, 
Mep2 has additional regulatory role; 11 predicted transmembrane 
regions; low mRNA abundance; hyphal downregulated; flow model 
biofilm induced 
-2.87 -3.76 -2.46 
HOM3 Putative L-aspartate 4-P-transferase; fungal-specific (no human or 
murine homolog); regulated by Gcn2 and Gcn4; early-stage flow 
model biofilm induced 
-2.87 -3.4 -3.53 
C6_03390W_
A 
Mitochondrial dicarboxylate transporter; possibly an essential gene, 
disruptants not obtained by UAU1 method 
-2.89 -2.5 -2.78 
MDR1 Plasma membrane MDR/MFS multidrug efflux pump; methotrexate is 
preferred substrate; overexpression in drug-resistant clinical isolates 
confers fluconazole resistance; repressed in young biofilms; rat 
catheter biofilm induced 
-3.12 -3.09 -2.47 
RNR22 Putative ribonucleoside diphosphate reductase;colony morphology-
related gene regulation by Ssn6; transcript regulated by tyrosol and 
cell density; Hap43-repressed; Spider biofilm induced 









Altogether, the findings in this dissertation demonstrate the central role of the Cek1 
MAPK in regulating cell wall β (1,3)-glucan masking in C. albicans. Davis et al. 
identified that loss of the phosphatidylserine (PS) synthase enzyme (Cho1) results 
in β (1,3)-glucan exposure in this organism. However, the mechanism by which 
loss of PS synthase leads to cell wall unmasking remained to be defined. To 
address this, in Chapter II I began using biochemical methods to identify the 
potential protein(s) causing this phenotype. Several proteins comprising molecular 
signaling pathways, which regulate fungal cell wall synthesis, are hyper-activated 
when the PS synthesis enzyme is disrupted. We hypothesized that one or a few of 
these signaling proteins may contribute to increased β (1,3)-glucan exposure in 
the cho1Δ/Δ mutant. I further discovered that when the protein kinase Cek1 is 
activated by itself, β (1,3)-glucan is exposed. The increased β (1,3)-glucan 
exposure exhibited from the strain containing hyper-activated Cek1 is shown to be 
immunologically relevant, reflected by stronger pro-inflammatory anti-fungal 
immune responses induced from murine macrophages. The GTPase Cdc42 is a 
central regulator of cell growth and morphological development. Cdc42 activity is 
found to be induced in the cho1Δ/Δ mutant, and genetic work demonstrated that 
hyperactivated Cdc42 results in the up-regulation of Cek1 activity. Based on these 
observations, we propose a model that Cho1 or its biochemical product PS impacts 
GTPase Cdc42 activity, which controls downstream Cek1 phosphorylation and 
thus induces β (1,3)-glucan exposure.  
Chapter III demonstrated a novel signaling cascade controls Cek1 activity, 
which is composed of a protein called Lrg1, which represses β (1,3)-glucan 
exposure and Cek1 activity, and its cognate small GTPase is Cdc42. The 
discovery that Lrg1 inhibits Cdc42 activity in C. albicans is novel and unexpected 
because Lrg1 was thought to act on another GTPase Rho1, a major regulator for 
cell wall biosynthesis. Activated Cdc42 further relays the activation signal to the 
downstream Cek1 pathway. This work uncovers a new aspect of basic biology of 
signaling transduction leading to Cek1 activation and β (1,3)-glucan exposure in 
C. albicans. The mouse model of systemic infection, which mimics the human 
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disseminated fungal disease, revealed that the hyper-activation of Cek1 
attenuates fungal virulence within the host and leads to better fungal clearance 
from the mouse kidney, which is the primary organ that C. albicans infects. Thus, 
we propose a model where loss of LRG1 results in Cek1 over-activation, which 
further leads to more β (1,3)-glucan exposure, and the cell wall remodeling 
increases immune detection within the host and results in more rapid immune 
clearance.  
Chapter IV described the genetic mechanisms responsible for the 
modulation of Cek1 activation on β (1,3)-glucan exposure in C. albicans. RNA-seq 
analysis was used to elucidate the whole genome transcriptional profiles regulated 
by activated Cek1 during β (1,3)-glucan unmasking. This strategy demonstrates 
that several cell wall associated genes are differentially manipulated 
transcriptionally when Cek1 is activated. Of interest, chitin production is 
significantly induced at the genetic level, e.g. CHS2, CHS3, CHS8 and PGA31 are 
upregulated. PGA31 is a chitin production-relevant gene [1]. Given the relationship 
of chitin hyper-production and (1,3)-glucan exposure [2], this implies that chitin 
levels might impact cell wall unmasking in the Cek1-overactivating mutant. Cek1 
downstream transcription factor Cph1 is also suggested to mediate cell wall 
dysfunction transcriptionally, as its transcript is induced significantly in the CEK1 
hyper-activating mutant. However, this is speculation and further research will be 
conducted to assess these hypotheses.  
 
Future direction 
To determine genetic target(s) downstream Cek1 causing β (1,3)-glucan 
exposure 
The work in this dissertation has described an entirely new physiological role of 
Cek1 activation in regulating cell wall architecture and the resultant 
immunomodulation. Cek1 disruption has already been proved to impact C. 
albicans cell wall structure by exposing polysaccharides including β (1,3)-glucan, 
β (1,2)-mannosides to their cognate immune receptors, and thus boost immune 
responses that aid in clearance of the pathogen more rapidly [3, 4]. In this 
168 
 
dissertation, we provide evidence that hyper-activated Cek1 is also able to cause 
cell wall structure problems, as evidenced by massive β (1,3)-glucan exposure, 
which causes induction of immune detection, as confirmed by in vitro cytokine 
secretion (Figure 2. 3 and Figure 3. 5), and efficient pathogen clearance as 
suggested by the in vivo mouse model (Figure 3. 6 and Figure 3. 7). These 
observations are quite interesting, but also raise some important questions, e.g. 
what major regulating factors are involved in mediating cell wall architecture 
defects driven by unbalanced Cek1 activity? Research is still underway to pinpoint 
the gene(s) causing β (1,3)-glucan exposure induced by Cek1 activation, but our 
transcriptome analysis does reveal a few potential targets (Figure 4. 4). Of 
particular interests, Cph1, a Cek1 downstream transcription factor, is induced ~9 
fold in the Cek1 activating mutant. Given the fact that the Cph1-overexpressing 
mutant exhibits pseuodohyphal structure under yeast-condition (cultured in YPD 
liquid at 30°C), and filaments have more β (1,3)-glucan exposure naturally [5, 6], it 
seems likely that the increased cell wall unmasking induced by Cek1 overactivation 
under yeast condition results from the transcriptional regulation mediated by Cph1. 
To test this, a Cph1-overexpressing mutant would need to be created to evaluate 
its impact on β (1,3)-glucan exposure. Second, the hyphal glucan of C. albicans 
was reported to exhibit a unique biochemical structure, which has “cyclical chain” 
architecture and an unexpected 2,3-linkage [6]. While the structural significance of 
the cyclical chain is not fully understood, it was speculated that this might be 
partially responsible for higher levels of cell wall unmasking. We hypothesize that 
the β (1,3)-glucan structure under the yeast condition when Cek1 is hyperactivated 
is transitioned to the hyphal β (1,3)-glucan structure. This can be determined by 
using nuclear magnetic resonance (NMR) and gas chromatography–mass 
spectrometry (GC-MS), and this work can be achieved potentially by collaboration 
with Dr. Michael Kruppa at East Tennessee State University.  
It was reported that C. albicans hyphae damaged by neutrophils exhibit 
increased β (1,3)-glucan, and this is mediated through delocalized CHS3 [2]. There 
is also a correlation between chitin overproduction and β (1,3)-glucan unmasking 
[7, 8]. Based on this, it seems likely that several transcriptionally up-regulated chitin 
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synthases might impact cell wall structure when Cek1 is hyperactivated. To 
address this speculation, it is necessary to perform genetic analysis by 
overexpression of those targets individually independent of Cek1. The level of β 
(1,3)-glucan exposure would be assessed by performing immunofluorescent 
staining with anti- β (1,3)-glucan antibody. If individual mutation results in mild but 
not significant increased unmasking, it is possibly that these proteins need to be 
together to have a synergistic effect. To test this possibility, we can try to 
overexpress those targets together (Chs2, Chs3 and Chs8) in wild-type, and the 
immunofluorescent assay would be performed to evaluate the impact on cell wall 
exposure. Second, the endo-β (1,3)-glucanase (Eng1) was determined to enhance 
the virulence of fungal pathogen H. capsulatum by removing surface-exposed β 
(1,3)-glucan from immune detection [9]. The transcript of C. albicans ENG1 
homolog is down-regulated by 2-fold when Cek1 is hyperactivated (Figure 4. 4 and 
Table 4. 1). Although CaEng1 is primarily responsible for cell separation during 
budding [10], we cannot rule out the possibility that it might also impact β (1,3)-
glucan structure as HcEng1 does. To assess this, it is necessary to quantify the 
level of β (1,3)-glucan exposure between the ENG1 disrupted mutant vs. wildtype.  
 
To identify signals involved in caspofungin-driven β (1,3)-glucan exposure  
Caspofungin is a well-known fungicidal drug with the mechanism of inhibiting β 
(1,3)-glucan biosynthesis. It also exposes this polysaccharide to the surface and 
therefore facilitates immune detection even at a sub-lethal concentration. 
However, the direct mechanisms by which cell wall structure is disordered by 
caspofungin treatment are unclear. Our results imply that the Cek1 signaling 
cascade is one signaling pathway responding to casponfugin. This was suggested 
by hyperactivation of Cek1 when incubated with caspofungin at ½ MIC, and the 
induction gets more pronounced over time (Figure 4.5). This is promising as it 
reveals one potential target leading to β (1,3)-glucan exposure induced by 
caspofungin. Future work can be done to evaluate if two downstream transcription 




Of interest, a genome-wide expression profile based on a microarray assay 
reveals that after Candida cells are exposed to ½ MIC of caspofugin for 3 hours, 
480 gene were found to be regulated in response to the drug, and 3% of the genes 
are involved in cell wall maintenance [11]. Several targets overlap with our RNA-
Seq data when Cek1 is hyperactivated, e.g. CRH11, PHR1, and KRE1 whose 
transcripts are upregulated, while SCW11 and ENG1 are down-regulated in both 
studies. Moreover, Xu et al. studied the in vivo response to caspofungin, where the 
fungal gene expression profile was measured 2hr after drug administration in mice 
that had already been infected by C. albicans for 24hr. 12 genes were found to be 
induced that are enriched for cell wall or secreted proteins, particularly of GCA2, 
PGA13, PGA31, PIR1 and RBR2 were also found in our RNA-Seq data when Cek1 
is hyperactivated. This highlights the significance of the Cek1 hyperactivation in 
restructuring the cell wall architecture in response to caspofungin. The 
abovementioned targets would need to be manipulated genetically in a wild-type 
background based on their expression profile. For instance, the individual deletion 
mutant would be made for those displaying upregulated transcripts in both 
caspofungin treatment and Cek1 overactivation situations. Further research would 
assess if the mutant rescues cell wall β (1,3)-glucan exposure after being exposed 
to caspofungin.  
 Several other signaling proteins are known to be responsive to caspofungin 
treatment, e.g. Mkc1, and Hog1 MAPKs. Therefore, it would be necessary to assay 
the rescue effect of the HOG1 or MKC1 disrupted mutant on β (1,3)-glucan 
exposure when induced by caspofungin. However, if none of those targets are 
involved in the caspofungin-driven β (1,3)-exposure, we would set off an extensive 
screen on the deletion mutant library on hand with ~700 nonessential gene 
mutants. The goal is to find the genetic network that is responsible for cell wall re-




To disentangle signaling rewiring that involves GTPases and associated 
molecules 
The findings of this dissertation have provided a greater general understanding of 
signaling transduction/rewiring in pathogenic C. albicans. There are several 
unanticipated findings in Chapters II and III. For instance, Cdc42 activity was 
shown to be stimulated when PS synthase enzyme Cho1 was deleted (Figure 2. 
4). We originally hypothesized that Cdc42 activity might be down-regulated due to 
the delocalization of GFP-Cdc42 in the cho1Δ/Δ mutant (Figure 2. 5). This 
phenotype was also seen in the model yeast S. cerevisiae where loss of Cho1 
delocalizes Cdc42 from polarized growth site to an internal membrane [12]. 
However, an in vitro study in S. cerevisiae showed that PS stimulates the GAP 
activity for ScCdc42, suggesting that loss of PS has less stimulation on Cdc42 
GAP activity and thus results in the increased Cdc42 activity [13]. Likewise, the 
mechanisms through which Cdc42 activity is stimulated by CHO1 deletion in C. 
albicans could be investigated in a similar way in vitro. To do this, radio-labeled [γ-
32P] GTP-bound CaCdc42 needs to be incubated with PS, along with its GAPs, 
e.g. Rga1, or Rga2. The GTP hydrolysis would then be assayed by measuring the 
radioactivity of [γ-32P] GTP-bound Cdc42 after incubation. Some other 
phospholipids such as phosphatidylethanolamine and phosphatidylinositol can be 
used as controls to assess if the stimulation effect on Cdc42 GAPs activity is PS-
dependent. Moreover, other GTPase GAPs, e.g. Sac7 as GAP for Rho1, can also 
be assayed to evaluate if PS is a universal inhibitor on GAPs.   
In Chapter III, Lrg1 inhibits GTPases Cdc42 and Ras1 activity in vivo (Figure 
3. 3), even though Lrg1 was originally suggested to act as a Rho1 activity repressor 
in this organism [14]. Research would demonstrate if Lrg1 functions as GAP for 
Cdc42, Ras1 and/or Rho1 by performing in vitro GTPases assay. In this 
experiment, Lrg1 protein will be incubated with [γ-32P] GTP-bound GTPases, and 
the radioactivity of [γ-32P] GTP-bound GTPases after incubation will be measured. 
To analyze if the CaLrg1 GAP homolog domain (representing amino acids 1183-
1375) exhibits true GAP activity, genetic manipulation will delete the rhoGAP 
domain and the inhibition on GTPase activity of Cdc42 or Ras1 by the 
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lrg1ΔrhoGAP mutant will be analyzed via biochemical assay in vitro as 
abovementioned. Furthermore, we found that hyper-activated Ras1 does not 
induce Cek1 phosphorylation (Figure 3. 3), although the epistasis evidence 
suggests Ras1 acts upstream of Cek1 [15].  
 
To explore the roles of Lrg1 in regulating C. albicans cell wall architecture 
Besides acting as a rho-GAP, Lrg1 has been shown to impact cell polarity, cell 
fusion, Mkc1 MAPK activity and β (1,3)-glucan biosynthesis etc. in S. cerevisiae 
[16, 17]. In N. crassa, LRG1 have also been studied and suggested to regulate 
polar tip growth [18]. In contrast, little is known about the function of Lrg1 in the 
pathogenic C. albicans. It was described that Lrg1 negatively controls filamentation 
in this organism [14]. In this dissertation, we further elaborated that CaLrg1 
controls β (1,3)-glucan exposure by negatively regulating Cek1 MAPK cascade, 
and the lrg1Δ/Δ mutant displays higher immunogenicity suggested by stronger pro-
inflammatory cytokines production from murine macrophages (Figure 3. 1, Figure 
3. 2, and Figure 3. 5). It seems likely that Lrg1 influences cell wall structure; 
however, questions remain regarding the mechanisms by which Lrg1 does so at 
the biochemical level. For instance, while loss of LRG1 induces β (1,3)-glucan 
exposure, we are not clear if it is due to a greater level β (1,3)-glucan being 
produced. Also, it is not clear if loss of LRG1 impacts chitin synthesis or localization 
in C. albicans, although it does so in N. crassa. Research can be done by staining 
Candida cells with aniline blue for β (1,3)-glucan and calcofluor white for chitin, 
respectively, to analyze their contents and localization. Moreover, it would be 
interesting to analyze the localization of Lrg1 in vivo by tagging it with GFP, and 
probe the deliver machinery of cell growth components, e.g. actin cytoskeleton 
simultaneously, which would help understand the correlation between Lrg1 
localization and new cell wall component deposition. Last, it was predicted by 
SMART.EMBL.DE that CaLrg1 contains two Zinc-binding LIM domains which 
generically help bind protein partners in eukaryotes; however, it not known how 
these two domains act specifically in C. albicans. It was suggested that NcLrg1 
contains three LIM domains which are required for localizing LRG1 to the growth 
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sites. It is possibly that these two domains act similarly in C. albicans, but research 
would need to be conducted by deleting these two LIM domains in CaLRG1, and 
localization of the mutated LRG1 can be assessed by tagging with GFP.  
 
To elaborate the mechanisms by which β (1,3)-glucan exposure impacts 
fungal virulence in vivo 
As described in Figure 3. 6 we determined that increased β (1,3)-glucan exposure 
seems to compromise fungal virulence, as evidenced by significantly longer mouse 
survival rates and faster pathogen clearance in mouse kidneys. This suggests that 
the phenotype of β (1,3)-glucan exposure is immunologically relevant. To 
demonstrate if the enhanced killing ability in vivo is due to higher levels of 
unmasked β (1,3)-glucan exhibited from the Cek1-hyperactivating mutant, ex vivo 
staining by using anti-β (1,3)-glucan antibody on homogenized tissues, e.g. kidney, 
liver would need to be done. Moreover, immune cell recruitment and cytokine 
profiles by flow cytometry are also necessary to demonstrate if immune responses 
are boosted in response to the exposed β (1,3)-glucan. This work can be achieved 
potentially through collaboration with Dr. Sparer, whose lab has established the 
techniques at the Microbiology Department at UT. Finally, it is valuable to evaluate 
if the enhanced immune responses are dependent on Dectin-1 and this can be 
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